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ABSTRACT
Infection of susceptible cells with foot and mouth disease virus (FMDV) results in 
multiplication of the RNA genome and assembly of mature virions. The entire 
process of genome replication is completed in a few hours and encompasses many 
intiacellular events. Like other picornaviruses, FMDV uses a peptide primed RNA 
replication mechanism. The factors that are required to uridylylate each of the three 
FMDV VPg peptides and the role of the FMDV cis-acting replication element (ere) 
or 3B Uridylylation Site (bus) in VPg uridylylation have been determined. The 
native N-terminus of the FMDV 3Dpol enzyme is a pre-requisite for VPg 
uridylylation in viti*o and the effects of mutations in the RNA template are consistent 
with a slide-back mechanism. The role of the poly(A) tail in uridylylating VPg was 
insignificant using full-length FMDV RNA tianscripts suggesting the possibility of 
an alternative mechanism of VPg incorporation into negative strand RNA. The 
optimal RNA sequences required for VPg uridylylation were found to be within the 
5’ non-coding region (NCR). Furtheraiore, the results also showed evidence for 
RNA-RNA interactions between distinct structures hom within the 5’ NCR that 
influence VPg uridylylation.. The polymerase precursor 3CDpro is also a 
prerequisite for uridylylation of each of the FMDV VPg peptides. However 3Cpro 
alone can substitute for 3CD, but is much less efficient. It also appeared that the 
overall charge of the VPg peptides determines their recognition by the FMDV 
3Dpol. The RNA binding activity of the 3C was found to be required for its 
stimulatory effects on VPg uridylylation. Unlike the poliovirus cloverleaf, the 
FMDV S-fragment (at the 5’ end of the genome) does not interact with the FMDV 
3CD precursor protein; however it binds specifically to a cellulai’ factor p48. The 
cmde replication complexes (CRCs) isolated horn FMDV-infected cells were found 
to synthesize viral RNA very efficiently and an in vitio RNA replication system 
developed using these CRCs can be used to study the complete RNA replication 
events of FMDV.
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1.1 Picornaviruses
Picornaviruses constitute one of the most important groups of animal and human 
pathogens. They are among the smallest of vimses measuring 22 to 30 nm in size. 
Picornaviruses infect a broad range of hosts and produce a variety of disease 
symptoms. Foot-and-mouth disease virus (FMDV), the first animal vims to be 
discovered (Loeffler and Frosch, 1897) and Poliovirus (PV), one of the most 
important human pathogens, both belong to the family Picornaviridae. Based upon 
the physical properties and nucleotide sequence, the Picornaviridae family has been 
sub divided into nine genera: Enterovirus, Rhinovirus, Cardiovirus, Aphthovirus, 
Hepatovirus, Parechovirus, Erbovirus, Teschovirus and Kobuvirus (Fauquet et al., 
2005). The genomes of picornavimses are positive sense single-stranded RNAs of 
about 7500 nucleotides and are infectious (Baltimore 1969; Belsham and Bostock 
1988). They have distinct but similar genome organisations and follow similar 
replication strategies. Picornaviruses replicate in the cytoplasm of infected cells and 
the genome directly acts as a messenger RNA to produce the viral proteins required 
for RNA replication and virion assembly,
1.2 Foot and mouth disease virus (FMDV)
Foot-and-mouth disease virus (FMDV) causes one of the most important diseases of 
farm animals. It is the prototype aphthovirus and infects a broad range of cloven 
footed domestic and wild anhnals including cattle, sheep, goat, pig, deer etc. Cattle 
and pigs infected with the vims shows severe clinical manifestation of the disease
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whereas symptoms are often sub-clinical in sheep and goats. The replication strategy 
of the virus resembles that of other picornavimses. However certain distinct features 
like its broad host range and presence of three distinct copies of the genome 
linked protein VPg makes FMDV unique among the picornavimses. It is interesting 
to note that even equine rhinitis A vims (ERAV), the other member of the genus 
aphthovims only possesses a single copy of VPg. The recent outbreak of foot and 
mouth disease in the UK (2001) caused tremendous economic losses of about £8 
billion due to slaughter of all those infected animals and the severe trade restriction 
imposed on countries with the disease. At present some of the factors like poor 
understanding of the replication mechanism of the vims, broad host range, high 
infectivity, diverse antigenicity and limited efficacy of the cuirently available 
vaccine make it imperative for continued research and understanding of the 
molecular biology of the virus.
1.2,1 Structure of foot-and-mouth disease virus
Foot-and-mouth disease virus is non-enveloped and has a capsid with an icosahedral 
symmetry. The capsid is composed of 60 copies of each of the viral capsid proteins 
VP1-VP4. VP1-VP3 constitute the outer surface; in contrast VP4 is completely 
internal. VP1-VP3 assume a fold that is conserved among RNA vimses and called 
the RNA virus fold (RVF). One of the important features of the FMDV capsid is 
that, it is devoid of pits and the canyon found in certain other picornavimses that acts 
as the anchoring point for receptor attachment (Luo et al., 1987; Hogle et al., 1985; 
Rossman et al., 1985; Acharya et al., 1989). In FMDV, the G-H loop (sparming 
residues 140-160 of VPl) is highly accessible on the smface and is the site of 
receptor binding on host cells (Leippert et al., 1997). A triplet of amino acid residues
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motif the Ai'g-gly-asp (RGD) within this loop interacts with the integrin receptor 
found on susceptible cells (Baxt and Becker., 1990). Mutation within the RGD motif 
prevents vims binding to cells and infectivity (Mason et a l, 1994). Furthermore 
vimses with a deletion in the RGD motif are attenuated in cattle and pigs (McKenna 
et al., 1995). The FMDV capsid possesses the highest buoyant density in CsCl 
amongst the picornavimses (Achaiya et al., 1989). The capsid is unstable in an acidic 
enviromnent, pH below 6.8 causes its dissociation into 12S pentameric subunits. In 
the case of PV and human rhinovims (HRV) the ^-barrel of VPl contains a 
hydrophobic pocket that accumulates a fatty-acid molecule called pocket factor. 
From a biological point of view, release of this pocket factor following vhus binding 
to receptors on host cells leads to an altered stmcture called the activated particle (A- 
particle) in which the VP4 is externalised and the viral RNA is released to the 
cytoplasm. The entire process is called uncoating. However FMDV does not assume 
any such intermediate stmcture like PV aird HRV for uncoating (Fry et al., 1999; 
Rueckert, 1996).
1.2,2 FMDV receptors
Foot and mouth disease vims preferentially infects epithelial cells of the host. This 
epitheliotropic nature is due to the affinity of the virus for integrin receptors found 
on the surface of these cells. Integrins are a family of iirtegral membrane anchored 
proteins which are heterodimers consisting of a and |3 subunits. They have important 
cellular functions including cell-cell and cell-matrix interactions in addition to 
transmitting signals in and out of the cells. Out of the different integrin complexes 
av(33, avp6, av(31 have been shown to act as FMDV receptors by binding to the 
RGD motif within VPl (Berinstein et al., 1995; Neff et a l, 1998; Jackson et a l,
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2000, 2002). Recent findings have shown that av(33 is predominantly found on 
endothelial cells rather than epithelial cells leading to the belief that avP6 is the true 
or primary receptor for FMDV rather than avp3 (Monaghan et al., 2005).
Besides using an integrin as a primary receptor for infection, certain tissue culture 
adapted viruses possess the affinity to bind heparan sulphate (HS) as an alternative 
receptor (Jackson et al., 1996; Sa-Carvalho et a l, 1997). This change in receptor 
specificity has been attributed to a net gain in positive charge on the outer capsid 
surface in tissue culture (Fry et a l, 1999). However viruses having higher affinity for 
heparan sulphate are attenuated in cattle (Sa-Carvalho et a l, 1997).
1.2.3 FMDV entry into cells
Having bound to the receptor on the cell surface, internalisation of the FMDV results 
fi'om endocytosis into early endosomes. The FMDV capsid is highly labile in the 
acidic environment of the endosome where protonation of a cluster of histidine 
residues at the pentamer boimdary leads to disassembly of the 12S pentameric 
subunits (van Vlijmen et a l, 1998) resulting in uncoating of tlie virus and by an 
unknown mechanism the release of the viral RNA to the cytoplasm. Pre-tieatment of 
the cells with certain lysomotropic ionophores like monensin and concanamycin-A 
increases the endosomal pH and prevents virus infection (Baxt 1987; Miller et a l, 
2001).
1.2.4 Genome organisation of FMDV
Foot and mouth disease virus RNA is about 8.4 kilo bases in length and directly acts 
as a messenger RNA for protein synthesis. Unlike cellular messenger RNA, the 5’ 
end is devoid of a modified nucleotide m^GpppN or the cap structure. Instead the 5’
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end is attached to a viral encoded short peptide 3BA/Pg. FMDV is different Rom 
other picornaviruses having three distinct copies of VPg which contain 23 or 24 
amino acids (Forss and Schaller 1982). The presence of tyiosine residue at position 
three of the VPg is absolutely conserved and is required for its linkage to the 5’ end 
of the genome. Both positive sense viral RNA and the antisense negative strand 
RNA are linked to one copy of VPg at the 5 ’ end suggesting a role of VPg in the 
RNA priming process during viral RNA replication. It is known that each VPg 
peptide can be linked to the viral RNA (King et al., 1980).
The foot and mouth disease virus genome begins with the 5’ untianslated region 
(UTR), and is separated Rom the 3’ untranslated region by a single large open 
reading Rame (FIG. 1.1). The FMDV 5’ UTR is about 1300nt in length and is the 
longest among the picornaviruses (Forss et al., 1984). It begins with a single long 
stem loop sRucture (about 3 7Ont) called the short Ragment or S-Ragment, which is 
followed by a 150-250 nt RNase T1-resistant ti'act that contains about 90% C 
residues called the poly(C) tract (Brown et al., 1974; Newton et al., 1985). To date 
no specific Rmction of the S Ragment has been investigated; however deletion of the 
S Ragment makes the RNA transcript non-infectious suggesting that this structure 
will have a role in virus RNA replication. The S-Ragment is believed to be the 
Rmctional counterpart of the cloverleaf RNA in PV and the highly base-paired nature 
of the S Ragment could prevent cellular exonuclease digestion of the viral RNA. 
Since VPg is cleaved soon after release of the viral RNA into the cytoplasm, there 
might be a role for the S-Ragment in providing stability to the FMDV RNA. The 
poly(C) tract has been implicated with virulence and pathogenesis of the virus 
(Harris and Brown 1977). However the presence of the polyC tr act is not absolutely
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FIG.1.1. Genome organisation of foot-and-mouth disease virus. Foot and mouth disease virus 
RNA is about 8.3 kb and contains three distinct regions. The 5’ non-coding region includes 
secondary structures namely S-fragment, poly(C) tract, pseudoknots (PKs), cis-acting replication 
element {cre/bus) and internal ribosome entry site (1RES). The coding region is translated into a 
single polypeptide that undergoes co-translational and post-translational cleavage to produce 4 
structural and 10 non-structural proteins. FMDV is unique in encoding three distinct copies of VPg. 
The 3 ’ non-coding region also contains regions of secondary structure including a lOOnt hetero­
polymeric tract and a poly(A) tail.
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required for virus propagation. Virus having only a 2‘C’ tract (C2) can be stably 
propagated in cell culture although the viruses have a higher particle:infectivity ratio 
compared to virus havmg longer polyC tracts (Rieder et al., 1993: Rieder and Mason 
unpublished data). It is also interesting to observe that vhus having a short polyC 
tract can rapidly acquire a longer polyC tract during propagation in cell culture 
indicating a selective advantage for maintaining a longer polyC tract in the genome 
for stable propagation. Though the exact role of the polyC tract is not yet Icnown, it 
has been hypothesised that the polyC binding protein (PCBP) a host cell protein that 
interacts with the clover leaf of the PV will also interact with the polyC tract of 
FMDV and might have a role in genome circularization as suggested for PV (Herold 
and Andino 2001). The FMDV polyC tract is followed by three to four pseudoknots 
(PKs) of unknown function. Recently a simple stem loop stnrctme has been 
identified just downstr eam of the PKs called a cis-acting replication element or ere 
(Mason et al., 2002) which has been implicated in genome replication. Unlike 
FMDV, other picornaviruses possess a ere structure in the polyprotein coding region 
instead of the 5’ untranslated region (this will be described in more detailed later). 
The 3’ end of the 5’ untranslated region contains a well characterised stmcture (~ 
450 nt) called the internal ribosome entry site (1RES) that directs the initiation of 
cap-independent translation of viral protein synthesis (Belsham and Brangwyn 
1990).
The FMDV RNA contains a single open reading frame that encodes a polypeptide 
of approximately 260 kDa and separates the 5’ UTR from the 3’ UTR. The 3’ UTR 
resembles that of cellular messenger RNA, which consists of a short heteropolymeric 
tract of about 100 nt that fold into secondary structures followed by a polyA tail.
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1.2.5 FMDV RNA translation
Following virus entry into a host cell, the viral RNA is released to the cytoplasm by 
means of capsid dissociation. Subsequently the VPg protein at the 5’ end of the RNA 
is cleaved by a eukaryotic cellular enzyme called VPg unlinkase (Gulevich et al., 
2002). This leaves the 5’ terminal of the viral RNA beginning with two uridine 
residues (UU) an important feature requhed for picomavirus RNA replication. Any 
change at the 5’ teiminal UU can abrogate viral RNA replication in a cell free 
system (Herold and Andino 2000). Though it seems beneficial for the virus to have a 
free 5’ end for vhal RNA rephcation, at the same time translation needs to be 
initiated for synthesis of viral proteins required for RNA replication and virion 
assembly. Translation of most cellular mRNA requires the m^G cap stiucture found 
attached to the 5’ end of the RNA. However, the absence of any such stiucture at the 
5’ end of the picomaviral RNA necessitates the use of an alternate mechanism for 
the initiation of viral protein synthesis. In FMDV, the 3’ portion of the 5’ 
untranslated region contains a specialised region of secondary stiucture of about 450 
nt where the ribosome lands for internal initiation of protein synthesis. This is called 
an internal ribosome entry site (Belsham and Brangwyn 1990; Belsham and Jackson 
2000). It has been demonstrated that FMDV uses two AUG initiation codons (84 nt 
apart) for RNA translation thereby producing two forms of Leader protease Lab and 
Lb respectively (Belsham 1992). It has been demonstrated that Lb start site is 
required for vhus infectivity while the Lab site can be removed (Cao et al., 1995; 
Piccone et al., 1995a). The FMDV 1RES along with the encephalomyocarditis virus 
(EMCV) 1RES comprise the group II of 1RES element which flmction efficiently in 
rabbit reticulocyte lysates in vitro (Belsham and Jackson 2000). At the early stage of 
infection the leader protease brings about the cleavage of the eukaryotic translation
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initiation factor eIF4G a scaffold component of the cap binding complex (eIF4F) 
and thereby inhibits cap-dependent protein synthesis (Devaney et ah, 1988; Medina 
et a l, 1993; Belsham et a l, 2000). Except for eIF4E, the FMDV 1RES essentially 
requires all the canonical tianslation initiation factors (including the C-terminal 
cleavage fragment of the eIF4G) for its activity (Filipenko et a l, 2000). In addition 
picomavirus 1RES elements also require tissue specific cellular factors for efficient 
1RES dependent tianslation (Belsham and Sonenberg 2000). Cellular factors like 
polypyi'imidine tiact binding protein (PTB), La protein and poly(rC) binding protein 
(PCBP2) are required for efficient PV 1RES dependant translation (Gosert et 
a l ,2000; Craig et a l, 1997; Blyn et a l, 1997). It has been demonstrated that FMDV 
requires PTB and ITAF45 for its activity in vitro (Luz and Beck 1991; Niepmann et 
a l, 1997; Filipenko et a l, 2000).
1.2.6 Polyprotein processing and mature virus production
During a picomavims infection in cells, the factors requhed for successful infection 
and progeny vims production are produced fiom the polyprotein. Under normal 
conditions the polyprotein corresponding to the entire open reading fiame is never 
observed in the cells. As the polyprotein is synthesized it is cotianslationally and 
post-tianslationally cleaved by viral encoded proteinases to produce mature and 
precursor proteins to serve specific functions in the vhus life cycle (FIG. 1.2). The 
polyprotein has been characterised to contain three distinct domains based on 
functionality. The PI region codes for viral proteins VP4, VP2, VP3 and VPl which 
are required for capsid assembly and hence is called the stmctural domain. The 
remainder of the polyprotein is divided into P2 and P3 regions which are known as 
replicative domains for their role in RNA replication.
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In poliovirus the entire stmctural domain is efficiently cleaved by the action of the 
3CDpro with the help of a cellular factor/chaperone (Blair et aL, 1993). Though 
3Cpro can carry out this function, 3CDpro has been characterised to be 100-1000 
times more efficient than the 3Cpro (Parsley et al., 1999). Initial processing of the PI 
region leads to appearance of VP0(VP4+VP2), VP3 and VPl. Subsequently VPO, 
VP3 and VPl assemble to form 5S protomers. Five individual protomers combine to 
form 14S pentamers. Assembly of the 150S provirion can take place by two different 
pathway; a) in the absence of poliovims RNA 12 pentamers can assemble to form an 
80S procapsid into which a single RNA is finally threaded to form I50S provirions, 
or b) in the presence of vhion RNA individual pentamers assemble themselves with 
the viral RNA to form the 150S provirion. This 150S provirion is short lived and 
undergoes a final maturational cleavage by an unknown mechanism in which VPO is 
cleaved to VP4 and VP2 to form the mature virion (Ainold et al., 1987).
Within the family Picornaviridae, both aphthovimses and cardiovimses encode 
leader proteins (L) at the N-terminus of the polyprotein, hi FMDV the leader protein 
is a protease and cleaves itself fiom the polyprotein (at the L/PI junction) as the 
primary cleavage event in polyprotein processing. In addition in FMDV, the L 
protease plays an important role in host cell protein synthesis shut-off (Strebel and 
Beck 1986; Devaney et al., 1988; Medina et al., 1993; Belsham et al., 2000). In 
cardiovhiises L protein does not possesses any detectable protease activity and is 
cleaved fiom the PI precursor by the action of the 3Cpro (Parks et al., 1986).In 
contrast, in enteroviruses and rhinovirTises cleavage at the P1/P2 junction (which 
takes place in cis at the N-terminus of the 2A) is the primary cleavage event and is 
carried out by the 2A protease. In aphthovirus and cardiovirus 2A mediated cleavage
10
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takes place at the 2A/2B junction that leads to the foimation of P I-2A and L-P1-2A 
precursors respectively instead of PI precursor alone (Gmbman and Baxt 1982). 
Subsequently 2A is separated from the PI by the action of 3Cpro in FMDV (Ryan et 
al., 1989). In all picomaviruses the rest of the polyprotein processing is carried out 
by the 3Cpro and its precursor 3CDpro. In poliovnnis 3CDpro is the major protease 
that carries out the majority of the polyprotein processing, in contrast 3Cpro in 
FMDV is sufficient to carry out ahnost all the polyprotein processing (Parsley et al., 
1999; Bablanian and Gnibman, 1993; Grubman and Baxt 2004). The P2 non- 
structural domain in enteroviruses and rhinovirnrses is processed into three mature 
proteins 2A, 2B and 2C whereas the P3 non-structural domain is processed mto 3A, 
3B, 3C and 3D.
1.2.7 Switching from translation to replication
In picomavirus infected cells viral protein synthesis occurs on rough endoplasmic 
reticulum (rER) derived membranes on polyribosomes (Caliguiri and Tamm 1969). 
This leads to the fonnation of multiple copies of the viral polyprotein and post- 
translational cleavage by viral proteases 2A, 3C and 3 CD to produce the structural 
and non-structural proteins along with various precursor polypeptides (Kitamura et 
al., 1981; Nicklin et al., 1987; Pahnenberg 1990). At some stage of the picomavims 
life cycle the translation of the viral RNA needs to be switched off so that the RNA 
can act as a template for negative strand synthesis. It has been reported that the vhal 
proteins are synthesized in PV infected cells for several hours after RNA replication 
has started (Levintow 1974). Thus it appears that the entire translating apparatus on 
viral RNA need not be switched off for RNA replication as there is interdependence 
of viral RNA translation and replication. The switch from translation to replication to
12
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synthesize negative stiand could occui' on a single RNA molecule and may then be 
followed by multiple rounds of positive strand RNA synthesis. It is interesting to 
note that in PV and may be in some other picomaviruses; proteins involved in RNA 
replication are required in cis (Novak and Kirkegaard 1994) thereby providing a 
partial check on genome functionality. In principle there is a potential conflict 
between the RNA translation and RNA replication machinery. During RNA 
replication the polymerase enzyme moves from 3’ to 5’ end whereas the ribosome 
during translation proceeds in a 5' to 3' direction. Evidence has been presented that 
the translating ribosome inhibits negative strand synthesis (Gamamik and Andino 
1998; Barton et al., 1999). Dmgs like cyclohexamide (CHI) inhibit polypeptide 
chain elongation and freeze the ribosome on the vfral RNA template and prevent 
normal clearance of the ribosome. Such blocked RNA templates do not support 
negative strand synthesis (Gamamik and Andino 1998; Barton et al., 1999) 
suggesting the polymerase of the poliovims can not dislodge the translating 
ribosome from viral RNA template. This necessitates the blockage of translation to 
allow switching of the viral RNA from translation to replication. Therefore there 
must be critical interplay between the tianslation and replication machinery on the 
same RNA molecule so that they do not collide with each other. One of the 
intiiguing features of picomaviral RNA rephcation is the RNA dependent RNA 
polymerase (3Dpol) should be delivered on the same RNA molecule from where it 
has been synthesized (Novak and Kirkegaard 1994). This suggests there must be 
some specific cis-signal associated with the genomic RNA, excluding the polyA 
sequence at the 3 ’ end that allows the viral polymerase to recognise cis-RNA rather 
than other viral RNA and cellular mRNA.
13
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Switching from tianslation of viral RNA to RNA replication necessitates the 
production of all proteins required for replication in sufficient quantities. It has been 
proposed that the concentration of the viral protein 3 CD, the precursor of RNA 
polymerase is critical for this switching (Gamamik and Andino 1998). Once the 
level of 3 CD reaches a critical level it may bind to the stem-loop D of the cloverleaf 
RNA and repress vhal RNA translation. That process could promote negative strand 
RNA synthesis, indeed it has been obseiwed that supplying an excess o f 3 CD in trans 
specifically inhibits viral translation. However, subsequent work suggested that this 
mechanism may not be totally tme. It has been found that binding of the 3CD to the 
cloverleaf RNA increases the cloverleaf s affinity for the cellular transacting factor 
PCBP-2 (Walter et al., 2002). PCBP-2 is functionally required for poliovirus 
translation and binds to stem loop IV of the 1RES during this process. Thus, it was 
suggested that upon binding of 3CD to the 5’ cloverleaf stmcture, PCBP-2 might 
preferentially bind at the cloverleaf structme and dissociate from the 1RES 
(Gamamik and Andino 1998). Dissociation of PCBP-2 from the 1RES would have 
the effect of inhibiting translation, thereby allowing the synthesis of negative strand 
to proceed. The reverse could be achieved when the 3 CD protein has been cleaved 
into its components, 3C and 3D. These proteins have a very low affinity for the 
cloverleaf stmcture, thus freeing PCBP-2 to bind stem loop IV of the poliovims 
1RES (Andino et al., 1993). However it is now believed that the amount of PCBP-2 
available within the cell may be sufficient to bind to both sites on the poliovhus 
genome. Thus, the model suggested earlier, which relies on PCBP-2 dissociation 
fiom the 1RES is unlikely to be the mechanism by which vimses switch between 
translation and replication of their genomes (Gamamik and Andino 2000). However, 
the concentration of PCBP-2 in the area of the cell where viral translation and
14
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replication takes place has not yet been determined. Demonstration that the local 
concentration of PCBP-2 is sufficient to bind to the 1RES and the 5’ cloverleaf 
structure simultaneously is required before this model can be totally disregarded 
(Gamamik and Andino 2000). Recently polypyi'imidine tract binding protein (PTB) 
has also been implicated to be involved in molecular switching fi'om translation to 
RNA replication. PTB or PTBl has been reported to occur in three different isoforms 
(PTBl, PTB2 and PTB4) (Michael et al., 1995). Dr*ugs like actinomycin D that 
inhibit cellular tr anscription lead to partial redistribution of PTB from the nucleus to 
the cytoplasm (Back et al., 2002). Though PTB predominantly remains inside the 
nucleus (Perez et al., 1997; Romanelli et al., 1997) during PV infection similar 
distribution takes place between the nucleus and cytoplasm (Back et al., 2002). PTB 
has four RNA recognition motifs (RRM), out of which the first two fbr-m the N- 
terminal segment that are required for interaction with other cellular proteins like 
PCBP2, hnRNP K, hnRNP L also to PTB itself (Hahm et al., 1998; Khn et al., 
2000). The C-ter-minal domain that includes the other two RRMs interacts with the 
1RES during translation. PV 3Cpro and/or 3CDpro cleaves all three isofoims of PTB 
which are required for 1RES dependent translation (Gosert et al., 2000). At the early 
stage of PV infection both PTB and PCBP2 facilitate the translation of PV RNA. 
PTB has been shown to interact with PCBP2 via RRMl and RRM2 (Kim et al 2000) 
and with the PV 1RES by RRM3 and RRM4 (Oh et al,, 1998; Hellen et al., 1993) 
and it has been suggested that PTB stabilises the binding of PCBP2 to the 1RES. 
Cleavage of PTB during the late stage of infection with 3Cpro and/or 3CDpro leads 
to localisation of the N-terminal segment in the cytoplasm and the C-terminal 
segment of the PTB remains attached to the 1RES (Back et al., 2002). This results in 
a decrease of intact PTB attached to 1RES and thereby causes the dissociation of
15
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PCBP2 from the 1RES as the binding domam of the PTB for PCBP2 is not present in 
the C-terminal fragment. In addition the presence of the C-terminal fr agment of PTB 
on the 1RES may produce a dominant negative effect by preventing the binding of 
intact PTB and thus reducing the affinity of the PCBP2 for the 1RES. Disconnection 
of the PTB and PCBP2 from the 1RES might facilitate the association of the PCBP2 
with the RNA-protein ternary complex formed at the cloverleaf (CL) along with the 
3CDpro of the PV and cause repression of translation and molecular switching to 
negative strand synthesis. The N-terminal segment of PTB might also be involved in 
repressing translation by sequestering other RNA binding protein like PCBP2, 
hnRNP K, hnRNP L which are known to interact with it (Back et al., 2002).
1.3 Picomavirus RNA replication mechanism
All picomavirus RNA replication follows a similar strategy, the viral genome is first 
transcribed into a complementary RNA (negative strand), which in tmn is used as a 
template for multiple rounds of syntliesis of new positive sense progeny genomes 
(FIG. 1.3 and FIG. 1.4A). For both these processes the RNA dependent RNA 
polymerase (3D °^*) plays a central role. The 3’ terminus of the positive-sense RNA 
(the poly(A) tail) and the negative-sense RNA template (antisense cloverleaf or S- 
fragment) are very different in sequence. Thus, the nature of the recognition process 
by the RNA polymerase must be complex but is not currently defined. However for 
this process to occur the polymerase enzyme needs a protein primer. The viral protein 
3B (VPg) serves this role, it must firstly be uridylylated to form VPgpUpU followed 
by template dependent elongation by the polymerase enzyme (FIG. 1.3). This reaction 
can be reproduced in-vitr o by using polyA or the cis-acting rephcation element (ere),
16
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FIG. 1.3. VPg uridylylation during positive strand synthesis involves a slide-back mechanism.
In poliovirus it has been suggested that 3Dpol catalyses the linkage o f  the first ‘U ’ residue to VPg 
to form VPgpU using the first ‘A ’ residue o f  the conserved AAACA motif as a template. In the 
subsequent step there is a slide back o f  the VPgpU to hydrogen bond with second ‘A’ residue.
In the next step addition o f  the second ‘U ’ residue takes place to form VPgpUpU using the first 
‘A ’ as template nucleotide.
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a small stem-loop structure as template (Paul et al., 1998). The role of the ere will be 
discussed in detail further below. Genetic studies have revealed the requirement of 
several non-stmctural proteins for the process of RNA synthesis (Kirkegaard 1992; Li 
and Baltimore 1988; Giachetti and Semler 1991; Burns et al., 1989). Furthermore for 
poliovirus RNA synthesis to occur the formation of a ternary ribonucleoprotein 
(RNP) complex is necessary in which viral proteins as well as host proteins are 
involved (Andino et al., 1993; Andino et al., 1990; Hanis et al., 1994; Herold and 
Andino 2001).
1.3.1 Genome circularization model for poliovirus RNA replication
An open question concerning the replication of RNA viruses is how the same viral 
replication machinery can initiate RNA synthesis from both positive and negative 
strands, considering they cany very different cis-acting elements. It is also intriguing 
that specific binding of the viral polymerase precursor (3CD) to die 5’-end of the 
RNA genome is required for the negative-strand RNA synthesis (Barton et al., 2001; 
Gamamik and Andino 1998; Herold and Andino 2001), given that initiation of 
negative-strand synthesis takes place at the opposite end of the genomic RNA. 
Clearly, successful initiation of negative-strand RNA synthesis depends on the 
specific recognition of the viral RNA as a template as well as the point of initiation 
for replication. The negative-strand synthesis of poliovirus is initiated within the 
poly(A)-tail of the genomic RNA (Herold and Andino 2001). Thus, the poliovims 
poly(A)-tail is an important cis-acting element for RNA replication and removal or 
shortening of the poly(A)-tail results in impaired RNA replication (Barton et al., 
1996; Sarnow 1989; Spector et al., 1975). This observation may reflect modification 
of the stability of the RNA or possibly a requirement for interactions between the 3’
18
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FIG. 1.4A. Linear solid bar depiction of replication mechanism in poliovirus
The polyA tail at the 3 ’ end of the poliovirus genome is considered to be an important cis acting 
RNA element required for the negative strand synthesis. For initiation of negative strand synthesis, 
the BDpol enzyme uridylylates VPg to form VPgpUpU possibly using polyA tail as a template. 
Subsequently the negative strand acts as a template for multiple round of positive strand synthesis. 
This process is highly asymmetric since the replication machinery favours an overwhelming 
proportion of positive strand synthesis against the negative strands. As a consequence during the 
virus life cycle more than 95% of the RNA that accumulates in the cytoplasm of the infected cells 
constitutes the positive strands. For initiation of positive strand synthesis 3Dpol uridydylates VPg 
by a slide-back mechanism using the cre/bus as a template.
FIG. 1.4B. Genome circularization model for poliovirus RNA replication. In poliovirus 
RNA replication, negative strand RNA synthesis initiates with the formation of a ternary 
ribo-nucleo protein complex at the 5’ end of the genome. The cloverleaf binds to viral proteinase 
3CD and cellular polyC binding protein (PCBP). PolyA binding protein (PABP) forms a 
RNA-protein complex with the polyA tail at the 3 ' end of the genome. PABP and PCBP forms 
a protein-protein complex, as a result genome circularization takes place via a 
RNA-protein-protein-RNA bridge.
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and 5’ teimini of the RNA potentially involving the poly(A) binding protein (PABP) 
which binds optimally to a sequence of at least 25 ‘A’ residues. However, the 
poly(A)-tail cannot be the only cis-acting element that specifically ensures replication 
of the viral RNA, as all cellular mRNAs contain poly(A) tails. Cw-acting elements at 
the 5’ end of the genome are also required for initiation of negative sb and synthesis 
(Barton et al., 2001, Herold and Andino 2001). Furtheimore, it appears that the 
opposite ends of the viral genome interact with each other through a protein-protein 
bridge (Herold and Andino 2001). The vhal 3CD binds to the 5’-end of the genomic 
RNA and reaches its site of action within the poly(A)-tail of the genome via 
chcularization of the genomic RNA using an RNA-protein-protein-RNA-bridge that 
involves at least two cellular factors, PCBP and PABPl (FIG. 1.4.B).These results 
explain the requirement for a long poly(A)-tail in RNA replication and reveal a dhect 
role for the 3CD binding to the cloverleaf in negative-strand RNA synthesis. 
Currently, no protein interactions with the FMDV S-fiagment have been identified. 
However, if  the S-fiagment does exist in a stable stem-loop stmcture, as predicted, 
then the 5’ end of the RNA would be close to the poly(C) tract which is likely to be 
bound to the poly(rC) binding protein, potentially achieving the same effect as 
proposed for the PV cloverleaf (Belsham and Martinez-Salas 2004).The fonnation of 
a circular genomic stmcture by interaction of the 5’- and 3’-ends may be a general 
mechanism by which positive-stranded RNA vimses initiate their replication.
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1.4. Role of the non-structural proteins in RNA replication
The non-stnictui'al proteins of picomaviruses carry out the necessary host cell 
modifications required for viral RNA synthesis and ultimately progeny vhus 
production. Proteins of the P2 non-structural domain are responsible for 
moiphological and biochemical changes associated with virus replication, that 
include inhibition of host cell transcription and translation (for enterovimses and 
rhinoviruses), active remodelling of the cellular cytoskeleton and vesicular 
membrane stmctuie, inhibition of protein secretion and also nucleocytolasmic 
ti’ansport. Proteins from the P3 non-stmctural domains along with some precursors 
are physically involved in RNA replication. The roles of these non-stiuctural 
proteins in the vims life cycle are summarized in Tab le-1.
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Non-structural
proteins
Functions
2Apro
Poliovims
Host cell protein synthesis shut off (Etchison et al., 1982)
Polyprotein processing
Apoptotic cell death (Goldstaub et al., 2000)
FMDV
Part of the P I-2A precursor (Ryan et al., 1999)
2B
Poliovirus
Blocks protein secretion (Doedens et al., 1997)
Cell permealisation (van Kuppeveid et al., 1997)
FMDV
Membrane association
Does not block protein secretion (M offat et al., 2005)
2C
Poliovirus
ATPase and GTPase activity (Rodriguez and 
Carrasco 1993)
RNA binding activity (Banerjee et al., 1997) 
Negative strand synthesis (Bienz et al., 1980) 
Increases intracellular Ca^ "^
Guanidine resistance
Regulatory effects on proteolytic activities 
of 2A and 3C (Banerjee et al., 2004)
FMDV
Guanidine resistance (Saunder and King 1982)
2BC
Poliovirus
Membrane alteration
ATPase activity (Pfister and W im m er 1999)
FMDV
Blocks protein secretion (M offat et ai., 2005)
3A
Poliovirus
RNA replication
Membrane association
Blocks protein secretion (Doedens et al., 1997)
Recruits 3Dpol to replication complex (Datta and
Dasgupta 1994)
Brefeldin resistance (Crotty et al., 2004)
FMDV
Membrane association (Moffat et al., 2005) 
Pathogenesis (Pacheco et al., 2003)
Host range and virulence (Nunez et al., 2001)
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3AB
Poliovirus
Membrane association (Datta and Dasgupta 1994) 
RNA replication
Binds to cloverleaf (H arris et al., 1994)
Binds to 3’UTR
Stimulates 3Dpol, 3CDpro activity in vitro (Lam a 
et al., 1994)
FMDV
Oligomerises in non-reducing condition
3C
Poliovirus
Binds to cloverleaf (Andino et al., 1990)
Stimulates VPg uridylylation (Yin et al., 2003)
FMDV
Major protease for polyprotein processing (G rubm an 
and Baxt 2004)
Cleaves host cell histone protein (Tesar and 
M arquard t 1990) and eIF4A (Belsham et al., 2000)
3CD Poliovirus
Major protease for polyprotein processing (Ypma wong 
et al., 1988)
Strong affinity for the cloverleaf (Andino et al., 1993) 
Stimulates VPg uridylylation 
Stimulates virus production in cell-free system 
Interacts with 3 ’ UTR together with 3 AB (Paul et al., 
1994)
FMDV (Not known)
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1.4.1 Role of P2 non-structural proteins in RNA replication
1.4.1.1 2A viral protease
In foot-and-mouth disease virus the 2A oligopeptide is about 18 amino acid long and 
mediates its own cleavage at its C-terminal ends to release it from the 2B region 
(Gmbman and Baxt 1982). That is why the 2A peptide remains with the PI stmctural 
proteins precuisor as P1-2A following initial cleavage of the polyprotein. Later on, 
the viral proteinase 3C brings about the cleavage of the 2A from the P I-2A 
precursor. Although the 2A protein does not have any direct involvement in RNA 
replication in PV, the 2A protein mediates cleavage of the eukaryotic initiation factor 
4G (eIF4G) and thus has been imphcated in the host cell protein synthesis shut-off 
mechanism (Etchison et al., 1982). It also induces apoptotic cell death in infected 
cells by a mechanism that differs from caspase mediated physiological cell death 
(Goldstaub et al., 2000).
The mechanism of cleavage mediated by the FMDV 2A at -NPG|P- junction has 
been studied in detail. Modelling of the 2A indicates the presence of an amphipathic 
helix and the confonnation of the 2A sequence produces strain on the 
peptidyltiansferase centre of the ribosome (Ryan et al 1999). That results in 
repositioning of tlie peptidyl (2A)-tRNA easter linkage. The steric effect that is 
generated by this process prevents the nucleophilic attack by the incoming (prolyl)- 
tRNA which is the first amino acid of the 2B protein thereby causing the release of 
the N-terminal product. It has been suggested that a proportion of the ribosomes stop 
tianslation while the rest cany out the translation of the downstream products. 
Further studies have suggested that protein synthesized upstr eam of the 2 A sequence 
were always present in greater molar excess than that of the protein downstream of
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the 2A sequence (Donnelly et al., 2001b). This leads to the idea that 2A-2B cleavage 
is not a proteolytic cleavage, rather an alternation of the translation machinery by the 
2A sequence or peptide which allows the release of the P I-2A from the ribosome 
while permitting the synthesis of the downstieam proteins (Donnelly et a l, 2001a, 
b).
1.4.1.2 Picomavirus 2B protein as a viroporin
Among different FMDV serotypes, the 2B region is found to be most conserved. In 
poliovirus, 2B protein has been shown to increase the permeability of cell 
membranes and it also blocks the protein secretory pathways (Doedens and 
Kirkegard 1995). Both in FMDV and PV, 2B along with 2C have been found to 
localise in the membranous vesicles which are the site of vims replication (Gosert et 
a l, 2000; Suhy et a l, 2000; Moffat et a l, 2005). There is very little literature on the 
FMDV 2B function, however infoimation derived from PV and recent studies in 
FMDV indicates that picomavirus 2B has got an important role in cell 
permeabilization during vims infection. The non-stmctural protein 2B, its precursor 
2BC and 3A in poliovirus have the ability to alter the cell membrane peimeability 
when expressed individually in cells (Doedens and Kirkegard 1995; Barco and 
Carassco 1995; van Kuppeveid et a l, 1997). However 2BC protein is the most active 
in terms of membrane alteration and shows some properties that differ fr om 2B and 
2C alone (Barco and Carassco 1995). In addition 2B, 2BC and 3A (3A being the 
most potent) also impair glycoprotein trafficking through the secretory transport 
system (Doedens and Kirekegard 1995; Doedens et a l, 1997). 2B protein alone has 
been shown to localise to the Golgi complex when expressed alone (De Jong et a l,
2003). FMDV 2B is found to be located in structures closely associated with the ER,
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and at high levels of expression, the 2B protein caused rean angement of the ER into 
a honeycomb of membranes close to the nucleus (Moffat et al., 2005). Unlike 
poliovirus, even though FMDV 3A, 2B, and 2C were located in membranes of the 
early secretory pathway, they did not individually block protein transport. However 
the precru'sor 2BC is able to block the secretory pathway (Moffat et al., 2005).
Picornavir-us 2B proteins are about 100 amino acids in length and contain two 
hydrophobic stretches in then sequences. In the Coxsackievirus 2B protein mutations 
that alter the first domain’s amphipathicity (residues 37-54) or the second domain’s 
hydrophobicity (residues 63-80) have an effect on the ability of the 2B protein to 
increase membrane penneability and viral RNA replication (van Kuppeveid et al., 
1995; 1996). The yeast two-hybrid approach has shown that 2B and 2BC alone can 
mediate hornomultimerization on their own (De Jong et al., 2002) and the domain 
that is involved in this reaction is located in the hydrophobic domain of the 2B 
protein. This might have important implications in the vims life cycle by creating a 
microenvironment required for vims replication as a result of membrane 
permeabilization. The ability of the 2B protein to permeabilise the membrane has 
been assessed using large unilamellar vesicles which support the idea that 2B acts as 
a viroporin that creates transmembrane pores which allow free diffusion of small 
solutes (Agirre et al., 2002). The mechanism currently proposed is that an oligomer 
form of the 2B, most likely a tetramer, forms a permeating unit or pore on the 
membrane surface (Nir and Nieva 2000; Nieva et al., 2003). As a result of this, 
compounds with molecular weight less than 1000 Da are able to enter and leave the 
cytoplasm during the mid phase of infection which leads to alteration of the
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monovalent ion concentration and hence membrane depolarisation, this finally leads 
to cell lysis.
1.4.1.3 2C protein has both RNA binding and NTPase activities
2C protein is the most conserved protein among the picomaviruses and has multiple 
functions (Argos et al., 1984). In poliovims, the N-teiminal region of 2C 
encompassing residues 21-54 contains a putative amphipathic helix supposed to play 
an hnportant role in membrane binding (Argos et al., 1984). It has also been reported 
that PV 2C has specific binding affinity for the 3’ end of the negative strand RNA 
but not to the complementary sequence of the positive sense RNA (Baneijee et al.,
1997). In addition Bchovims-9 2C protein can bind to both positive and negative 
sense viral RNA non-specifically (Klein et al., 2000) indicating a conserved RNA 
binding activity of picomavirus 2C protein. The membrane binding and RNA 
binding properties suggests that PV 2C might have an important function in viral 
RNA rephcation by keeping the 3’ end of the negative sense RNA immobilised on 
the replication complex where the necessary viral and cellular factors can assemble 
to initiate positive sense RNA synthesis.
PV 2C has been reported to contain three conserved motifs. Motif A and motif B 
constitute the NTP-binding site whereas motif C has been found to be present in 
members of the helicase superfamily III. The function of the motif C is not known 
and no helicase activity of the 2C has been reported yet. Motif A and motif B are 
involved in ATPase and GTPase activity which are required for RNA rephcation 
(Rodiiguez and Carrasco 1993). Point mutations resulting in changes in consemed 
amino acid residues in the NTP-binding motif have been shown to yield RNA
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transcripts that are non-infections and act by interfering with RNA replication 
(Mirzayan and Wimmer 1994; Teterina et aL, 1992). Multiple studies on PV 2C have 
revealed two distinct functions of this protein in viral RNA synthesis; a cw-acting, 
guanidine-sensitive RNA synthesis initiation event and a trans-?icXmg elongation 
process. Low concentrations of guanidine-hydrochloride (up to 2-10 mM) inhibit 
picomavirus replication and are found to inhibit negative shand synthesis by 
interfering with the function of 2C (Bienz et al., 1980). In poliovimses and foot-and- 
mouth disease vimses resistance to guanidine has been associated with mutations 
that have been mapped to be within the 2C coding region (Saunders and King 1982; 
Pincus and Wimmer 1986; Pariente et al., 2003). Evidence has been presented that 
many mutations in the 2C region can be lethal. In addition some of the non-lethal 2C 
mutants have been shown to display abnoimalities in RNA replication such as a 
temperature-sensitive phenotype, or guanidine hydrochloride resistance or 
dependence phenotype (Wimmer et al., 1993). In addition to the role of 2C in viral 
RNA replication it has been found to be involved in vims encapsidation (Vance et 
al., 1997). Very recently it has been reported that serine protease inhibitor or ‘serpin’ 
motifs are found to be present thioughout the 2C sequence which are capable of 
inhibiting the activity of viral protease 3C^’^° and 2A’’™ in-vitio (Baneijee et al.,
2004). These workers also suggested that serpins in the 2C might interacts with the 
3C active site, inhibiting its proteolytic activity and may thereby play a key role in 
viral replication and pathogenesis.
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1.4.2 Role of P3 non-structural proteins in RNA replication
1.4.2.1 3A protein
Foot-and-mouth disease vims 3A protein is about 153 amino acids in length and 
differs in size from other picomavims 3A protein. It is about 50% larger than the PV 
3A protein which is only 87 amino acids (Kitamura et al., 1981). In all the 
picornavimses, the 3A protein contains a 15-20 amino acid hydrophobic domain 
located 20-23 amino acids downstieam of the N-terminus. In FMDV the region 
downstieam of the hydrophobic region has been implicated in species specificity. 
Earher studies have indicated that the length of the 3A protein has important 
implications for producing disease in different hosts. Live attenuated stiains of 
FMDV that have been passaged thiough chicken embryo cells displayed an apparent 
reduction in 3A size that has been suggested to be required for an attenuated 
phenotype in bovines. Subsequently these changes were mapped to a deletion of 
about 20 amino acids in the C-terminal third of the 3 A protein (Gimado et al., 1990). 
Subsequent evidence of a role of 3A length on species specificity became clearer 
after the outbreak of FMDV in Taiwan in pigs which had a similar deletion in 3A; 
this vims did not affect the cattle population (Beard and Mason 2000). It has also 
been shown that deletions within the 3A sequence (amino acids 93-102 and amino 
acids 93-144) resulted in reduced RNA synthesis in both bovine and porcine kidney 
cells indicating impaired RNA replication in both types of cells. Such vims strains 
showed an attenuated phenotype using bovine cells in culture. However such 
deletions within 3A had no detectable effect on growth in porcine kidney cells 
(Pacheco et al., 2003; O’Donnell et al., 2001; Sagedahl et al., 1987 Giraudo et al., 
1987). Recently the ability of FMDV isolate to produce disease in pigs has been 
mapped to a point mutation in 3 A (changes fr om glutamine (Q) to an arginine (R) at
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residue 44) suggesting a role for 3 A in FMDV virulence and its broad host-range 
(Nunez et al., 2001).
In addition to the role of 3A in pathogenesis, it also plays a major role in the 
biochemical and morphological changes that are associated with picomavirus 
replication. In PV infected cells, the 3A protein blocks endoplasmic reticulum (ER) 
to Golgi traffic causing accumulation of secretory components and swelling of the 
ER lumen (Doedens et al., 1997). Removal of the N-teiminal ten amino acids of the 
3 A protein significantly reduced the ability of the protein to inhibit protein secretion 
suggestmg a role for the N-temiinus either in membrane interaction or proper folding 
of the protein required for 3A protein secretory inhibitory function. It has been 
suggested that PV 3A inhibits ER-to-Golgi tiansport by blocking the fonnation or 
budding of the COP Il-coated vesicles known to mediate anterograde transport fiom 
ER-to-Golgi (Doedens et al., 1997). Recently a brefeldin resistant phenotype in 
poliovimses has been mapped to either a single point mutation in the 2C (G-^A at 
nucleotide 4361) or in the 3A (C—>U at nucleotide 5190) coding sequence 
suggesting a role of 3 A for interaction with cellular proteins like ARFl and other 
homologues that play an important role in the cellular vesicular trafficking system 
(Crotty et al., 2004). Recent studies on FMDV 3A protein suggest a different role of 
3A in RNA replication. The FMDV 3A protein is found to be located in the 
membrane stiuctuie within the ER, but does not block protein tiafficking in the cells. 
However 2B precursor protein 2BC has been assigned a role in blocking protein 
tiansport fiom the ER to Golgi (Moffat et al., 2005).
30
CHAPTER ONE INTRODUCTION
1.4.2.2 3B/VPg
Unlike any other picomaviruses, FMDV encodes and uses thiee distinct copies of 
VPg during RNA replication. Even the other sole member of the aphthovirus genus 
equine rhinitis A vims (ERAV) only possesses a single copy of the VPg. Each copy 
of VPg can be linked to the 5 ’ end of the genomic RNA in approximately equimolar 
ratio (King et al., 1980; Forss and Schaller, 1982). To date no natural isolates of 
FMDV have been discovered that contain less than tliree copies of the VPg, 
indicating a selective pressure in maintaining apparently redundant copies of the 
VPg. Recently it has been shown that FMDV lacking VPgl and VPg2 sequence in 
its genome could replicate well in BHK cells and porcine kidney cells, albeit with 
lower efficiency in fetal bovine kidney cells suggesting a role of VPg copy number 
in broad host-range and pathogenecity (Pacheco et al., 2003). VPg copy number in 
FMDV is also known to influence RNA synthesis and production of infectious vims 
particles in cell culture (Falk et al., 1992). Studies with single-VPg vimses have 
shown that they are > 1000 fold less pathogenic than the thr ee-VPg vimses based on 
their ability to produce vesicular lesions at the site of inoculation (Pacheco et al., 
2003). But all three single-VPg vimses were capable of systemic infection albeit 
with symptoms milder compared to the three-VPg containing viruses. It was also 
reported that single-VPg copy viruses are attenuated in both cattle and pigs which 
explains the maintenance of the tln’ee copies of VPg found in all natural isolates of 
FMDV.
Among the three copies of the VPgs, VPg3 is critical for vims replication in cultured 
cells. However such a defect was attributed to improper proteolytic processing 
associated with 3B/3C cleavage junction (Falk et al., 1992). However, the possibility 
that this phenotype was due to replication defect as well cannot be fully excluded. To
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date amongst all isolates examined, VPg3 is the most conseiwed whereas VPgl and 
VPg2 are more variable and undergo selection (VPgl aa 4, 11 and VPg2 aa 17, 18 
and 19) suggesting a role for VPgl and VPg2 in FMDV vimlence and host range 
(Pacheco et al., 2003).
The tyrosine residue at the position three is conserved among all picornavimses 
VPgs and is requhed to form a covalent bond with the 5’terminal uridine residue of 
the picomavims genome (Ambros and Baltimore 1978; Rothberg et al., 1978). The 
importance of this residue can be easily assessed from the fact that mutation in this 
residue in VPg abolishes RNA replication. The linkage of the VPg in nascent 
positive strands, negative strands and replicative intermediates indicates a role for 
the VPg in the RNA priming reaction during RNA replication (Wimmer 1982). The 
function of VPg in the RNA priming reaction was made evident from the finding 
that VPg acts as a substrate in vitro to form VPgpUpU (the functional peptide primer 
for RNA replication ) in the presence of 3D and 3 CD using PV 2C RNA transcripts 
as a template (Paul et al., 1998; Goodfellow et a l, 2000; Paul et a l, 2003a,b).
1.4.2.3 3C protease
Stmctural studies on the picomavims 3C proteases from poliovims (PV), hepatitis A 
vims (HAV), human rhinovirus (HRV) and recently FMDV have provided insight 
into a unique class of cysteine proteases with thr ee dimensional stmctures similar to 
chymotr ypsin-like serine proteases. All of them possess a Cys-His-Asp/Glu catalytic 
triad at the active site (Allaire et a l, 1994; Matthews et a l, 1994; Mosimann et a l, 
1997; Birtley et a l, 2005). In FMDV, the 3C protease has an important role in viral 
protein expression str ategy by carrying out most of the post-tr anslational cleavages
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of the polyprotein (10 out of 13) (Gmbman and Baxt 2004). The crystal structur e of 
the FMDV 3C protease has shown that the overall fold of the enzyme is similar to 
that of chymotrypsin containing two ^-barrel domains, each having a pair of four- 
stranded anti-parallel p -sheets that pack together to fonn a shallow peptide binding 
cleft. Unusually FMDV 3C structure lacks the extended p-ribbon that folds over the 
peptide binding/substrate binding cleft found in other picomavirus 3C proteases. 
That makes FMDV 3C substrate binding cleft more solvent exposed and may 
account for the more relaxed substrate specificity (Birtley et al., 2005). In PV, 3C 
mediated cleavage is specific to sites between Ghi-Gly (Pahnenberg, 1990); whereas 
FMDV 30 shows cleavage specificity for a range of dipeptides sequence including 
Gln-Gly, Glu-Gly, Gln-Leu and Glu-Ser (Pahnenberg, 1990; Robertson et al., 1985). 
Studies on PV indicates that the precursor 3CD is the major enzyme involved in 
structural protein processing (Ypma-Wong et al., 1988; Parsley et al., 1999) whereas 
in FMDV, 30 alone is sufficient to carry out most of the proteolytic processing 
(Ryan et al., 1989; Bablanian and Gmbman, 1993). hi addition to the role of FMDV 
30 in polyprotein processing, it also cleaves the cellular protein eIF4A (an RNA 
helicase associated with the cap-binding complex) and eIF4G (in BHK cells and 
some rodent cells) durmg late stage of infection (Belsham et al., 2000; Strong and 
Belsham 2004). PV 30 is also involved in the cleavage of specific transcription 
factors including TATA-binding factors involved in RNA polymerase II mediated 
transcription (Clark et al., 1991; Yalamanchili et al., 1997; Kundu et al., 2005). The 
viral function of this inhibition could be to block host defences that require new 
RNA synthesis, to increase the intracellular concentiation of ribonucleotides, or to 
disassemble nuclear complexes. FMDV 30 also brings about the cleavage of the N- 
terminal 20 amino acid of the histone H3 (Tesar and Marquardt 1990) suggesting
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FMDV might have an alternate mechanism of host-cell transcription shut-off 
compar ed to other picornavimses.
The picomavirus 3C protein and its precursor 3 CD have been reported to possess 
RNA binding properties that are required for viral RNA replication (Andino et al., 
1990; 1993). In PV the RNA binding site has been mapped to the highly conserved 
amino acid sequence motif KFRDI, which is located on the face opposite to the 
active site of the enzyme. Within this motif R84 and 186 have been reported to be 
involved in RNA binding. The importance of the RNA binding activity of the 3C in 
VPg uridylylation can be easily assessed from the fact that the mutation R86S blocks 
the ability of this protein to support PV VPg uridylylation (Paul et al, 2000). 
Subsequently it was found that 3C or its precursor protein 3 CD stimulates VPg 
uridylylation in vitio by forming a RNA-protein complex with the ere (Yin et al., 
2003). Previous studies have reported the binding of the 3C protein to the clover-leaf 
(CL) found at the 5’ terminus of many picoraavirues RNAs (Andino et al., 1990, 
1993; Kusov et al., 1997; Walker et al., 1995). However in some other members of 
the picornavimses including aphthovimses and cardiovimses the CL strircture is 
replaced by an S-fr agment which has been predicted to form a single large stem-loop 
stmcture (Clarke et al., 1987).
1.4.2.4 3D is an RNA dependent RNA polymerase
The 3Dpol or RNA dependent RNA polymerase is the key non-stmctural protein that 
initiates RNA replication with the aid of other viral proteins and possibly with some 
cellular factors. In PV infected cells 3Dpol was found to be associated with a 
membranous replication complex (Bienz et al., 1983; Schlegel et al., 1996, 1997)
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and recruitment of the 3Dpol to the replication complex is believed to be carried out 
by the 3B precursor protein 3AB (Datta and Dasgupta. 1994).
X-ray crystallographic stmcture of the PV polymerase, the first RNA dependent 
RNA polymerase to be studied, provided a classic example for understanding the 
structure, function and evolution of the rest of the picornavims polymerases (Hansen 
et al., 1997). Foot and mouth disease polymerase and poliovims polymerase belong 
to the group 1 polymerases (Koonin 1991). The overall topology resembles other 
classes of nucleic acid polymerase, which is like a cupped right hand with finger, 
palm and thumb domains (Hansen et al., 1997). The palm domain contains four 
stmctural motifs (A-D) which are found in all classes of polymerase. It also has a 
fifth motif (E) found only m enzymes such as RNA dependent DNA polymerases 
which utilise RNA templates.
Across all species of positive sti and vimses of eukaryotes, only six residues within 
the polymerase are completely conserved. All picornavims polymerases possess a 
conseiwed GDD sequence which is located in the motif C region of the poliovims 
polymerase. The first aspartic acid is supposed to be critical for enzyme flmction and 
postulated to be involved in the metal ion co-ordination at or near the catalytic active 
site of the enzyme (Delame et al., 1990). Mutational analyses have shown that any 
changes at the fiist aspartic acid results in an enzyme that is inactive in-vitro as well 
as in-vivo, however mutation at the second aspartic acid resulted in an enzyme with 
a metal ion requhement for Mn^ "^  for activity both in vitro as well as in vivo 
(Jablonski and M o i t o w  1995). In addition, in the poliovims polymerase, the residue 
lys-61 is implicated in the catalytic activity in the polyiuerization reaction and
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regarded as the nucleotide ti’i-phosphate (NTP) binding site. Residues Val391, 
Phe377, Arg379 and Glu382 are all supposed to be involved in the 3AB-protein 
binding that recruits the polymerase to the membrane bound replication complex and 
mutation of these residues affects the process of VPg uridylylation (Lyle et al., 
2002). In vitro studies have shown that the PV 3Dpol exhibits co-operativity in its 
polymerase activity (Pata et al., 1995) and it has been suggested that PV 3Dpol 
functions as a multimer in vivo.
In addition to PV 3Dpol, the tliree dimensional crystal structure of polymerases of 
many other positive strand RNA viruses have been solved to date including FMDV 
and HRV (picornaviridae family) (Hansen et al., 1997; Appleby et a l, 2005), 
hepatitis C virus and bovine viral diarrhoea virus (Flaviviridae family) (Bressanelli 
et a l, 1999; Lesburg et a l, 1999), rabbit hemorxhagic virus and Norwalk virirs 
(Caliciviridae family) (Ng et a l, 2002; Ng et a l, 2004) and the double-stranded 
RNA bacteriophase 06  (Butcher et a l, 2001). One of the common important features 
of this class of polymerase is the presence of a fully encircled active site.
Foot and mouth disease virus polymerase shares about 29% sequence identity to PV 
polymerase. The recent three dimensional crystal structure of the FMDV 3Dpol 
provides further understanding of picornavims polymerases (Orta et a l, 2004). The 
N-terminal segment comprising residues 1-96, called the finger tips, bridges the 
fingers and thumb sub-domains which encircle the active site of the enzyme similar 
to PV and HRV. In addition, comparison of the FMDV 3D in its bound and free 
form (ternplate-primer RNA decanucleotide) showed no movement of sub-domains 
to accommodate the template-primer unlike the Human immunodeficiency vims
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(HIV) Reverse transcriptase (RT). For HIV RT, movement of the region following 
motif E is required as a pivot point for the movement of the thiunb sub-domain to 
accommodate the template-primer RNA complex. Unlike the PV polymerase, the 
crystal stmcture of FMDV polymerase did not show any evidence of higher order 
stmcture, like the head-to-tail fibres described for PV.
However, differences exist among vhiises with respect to the mechanism of initiation 
of RNA synüiesis by the polymerase. HCV and bacteriophage 06  polymerase 
follows a de-novo RNA synthesis ruechanism without the aid of any primer. Both 
HCV and 06  polymerase posses a large and extensive thumb sub-domain with a p- 
hairpin extension. It has been proposed that the p-hairpin and the C-teiininal region 
of the enzyme form a scaffold upon which the 3’ terminal initiation complex 
assembles (Hong et al., 2001; O'Farrell et al., 2003). PV, HRV and RHDV use a 
protein primed initiation mechanism for RNA synthesis where a small vhus encoded 
peptide VPg/3B, is first uridylylated to form VPgpU(pU) which then acts as a 
functional primer for RNA synthesis (Paul et al., 2003; Machin et al., 2001). In the 
case of PV, 3Dpol is inactive in the context of its precursor 3CDpro (Thompson and 
Peersen 2004). Proteolytic cleavage of 3Dpol is required for activation of the 
enzyme for its biological activity. In all picornavimses, glycine is the first amino 
acid of the polymerase. In PV, deletion of the first glycine residue or addition of a 
single amino acid residue at the N-terminus results in complete loss of polymerase 
activity (Thompson and Peersen 2004). Based upon the above observation, it was 
contemplated Üiat the N-terminus could be an integral part of the active site. Recent 
studies with the PV polymerase suggested that the proteolytic processing of the 
3CDpro leads to polymerase activation following a structural change in which the N-
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terminal glycine residue is buried in a pocket at the base of the finger domain. The 
buried N-terminus stabilises the structure and allows the direct positioning of the 
aspartate 238 for binding to the 2’ OH gr oup of the incoming nucleoside in the active 
site (Thompson and Peersen 2004). In RNA polymerase, this aspartate hydrogen 
bond to the 2’OH of the incoming rNTP allows the selection of rNTPs over dNTPs 
(Huang et al., 1997; Gohara et al., 2004). In addition the interaction between the 
finger and thumb completely encircles the active site and creates an NTP entry 
turmel at the back of the polymerase (Thompson and Peersen 2004). The unique 
extensive interactions between the thumb and finger domains associated with all 
RdRp results in a closed globular conformation (Thompson and Peersen 2004; 
Appleby et al., 2005), whereas a U shaped conformation is observed in the case of 
the DNA polymerases, DNA-dependent RNA polymerases, and the HIV RT.
The 3Dpol from PV and HRV catalyse two different types of phosphoryl transfer 
reaction. The enzyme can nucleotidylate the virus encoded peptide, 3BATg to 
generate the functional prhner for initiation of RNA synthesis a process called VPg 
uridylylation. The second flmction includes the ability of the enzyme to elongate the 
nascent chain of nucleotides during the RNA elongation reaction (Paul et al., 1998; 
Gerber et al., 2001b). Both the reactions require Mg^^ or Mn^ "^  as cofactors. The 
requirements and specificities of both type of reaction are considered to be different 
and are not known. For VPg uridylylation 3Dpol uses a ‘slide-back’ mechanism for 
nucleotidylation of the VPg peptide to form VPgpUpU in the presence of the ere as a 
template (Paul et a l, 2003a,b). The nucleotide elongation activity of the enzyme has 
been well studied and the detailed mechanism of action determined. In addition 3D^ °^  
has both terminal transferase activity (Neufeld et al., 1994) and strand displacement
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activities (Cho et al., 1993). The enzyme is efficient in template switching and is 
capable of catalysing prhner-independent RNA synthesis (Arnold and Cameron 
1999).
All classes of nucleic acid polymerase (e.g. DNA dependent DNA polymerase (e.g. 
Klenow Fragment) and RNA dependent DNA polymerase (e.g. HIV RT) can use two 
divalent cations as the cofactor for the phosphoryl transfer (Brautigam and Steitz
1998). Most of the polymerases known use Mg^ "^  as a cofactor which resembles the 
conditions in vivo (Romberg and Baker 1991). Mn^^ has been shown to be an 
effective cofactor for a variety of polymerase systems (Huang et al., 1997). However 
Mn^^ usually alters the biochemical properties of the polymerase, decreasing the 
stringency of the substrate selection and incorporation fidelity permitting increased 
use of DNA template, nucleotides with incon-ect bases or nucleotides with incorrect 
sugar configurations (e.g. 2’-dNTPs, 3’-dNTPS and 2’,3’-ddNTPs) (Arnold et al.,
1999).
In the presence of Mn^^, the ground state binding of the correct nucleotide is more 
stable than in the presence of Mg^ "^  suggesting Mn^^ has additional adventitious 
interactions with the enzyme. Being a transition metal it has been suggested that 
during the course of interaction with the enzyme, Mn^ "^  has the additional ability to 
interact with the backbone or nitrogen and sulphur containing residue ligands near 
the binding site of the metal (Bock et al., 1999).
Though RNA dependent RNA polymerases are associated with an extraordinarily 
high mutation rate (Domingo et al., 1996), recent data suggested that the intrinsic
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fidelity of PV 3Dpol is similar to that of the T7 DNA polymerases (Wong et al., 
1991). The important aspects of the kinetic data suggested that once 3Dpol has 
initiated RNA synthesis it will not dissociate from the nascent RNA until it reaches 
the end of the genome (Arnold and Cameron 2004).
1.4.3 Role of precursor proteins in RNA replication
Positive stiand RNA viruses including picornavimses have limited genetic 
information due to their relatively small genomes. During the vims life cycle many 
positive strand RNA vimses follow different strategies to subvert the cellular 
machinery for their favour" that allows efficient replication and new progeny virus 
production. One of the important strategies is to utilise cellular proteins for 
recmitment into their translation and replication machinery. They also produce 
proteins that have multiple functions. In addition, during polyprotein processing they 
generate many intermediate precursor proteins; these can have completely different 
functions compared to their" mature cleavage counterparts (Wimruer et al., 1993).
Viral proteins 2C and its precursor 2BC are loiown to possess ATPase activity 
(Pfrster and Wimmer 1999) and are capable of membrane rearrangements in the 
infected cell. Protein 2B and its precursor 2BC increase the intracellular calcium 
level, due to disruption of the endoplasmic reticulum and alter the permeability of 
the plasma membrane (Aldabe et a l, 1996; 1997; Imrzun et a l, 1995; Vance et a l, 
1997). However, striking difference in the activities of 3CD^^° and 3C polypeptide 
has been observed in picornavimses. 3C has been shown to possess RNA binding 
determinants and the motif requir ed for this could be separated froi"n those requhed 
for proteolytic activity. Though the proteinase and the RNA binding sequences 
reside within 3C, 3CD complexes differs froiu 3C with respect to these activities. In
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poliovims both the 3C and 3 CD recognize the RNA cloverleaf element at the 5’ end 
of positive stiand genome, in the presence of cellular protein PCBP2, to form a 
ternary complex (Parsley et al., 1997). However 3CD has an enhanced ability to 
form this ternary complex compared to 3C, and for this reason the 3 CD 
/PCBP2/RNA complex is thought to be the biologically relevant one (Andino et al, 
1990). In addition, as proteinases, 3 CD has a dramatically enhanced ability to cleave 
the stmctural (PI) protein precursor compared to 3C (Ypma-wong et al., 1988). No 
specific role for the FMDV 3CD protein has yet been determined and FMDV 3C is 
sufficient for all FMDV polyprotein processing.
In addition to 3C, poliovims 3D is the other cleavage counterpart of 3CD and 
mediates uridylylation of VPg to form VPgpUpU that acts as the primer to initiate 
RNA replication (Paul et al., 1998). The 3CD’^'^ ° from PV does not posses any 
elongation activities in vitro. However evidence suggests that the precursor (Pro-pol) 
form of the polymerase in calicivimses is the most active and biologically relevant 
form of the enzyme (Wei et al., 2001). Recently a more defined role of the 3CD*’™ in 
RNA replication has been established. It has been shown that 3 CD stimulates the 
VPg uridylylation in vitro up to 100 fold by foiming a stable complex with the PV 
cis-acting replication element (ere) (Yin et al., 2003). In addition supplementation 
with mRNA encoding 3CDpro or purified 3CDpro stimulates vims production in a 
cell-free system up to 100 fold, but has no effect on protein translation (Franco et al., 
2005). This stimulatory effect is only obseiwed when 3CDpro is added in the 
reaction within 2-4 hi’s of the initiation of cell-free reaction indicating the time of 
maximum protein translation and replication complex assembly. It should be noted 
that both 3CDpro and 3Cpro inhibits vims production when added at the beginning
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of the reaction. Furthermore 3CDpro has no effect on pre-initiation replication 
complexes isolated after treatment with guanidine. This indicates that 3CDpro 
produces its stimulatory effects only when it is added to the system at the time of 
replication complex assembly but loses its activity once replication complexes are 
formed. Since 3C or 3D alone do not stimulate this reaction it suggests that besides 
3C, the 3D domain is also involved in the stimulation process. Mutations in the 3D 
domain in the context of 3CDpro in interface I that dismpt oligomerization of 3Dpol 
also results in loss of the stimulatory activity suggesting that either interaction 
between 3CDpro molecules or interaction between 3CD and 3D is required for this 
stimulation (Franco et al., 2005). In addition, mutations in the 3C domain within the 
context of 3CD that disrupts the RNA binding properties of 3C (R84S/I86A) also 
destroys the stimulatory activity (Franco et al., 2005). However 3Cpro alone, with 
intact RNA binding activity does not have any stimulatory effect on virus yield at 
any stage of in vitro vims synthesis. It is well known that along with 3CD, 3C alone 
can stimulate ere template mediated VPg uridylylation, thus it was suggested that the 
3 CD stimulation of vims yield is mediated by a CL-3CDpro mediated interaction. In 
other words, it was suggested that this stimulatory effect of the 3CD on vims yield in 
cell-free system is ere independent (Franco et al., 2005).
The 3 CD protein has also been shown to interact with the 3’NCR of PV, which may 
provide a source for a polymerase molecule proximal to the 3 ’ end of the RNA to 
initiate negative strand RNA synthesis (Harris et al., 1994). This 3’ NCR interaction 
may be stabilised fru'ther by 3D domain mediated contacts with the viral polypeptide 
3AB. Evidence for a 3D-3AB protein-protein interaction has been generated 
previously using the yeast two hybrid system (Hope et al., 1997; Xiang et al., 1998).
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The viral protein 3 AB, the precursor of VPg, has been suggested to be an important 
component of the replication complex because of its ability to interact both with 
membranes and the RNA polymerase (Datta and Dasgupta. 1994). The yeast two- 
hybrid system has shown a strong interaction between the 3AB or 3B with the 
polymerase and the contact point between the two proteins has been mapped to be in 
the 3B domain of the 3AB. In addition, the polymerase activity of purified 3D 
polymerase (Lama et al., 1994; Paul et al., 1994; Plotch and Palant. 1995) and 
proteolytic activity of the 3 CD*’™ (Lama et al., 1994) are both stimulated by addition 
of the detergent solubilized 3AB but not by 3A in vitro. However, detergent 
solubilized 3AB is not a substrate for 3 CD cleavage, whereas membrane-associated 
3AB is (Molla et al., 1994). 3AB has also been iiuplicated to have non-specific RNA 
binding activities as well as a specific affinity for the CL structure at the 5’ end of 
the genome (Hams et al., 1994; Paul et al., 1994). These in vitro properties are 
consistent with a function for 3AB in the replication of the viral genome, and 
interpretation of viral defects stemming fi’om mutations in 3 A has frequently 
presumed that the mutations were disrupting 3AB function. Both 3A and 3AB are 
membrane associated in infected cells (Semler et al., 1982) and this association is 
thought to be mediated by a 22 amino acid hydrophobic domain near the C-terminus 
of the 3A protein. It has also been suggested that in addition to 3B/VPg protein, 
other precursor proteins like 3AB, 3BC could also act as substrate for VPg 
uridylylation.
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1.4.4 Cis-acting RNA elements involved in picomavirus RNA 
replication
Studies carried out using poliovims as a model organism have shed light on the 
requirements of proteins and RNA stmctures required for viral RNA replication. 
These RNA stmctures are located in the 5’ non-coding region that is the cloverleaf 
(OriL), the 3 ’ non-coding region (including the heteroplymeric tract and the polyA 
tail (OriR) and 2C(cre)(0riC) have been well documented (Andino et al., 1990; 
1993, Filipenko 1992, 1996, Wang et al., 1999; Melcher et al., 2000; Goodfellow et 
al., 2000). However very little work has been pursued in this area for foot-and-mouth 
disease vhus. The stmcture and location of these c;a'-acting RNA elements involved 
in FMDV replication vary from those of the poliovims, however a shnilar pattern of 
function in FMDV RNA replication could be expected.
1.4.4.1 The cloverleaf of PV participates in the formation of a ternary 
ribonucleoprotein complex
In poliovims the first 90 nt has been predicted to form a cloverleaf-like secondary 
stmcture that is necessary for viral RNA replication (Riviera et a l, 1988; Skinner et 
a l, 1989). Detailed stmctural analysis of the CL revealed the presence of 4 domains 
namely stem a, stem-loop b (SLB), stem-loop c (SLC) and stem-loop d (SLD). SLD 
is again divided into sub-domains d l, d2, d3 and d4 (Andino et a l, 1990;1993). SLB 
and the sub-domain d3 play important roles in negative strand synthesis by 
participating in the formation of a ternary ribonucleoprotein complex around the 5’ 
end of the poliovims RNA by interacting with cellular protein PCBP2 and the viral 
proteinase 3CD respectively (Andino et a l, 1990; Gannarnik and Andino 1997;
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Paisley et al., 1997; Barton et al., 2001). The importance of this interaction between 
CL and 3 CD was made clearer following the observation that an insertion of 4 nts in 
the CL resulted in compensating mutations in the 3C domam of the 3 CD that 
suppressed the replication defects (Andino et al., 1990). The CL has been reported to 
be involved in negative strand synthesis but not in the positive stiand synthesis 
(Andino et al., 1990). Recently poliovims 5’ terminal CL has also been shown to be 
required in cis for VPg uridylylation and negative stiand synthesis (Rieder et al., 
2003). In addition to the role of CL in RNA replication recent evidence suggests a 
role for the CL in viral RNA stability (Murray et al., 2001).
If the S-fragment in FMDV has to function as a CL substitute in RNA replication, as 
a matter of speculation it may be expected to interact with viral protein 3C or 3 CD 
alone or in combination with other viral and cellular proteins to form a ribonucleo­
protein complex at the 5’ end of the RNA genome. To date no such interactions 
between the S-fragment and any viral or cellular proteins have been established.
1.4.4.2 Role of 3’ non-coding region in viral RNA replication
In picornavimses the 3’ non-coding region has been known to fold into higher order 
stmctural elements that interact with both viral and cellular proteins for RNA 
replication (Hams et al., 1994; Filipenko et al., 1996; Mirmomeni et al., 1997; 
Melchers et al., 1997, 2000; Wang et al., 1999; Waggoner and Sarnow 1998; 
Meredith et al., 1999). The poliovims 3’ UTR RNA contains two haiipins, 
designated domain X and Y and a third domain designated the K (kissing) domain 
which involves interactions between the X and Y domains. Experimental data have 
shown the importance of the 3’ non-coding region in RNA replication as it can not
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be replaced with non-viral sequences (Rohll et al., 1995). It is reasonable to assume 
that the 3 ’ non-coding region plays an important role in poliovims RNA replication 
as it contains the binding site for the poliovims protein 3AB and 3CD (Harris et al., 
1994). The 3’ UTR of FMDV RNA consists of two components, a region of about 
100 nt of heterogeneous sequence and a poly(A) tail. Deletion of the unique 
(heterogeneous) 3’UTR sequence blocks infectivity of FMDV RNA (Saiz et al, 
2001). This may not be tme for other picornavims like PV and HRV, where viable 
vimses lacking the unique 3 ’UTR sequence can be propagated albeit less efficiently 
(Todd et a l, 1997).
It has been also reported for HRV 14 that the 3’UTR forms a complex with a 34 to 
38 kDa host protein which is induced during viral replication (Todd et al., 1995). In 
contrast to the PV 3’UTR, the rhinovims 3’UTR foiins only a single stem-loop, 
which, at the level of secondary stmcture is highly conserved amongst rhinovimses. 
Mutations in the loop and in the stem that altered the stability of the stem have been 
observed to reduce rhinovims replication efficiency (Rohll et al., 1995). A mutation 
in the 3’ NCR of poliovims has been reported that resulted in a temperature-sensitive 
defect in RNA replication (Sarnow et al., 1986). Furthermore, it has been reported in 
encephalomyocarditis vims (EMCV) that the poly(A) tract is required for the 
recognition of the viral genomic 3’ end sequence by purified EMCV 3D*’“* (Cui et 
al., 1993). Studies on the 3’ UTR of cardiovims RNA have shown evidence for 3 
stem-loop sti'uctures, one of which is essential for vims viability (Duque and 
Pahnenberg 2001). It is possible that sequences within the vhal coding sequence (but 
perhaps near the 3 ’ end of the genome) are required to provide the specificity of viral 
RNA recognition that must be achieved by the replication machinery, especially for
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the PV mutant lacking the usual 3’ UTR sequences (Todd et a l, 1997). The length of 
the poly(A) tail detennines the infectivity of PV RNA (Spector & Baltimore 1974), 
but the mechanism involved in this is not elucidated. In addition the polyA tail has 
been proposed to be involved in negative strand synthesis by acting as a template for 
VPg uridylylation (Paul et al., 1998).
Another crucial feature of the poliovims RNA is the binding affinity of the polyA 
tail to a cellular protein polyA binding protein (PABP) (Herold & Andino 2001). 
The viral 3CD binds to the 5’-end of the genomic RNA and reaches its site of action 
within the poly(A)-tail of the genome via circularization of the genomic RNA using 
an RNA-protein-protein-RNA-bridge that involves two cellular factors, PCBP and 
PABP 1 (Herold & Andino 2001).
1.4.4.3 Cis-acting replication element (ere)
Evidence has accumulated for the presence of cw-acting RNA elements located 
internally within picornavims genomes that are required for RNA replication. 
Initially it was found that certain sequences within the PI-coding sequence of HRV- 
14 were required to achieve efficient replication of replicons based on this vims 
(McKnight and Lemon 1996). This contrasted with previous studies on PV that had 
demonstrated that the entire capsid coding sequence could be deleted without 
affecting RNA replication (Kaplan and Racaniello 1988). Further work (McKnight 
and Lemon. 1998) identified the critical RNA element as a specific stem-loop 
stmcture, tenned a c/.s-acting replication element (ere), and located within the ID 
(VPl) coding region of the HRV-14 genome. Subsequently, similar ere motifs have 
been identified in other picornavims genomes (Gerber et al., 2001; Goodfellow et
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al., 2000; Lobert et al., 1999). Each of the cre’s includes a conserved sequence motif 
of AAACA located within a loop at the end of a stable stem structure. These 
elements (about 50-60nt in length) occur" in different places within the picornavims 
genomes; the cre’s from HRV-14, HRV-2, cardiovimses and PV are within the 
coding regions for ID, 2A, IB and 2C respectively (Gerber et al., 2001; Goodfellow 
et al., 2000; Lobert et a l, 1999; McKnight and Lemon 1996). Furthermore the ore's 
can be moved without blocking function (Goodfellow et a l, 2000). It has been 
shown that the PV and HRV-2 ere structures act as the teruplate for the uridylylation 
of VPg (3B) (to produce VPgpU and VPgpUpU) by the 3D RNA polymerase in 
vitro (Gerber et a l, 2001; Paul et a l, 2000). Evidence has been presented that this 
process involves a “slide-back” mechanism on the AAACA motif (Paul et al 2003). 
The first A residues in the AAACA sequence acts as template for the addition of two 
uridine residue to the VPg peptide to form VPgpUp(U). The VPgpUpU has been 
thought to acts as a primer for both positive and negative strand synthesis (Paul et 
a l, 2000; Goodfellow et a l, 2003). However it is noteworthy that, within cell-free 
replication systems, the PV ere is only required for the synthesis of +ve sense RNA 
strands (Morasco et a l, 2003; Muii'ay and Barton 2003; Goodfellow et a l, 2003). In 
addition it has been found that there is a direct conelation between the ability of the 
ere to support uridylylation in vitro and replication in vivo (Yang et a l, 2002).
Recently, Mason et a l, 2002 presented evidence for a ere within the genome of 
FMDV. This element is about 54nt in length and includes a conserved AAACA 
sequence but in contrast to all other picomavirus ere structures it is located within 
the 5’UTR of the viral genome, irumediately upstream of the 1RES. This FMDV ere 
could be moved to the 3 ’ UTR whilst retaining activity. This feature conoborates the
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assumption that the sequence of the are and its secondary structure rather than the 
coding sequence is important for RNA replication. A role for this FMDV sequence 
in the uridylylation of FMDV VPg (3B) has not been reported but is assumed. The 
identification of a are within the 5 ' UTR of FMDV explained the phenotype of a 
temperature-sensitive (ts) mutant (ts303) of FMDV which is RNA replication 
defective under the non-pennissive conditions (Tiley et al., 2003). Unexpectedly, the 
ts lesion in this virus was located within the 5’ UTR and this mutation is now known 
to reduce the stability of the stem of the FMDV ere (Tiley et al., 2003). A revertant 
of the ts mutant had a second mutation that restored the stability of this structure. A 
remarkable feature of this mutant is that its defect in replication could be 
complemented in trans^ thus it appears that the FMDV ere can function in trans and 
it was suggested (Tiley et al., 2003) that a better name for this element may be a 3B- 
uridylylation site (bus). It is interesting to note that the role of the PV ere in the in 
vitro uridylylation of the PV VPg can also be performed in trans (Goodfellow et al., 
2003).
One of the important features of the ere is that the structural stability of the ere plays 
an important role in VPg uridylylation since the stem must present the unpaired 
terminal loop in a proper spatial configuration. Though the whole viral genome 
contains a number of AAACA motifs, not all of these sequences are capable of 
supporting VPg uridylylation. The poliovims CL possesses such a motif that is 
incapable of supporting VPg ruidylylation. It appears that the flanking nucleotide 
sequence and local structure adopted by the AAACA motif in the CL promotes 
complete base pairing (Andino et al., 1990, 1993). Further evidence came into the 
picture by ribonuclease mapping of the PV ere with ssRNA-specifrc T2 nuclease that
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indicated an unpaired nature for the terminal loop of the ere (Goodfellow et al., 
2003). In PV the entire stem of the ere can be replaced with an artificial stem of 
similar stability without compromising its function (Goodfellow et al., 2003). This 
suggests that the stability of the stem, not its sequence, is critical for ere function. 
Structural stability of the ere is also temperature dependent and the optimum 
temperature to support uridylylation is 30-34°C in vitio. Interestingly in a ts mutant 
of FMDV where the replication is significantly suppressed at non-permissive 
temperature, the mutation was mapped to the stem of the ere (transition of the C-U at 
the 47 position) making it less stable (Tiley et a l, 2003). Revertant mutants with 
compensating mutations that stabilised the stem enabled the virus to replicate again 
at the elevated temperature making it reasonable to assume that the temperature 
dependence of the ere fimction has a role in uridylylation in vitro and also during in- 
vivo replication. Despite the difference in the location of the ere and limited 
sequence similarities it is probable that all picomaviiiis members may have evolved 
a conserved mechanism for RNA replication. Furthermore the presence of multiple 
functional ere elements in the genome does not have any effect on the replication 
process (Yin et a l, 2003). Recently the solution stmcture of the minimum functional 
ere sequence (33 nt) of HRV has been studied by NMR (Thiviyanathan et a l, 2004). 
One of the important observations that were made is the orientation of the conseiwed 
adenosines towards the inside of the loop that participate in a ‘slide-back’ 
mechanism of VPgpUpU synthesis. However it was suggested that during VPg 
uridylylation the adenosine residues are available for base templating (Thiviyanathan 
et a l, 2004).
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1.4.5 Replication complex assembly
One of the important features of positive strand RNA vimses is that they assemble 
specialised replication complex machinery in infected cells. It leads to extensive 
stmctural reorganisation of the cellular organelles that leads to cytopathology and 
ultimately cell death. The replication complex provides a platform for accumulation 
of all the replication factors (both cellular and viral proteins) required for RNA 
synthesis. It has been proposed that translation of PV RNA into proteins, generation 
of vesicles and their association into functional replication complex is a coupled 
process (Egger et al., 2000). In other words, for vesicle assembly and RNA 
replication all the proteins and RNA must be provided in cis. PV utilises membrane 
stmctui'es from the host cell for vesicle assembly. The exact nature and source of 
these membranes from where they are derived is not clear. In PV it has been 
suggested that the early vesicles are derived from the ER (Rust et al 2001) whereas 
the late vesicles arise fr om other cellular organelles like lysosomes and the Golgi and 
co-localize with Golgi protein markers (Rust et al., 2001; Bolten et al., 1998; 
Schlegel 1996). Infection by PV, E V ll and EMCV results in vesicles similar in 
moiphology which are heterogeneous in size and aiTanged as tightly packed clusters. 
However another picornavfrus, human parecho vims 1 (HpeV-1), forms 
homogenously sized vesicles which are less numerous and do not form clusters 
(Gazina et al., 2002). In the case of PV, the replication complex appear like rosettes 
in infected cells, which are covered by double layer membrane stmctures that 
surround and protects the input and newly synthesized viral RNA rendering majority 
of them resistant to the action of RNaseA (Fogg et al., 2003). Such a structure is 
functionally important for the vims survival as it sequesters the replication process 
from other potentially competmg events such as translation inside the cells. In
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addition, it also safeguards the virus against any double stranded RNA induced host 
defence response such as RNA interference or interferon induced responses 
(Ahlquist, 2002).
Poliovims assembles its repHcation complex using membrane stmctures derived 
from the components of the cellular anterograde membrane tiaffrc pathway (Rust et 
al., 2001; Suhy et al., 2000). Such replication complexes are associated with both 
viral stmctural and non-stmctural proteins. In mammalian cells cellular secretion 
between ER and Golgi is dependent upon the function of two coat protein complex, 
COP I and COP II. The secretory pathway follows a route from the endoplasmic 
reticulum to the microtubule organising centre (MTOC) harbouring the Golgi 
complex. In the first step ER protein cargo is tiansported through COP II coated 
vesicles to a vesicular tubular cluster (VTC). In the next step the COP I coated VTC, 
without any trace of COP II, travels to the Golgi complex (Stephen at al., 2000). In 
both steps, the transport is aided by microtubule infrastmcture present in the cell 
(Rios and Bomens., 2003). Different picornavimses show different degrees of 
sensitivity to the action of drug brefeldin A. Replication of PV, E V ll and BEV are 
sensitive to the action of this drug. However both FMDV and EMCV are resistant 
(Gazina et al., 2002; O’Dormell et a l, 2001) and HpeV-1 is partially resistant 
(Gazina et a l, 2002). The possible explanation for insensitivity to the action of BFA 
in case of FMDV and EMCV might be due to involvement of different cellular 
factors for vesicle assembly or they might have a different site of replication. Recent 
work has suggested that PV resistance to BFA action can replicate efficiently in cells 
where the secretory function has been completely blocked and determinants of such 
BFA resistant have been mapped within 2C and 3A. These data suggest that BFA
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inhibits a specific step in PV replication that may involve direct interaction of 2C 
and 3 A with the cellular factor ARFl (Crotty et al., 2004)
Infection of susceptible cells with FMDV results in the accumulation of the majority 
of the cellular organelles to a distinct region located to one side of the nucleus 
termed the vims replication site (Monaghan et al., 2004). The morphological changes 
that occui' during this process are different from those seen with other 
picomavfruses. Changes in the ER appear first, these are followed by stmctural 
changes in the Golgi. The number of vesicles grows in number as the infection 
progiesses towards the late stage of infection. FMDV forms considerably fewer 
vesicles than PV and does not form clusters or rosettes, these observation are similar 
to those seen with HpeV-1 (Gazina et al., 2002). Though both single and double 
layered vesicles appears in FMDV infected cells, the latter stmcture is rare compared 
to PV and appears only during the mid and late phase of vims replication (Monaghan 
et al., 2004).
It has been demonstrated that the site of capsid dissociation after vims entry and site 
of RNA replication are different in location inside PV infected HeLa cells. The 
former takes place towards the peripheral region, whereas the latter localises to the 
perinuclear position (Egger and Bienz, 2002) suggesting a pattern of migration of the 
components of the PV replication machinery. Once the viral RNA is released in the 
cytoplasm it migrates to the endoplasmic reticulum in a microtubule (MT) 
independent manner where the translation of the viral RNA starts to synthesize the 
proteins required for RNA replication. This nascent replication complex then 
migrates towards the perinuclear location in a MT dependent maimer and is thus
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sensitive to the treatment of Nocodazole (Egger and Bienz, 2005). Nocodazole 
tr eatment results in the appearance of viral RNA dispersed throughout the cytoplasm 
but does not block replication indicating that the migration step is not absolutely 
required for RNA replication. When the Replication complex (RC) reaches the 
perinuclear location the number of individual RCs decreases as they coalesce. It has 
been suggested earlier that such coalescence would increase the chance of mixed 
RCs inside the cell infected with two different virus strains (Egger and Bienz, 2002). 
This process might have an important selective advantage in evolution of new strains 
of virus by means of recombination.
1.4.6 Cell free replicatiou systems for picornaviruses
In picornaviruses the infection cycle begins with the synthesis of all viral proteins 
and these are required for initial negative strand and subsequent positive strand 
synthesis. The whole process of initial translation and subsequent replication is 
interdependent. That makes it difficult to dissect individual steps in a synchronous 
manner during vir-us infection in tissue culture. Subsequently this difficulty has been 
overcome by the development of cell-free replication system in poliovims (Molla et 
al., 1991) and more recently in EMCV (Svitkin and Sonenberg 2003). Essentially 
cell-fiee replication reactions constitute the assembly of an in-vitro reaction using 
HeLa SIO extract programmed with satmating amounts of viral RNA transcripts that 
does not necessitate the generation of new viral mRNA for protein tr anslation (Molla 
et al., 1991; Barton and Flanegan 1993; Barton et al., 1995). Such a system allows 
the dissection of individual steps including viral protein synthesis, RNA replication 
and infectious virion particle production in synchrony that can be detected by ^^ S and 
pulse labelling. However addition of VPg linked RNA isolated from virion itself
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support RNA synthesis more efficiently compared to RNA transcripts made in-vitio 
(Elizabeth Rieder 2005, Europic meeting, The Netherlands; Paul et al., 2005 Europic 
meeting). In addition, the stimulatory effects of 3CD protein on RNA synthesis in 
viti'o also requires VPg linked RNA (Franco et al., 2005). This in-vitro system also 
allows the isolation of pre-initiation replication complexes (PIRC) by using 
guanidine at low concentration (2mM) (Barton and Flanegan 1997). Guanidine at 
low concentrations is non-toxic to the cells and acts as a reversible inhibitor of 
initiation of negative strand synthesis, but does not have any effects on the 
elongation of negative str ands, initiation of positive str ands or elongation of positive 
strand synthesis. Such PIRC can be made replication competent by removing the 
guanidine which then allows the synthesis of negative strands and asymmetric 
positive strand synthesis. To summarize the utility of this system, it allows the 
complete rephcation cycle in vitro in a step by step manner that includes translation 
of viral RNA, assembly of membrane associated replication complexes, VPgpUpU 
formation, VPg linked negative strand RNA synthesis, VPg linked positive strand 
RNA synthesis and complete infectious virion parficle production (Morasco et al., 
2003; Murray et al., 2003). However it should be noted that programming of the 
HeLa SIO extracts with T7 RNA polymerase derived transcripts allows the detection 
of negative strand synthesis but un-detectable levels of positive strand synthesis 
(Barton and Flanegan 1997; Herold and Andino 2000). In vitro derived T7 RNA 
tr anscripts generate RNA with two ‘G’ residues at the 5’ end that are copied into two 
‘C’ residues in the 3’ end of the negative sense RNA which then blocks VPgpUpU 
mediated positive strand synthesis. However T7 transcripts with two ‘G’ residues are 
corrected in tissue culture and there is generally a lag phase of a few hours to corTect 
the non-viral ends. It is still not clear why two non-viral ‘G’ residues can not be
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corrected in cell-free replication system. However this problem can be overcome in 
cell-free system by using either virion RNA or T7 RNA polymerase derived RNA 
transcript with a hammer-head ribozyme at the 5’ end. Ribozymes are antisense 
RNA molecules that are enzymatically active (Scott 1997). They function by binding 
to the target moiety through Watson-Crick base pairing and act by cleaving the 
phosphodiester back bone at a specific target site. The name of hammerhead 
ribozyme is given due to the similarity between its secondary structure and the shape 
of a hammerhead (Birikh et al., 1997). They are the best understood subcategory of 
all ribozymes. Insertion of a hammerhead ribozyme sequence at the 5’ end of the 
viral cDNA produces RNA transcripts in vitro with an authentic 5’end that replicate 
efficiently in the cell-fr ee system (Herold and Andino 2000).
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1.5 Research objectives
1,5.1 Development of a VPg uridylylation assay for foot-and-mouth disease 
virus
Previous studies with poliovims (PV) and human rhinovims (HRV) have shown the 
requirement of VPg peptide for RNA replication. The 3Dpol enzyme first uridylylate 
VPg peptide to form VPgpUpU that acts as the functional primer for both positive 
and negative strand synthesis. Synthesis of VPgpUpU can be reproduced in vitro by 
using either ere or polyA as template ((Paul et al., 1998; Goodfellow et al., 2000). 
Unlike other picomavhuses foot and mouth disease vims (FMDV) contains genetic 
infomiation that encodes three distinct copies of the VPg and the ere function can be 
complemented in trans (Tiley et al., 2003). On the premise of information available 
for other picornavimses, a role of VPg in FMDV RNA replication has been assumed. 
To this end we are interested in developing a VPg uridylylation assay for FMDV. In 
addition, defined roles for ere/bus and 3Dpol precursor protein 3CDpro in this assay 
will be determined. The functional significance of the three distinct copies of the 
VPg and theii" efficiency in FMDV uridylylation system also need to be determined.
Poliovims 3Dpol is able to utilize as a substrate, in addition to its own VPg, the VPg 
of HRV 14 when either poly(A) or cre(2C) RNA is used as a template. In contr ast to 
HRV 14 VPg, the VPgs of HRV2 and HRV89 have barely detectable substrate 
activities on both templates (Paul et al., 2003). Based on those obseiwations, using 
the poliovims polymerase, PV VPg as well as the PV ere, the compatibility of these 
components with the FMDV uridylylation assay will be detemiined.
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1.5.2 Functional analysis of proteins and RNA elements required for RNA 
replication
It has been suggested for PV that some of the precursor proteins like 3AB, 3BC, 
3BCD (precursors of the VPg) could be uridylylated in vitro; the objective will be to 
deteiinine the role of the precursor proteins in the FMDV uridylylation system. In 
addition analysis of the minimum ere sequence requhed for VPg uridylylation will 
be performed.
The function of the 300**™ can be substituted with the 3C protein in PV uridylylation 
system (Pathak et al., 2002). FMDV 30 differs fi’om PV 30 with respect to 
polyprotein processing and the RNA binding activity of the FMDV 30 protein has 
not been established. The nature of the RNA binding activity of the FMDV 30 
protein and its role in RNA replication will be determined.
1.5.3 Development of an in-vitro RNA replication assay for FMDV
In FMDV infected cells RNA replication takes place on specialised membranous 
vesicles (Monaghan et al., 2004). In PV it has been shown that such replication 
complexes are capable of supporting RNA synthesis in vitio (Takeda et al., 1986). In 
this context, the ability of isolated replication complexes, derived hom FMDV 
infected BHK cells will be used to analyse FMDV RNA synthesis in viti'o.
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Bacterial cells, cell lines and viruses
2.1.1 Bacterial cells
E.coli cells DH5a (Invitrogen), SCS 110 (Stiatagene), M15 (Qiagen), BL21DE3 
(Novagen), BL21DE3pCGl (Modified BL21DE3), ER2925 (NEB) and
BL21DE3pLysS (Novagen) were streaked onto LB (Liiria-bertani) agar plates 
supplemented with antibiotics as required and incubated at 37°C overnight. A single 
colony was picked, grown overnight at 37°C in 5ml LB medium. 50|il of the 
overnight culture was added to 5ml LB medium and grown at 37°C until cells 
reached mid log phase ODgoo: 0.2-0.8. 400p.l of this culture was then added to 600p,l 
of a 20% LB-glycerol solution (Appendix II). The cell suspension was vortexed 
gently for uniform mixing and frozen at -70°C until required.
2.1.2 Cells and viruses
Baby Hamster Kidney (BHK) cells were cultured in Dulbecco’s Modified Eagles 
Medium (DMEM) supplemented with 5% foetal calf serum (PCS), 2 mM glutamine, 
penicillin (100 SI Units/ml) and stieptomycin (100 pg/ml).The virus used in this 
study was the FMDV sti'ain 01 BPS. This virus has been passaged through BHK cell 
lines multiple times and uses heparan sulphate (HS) as its receptor in the absence of 
fimctional integiins (Jackson et al., 1996).
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2.2 DNA techniques
2.2.1 PCR
Polymerase Chain Reactions (PCR) (gradient PCR, overlapping PCR) were 
performed using the oligonucleotides listed in Appendix III.
25-5Ong of template DNA was added to 10 pmole of each oligonucleotide (forward 
and reverse), lp.l of dNTP mix (10 mM of each dNTP, Promega), 5p,l of lOX 
Pyrococcus furiosus (Pfu)lThermus aquations (Taq) enzyme buffer and 0.5p.l of 
Pfu/Taq enzyme. The reaction volume was made up to 50p,l with mQ H2O. The 
reactions were subjected to the following amplification cycle: -
Step 1 : Initial dénaturation
Step 2: Dénaturation
Step 3 : Primer annealing
Step 4: Elongation
Step 5 : Repeat steps 2-4 29 times
Step 6: Final elongation
95°C
95T
55°C
72^3
72°C
5 minutes 
1 minute 
1 minute 
2-5 minutes
5 minutes
The PCR samples were stored at -2 0 ‘^ C until required.
2.2.2 Restriction digest
For analytical digests, 5|il of the miniprep DNA, or 0.25 p,g of the midiprep DNA 
were treated with appropriate restiiction enzyme, 2|li1 of the lOX restiiction digestion 
buffer and made up to 20pl with mQ H2O. Digests were incubated for 2 houis at
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37°C. Samples were loaded into the wells of the agarose gels following addition of 
4|li1 of blue/orange 6x loading dye (Promega) and visualized under UV.
For preparative digests, 2.5|Lig of the DNA was added to 5 units of restriction 
enzyme, 2|xl of lOX restriction digestion buffer and made up to 20|il with mQ H2O. 
Digests were incubated for 2 hours at 37°C water bath and 0.5-l|u.l of the digest was 
analyzed on a 1% agarose gel.
2.2.3 Alkaline Phosphatase treatment
Linearised plasmid vectors used for cloning and expression purposes were treated 
with Calf Intestinal Alkaline Phosphatase (CIAP) or Shrimp Alkaline Phosphatase 
(SAP) to prevent recirculaiization and imwanted backgrounds during the cloning 
procedure.
2.2.3.1 CIAP treatment
The digested DNA was incubated for 45 minutes at 37°C water bath using Ijal CIAP 
enzyme/pg of DNA (lU/pl) and 5 pi lOx dephosphorylation buffer (Promega) in a 
50pl reaction volume. For recessed ends a second aliquot of the fresh enzyme was 
added and incubated for 45 min at 55°C. After the incubation, the enzyme was 
inactivated by heat treatment at 15°C for 10 minutes and the fragments were gel 
purified.
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2.23.2 SAP treatment
For SAP tr eatment, digested vectors were treated with SAP enzyme (lU /pg of vector 
DNA) and lOx dephosphorylation buffer (Promega) for 30 min at 37°C and 
inactivated at 65 °C for 15 min.
2.2.4 Agarose Gel Electrophoresis
Agarose gels (1%) were made using electrophoresis grade agarose powder 
(Inviti'ogen) and Ix Tris-acetate-EDTA (TAE) buffer (Appendix II). Ethidium 
bromide was added to the molten agarose at a final concentiation of 0.5pg/ml and 
the gel was allowed to set for at least 30 min at room temperature. Gels were run in a 
Ix TAE buffer containing 0,5pg/ml ethidium bromide. Bands were visualized on 
GelDoc (BIO-RAD).
2.2.5 Low Melting Point Gel Electrophoresis
Low melting point (LMP) agarose gels were used for purification of DNA. LMP 
agarose gels (1%) were made using Ix TAE buffer using electrophoresis giade LMP 
agarose powder (Invitiogen). Ethidium bromide was added to the molten agarose at 
a final concentiation of 0.5pg/ml and the gel was then cast. Gels were run in IxTAE 
buffer containing 0.5pg/ml ethidium bromide. The DNA bands were visualized 
under low intensity UV light and the appropriate bands were excised fiom the gel 
using a scalpel. The DNA was eluted and purified firom the agarose using Amersham 
GFX™ PCR DNA and Gel Band purification kit, according to the manufacturer’s 
protocol. The DNA was eluted in 50pl of mQ H2O and the purified DNA was 
quantified by comparison with XIII DNA marker on a 1% agarose gel.
62
CHAPTER TWO MA TERIALS AND METHODS
2.2.6 Ligation
2.2.6.1 Directional cloning
Ligations were cairied out using 25-lOOng of vector and insert DNA at a molar ratio 
of 1:1 or 1:3. To this, Ijxl of lOx T4 DNA ligase buffer (Promega) and 0.5pl of T4 
DNA ligase enzyme (Promega) was added and the reactions made up to lOp.1 with 
nuclease free H2O. The ligations mixtures were incubated at 16®C overnight and then 
ti*ansformed into suitable competent cells.
2.2.6.2 Blunt end ligation of PCR products
PCR fr agments amplified using Pfu enzyme were ligated into 25ng of the pTT-blue 
blunt ended linearised vector (Novagen). Inserts were made up to a final volume of 
8.7|Li1 with nuclease-free H2O and incubated with 1|li1 T4 DNA ligase buffer 
(Promega) and 0.3|il PolyNucleotide Kinase (PNK) (Promega) for 30 minutes at 
37°C and then for a further 15 minutes at 70°C for the heat dénaturation of the 
enzyme. The pT7-blue vector was then added to each reaction with 0.3p.l of T4 DNA 
ligase. The reactions were incubated at room temperature overnight and tiansfbrmed 
into NovaBlue (Novagen) or DH5a cells.
PCR fragments amplified using Thermus aquations (Taq) polymerase were first 
treated with end conversion mix (Novagen) to polish the ends for blunt end ligation.
2.2.6.3 Oligonucleotide ligation
Complementaiy 5’ phosphorylated oligonucleotides were mixed in a single PCR 
tube (Ipl each of the 100 pmole/(i.l forward and reverse primer stock), denatured for
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2 min at lOO^C and allowed to cool down giadually at room temperature for Ihr. A 
small aliquot of the reaction (0.1 p,l -0.2 (il) was added to the restriction digested 
vector for ligation at 16^C overnight. 5 |nl of the ligation reaction was used for 
transformation.
2.2.7 Preparation of competent £*. coli cells
E. coli cells from the glycerol stocks were streaked on an LB-agar plate and left at 
37°C overnight. Single colonies were picked and giown overnight at 37”C in LB 
broth containing 20mM MgS0 4 . 1ml of the overnight culture was added to 10ml 
fresh LB broth containing 20mM MgS0 4  and incubated at 37°C until the cells had 
reached raid log (ODeoo = 0.2-0.8). These cells were then tiansferred to a 1 liter flask 
containing 50ml LB broth and 20mM MgS0 4  and grown at 37°C until cells reached 
ODeoo 0.9. 200ml LB broth containing 20mM MgS0 4  was then added to the cells 
and they were incubated at 37“C until cells reached ODôoo 0.6. The cells were then 
centrifriged at 4°C, 4,200 rpm for 15 minutes. The pellet of cells was resuspended in 
50ml fresh tiansfbrming buffer 1 (TFBl) (Appendix II) and incubated on ice for 5 
minutes, before being spun at 4”C, 4,200 rpm for 15 minutes. The resulting pellet 
was resuspended in 10ml of ice cold tiansforming buffer 2 (TFB2) (Appendix II) and 
the cell suspension aliquotted into 200|xl sample. These were snap frozen and stored 
at -70°C until required.
2.2.8 Transformation of the competent cells
lOjLil of the ligation reactions were added to 190pl of TCM (Appendix II) and kept 
for 5 minutes on ice. Competent cells were thawed on ice and lOOpl added to the
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mixture for one hour. The samples were then heat shocked at 42*^ C for 30 seconds 
and again kept on ice for 5 minutes. Then 700p,l of room temperature SOC 
(Appendix II) was added and incubated for a further 60 minutes at 37°C with 
constant shaking. The cultuies were centrifuged at 10,000 rpm for one minute and 
most of supernatant removed. The pellet was resuspended in the remaining media 
and the transformed bacterial cells were then plated out onto LB-agar plates 
containing the appropriate antibiotics. For midi plasmid preparations, the cells were 
added to 50ml LB media containing the appropriate antibiotic.
2.2.9 Mini preparation of plasmid DNA
Colonies were picked from the agar plates and grown up overnight at 37®C in 3ml 
LB media containing appropriate antibiotics. 1ml of the overnight culture was 
centrifriged for 2 minutes at 14,000 rpm and the supernatant removed. The plasmid 
DNA was obtained from the pelleted cells using the Wizard Plus Miniprep DNA 
purification system (Promega) as described by the manufacturer. DNA was eluted in 
50pl niQ H2O and 5p,l of the sample was analyzed by restriction analysis and 
agarose gel electrophoresis.
2.2.10 Plasmid midi preps
Midi-prep DNA was obtained using the Qiagen Hi-Speed Plasmid Midi Prep Kit and 
the DNA eluted in 1ml mQ H2O. The DNA was then precipitated using 2.5 volumes 
100% ethanol and 1/10**' volume salt (3M NaOAc). The DNA was quantitated using 
the spectrophotometer.
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2.2.11 QuikChange site directed mutagenesis
Quik-change site directed mutagenesis reactions were performed using mutagenic 
oligonucleotides with desired nucleotide changes according to the manufacturer’s 
insti'uctions (Stratagene). Briefly target DNA was grown in E.coli cells with darn^ 
genotype. QuikChange site directed mutagenesis was performed by using PfiiTurbo 
(Stiatagene) enzyme in a thermal cycler for 12-18 cycles depending upon the number 
of nucleotide changes. Following temperature cycling the amplified product was 
treated with 1 p.1 of Dpnl restriction enzyme (which only cuts methylated DNA) for 
2hr at 37®C, transformed into DH5a cells and colonies selected on LB plates 
containing suitable antibiotics. Five colonies were picked and mini prep DNA was 
isolated. Sequencing of the plasmids DNA was carried out to confirm the presence of 
the desired mutation.
2.2.12 Sequencing of DNA
2.2.12.1 DNA Preparation
0.25-0.50 pg of plasmid DNA was dissolved in dHiO to a final volume of 8.8pl and 
the mixture was heated for 2 minutes at 96°C. The DNA sample was immediately 
placed on ice for 2 min and 3.2pmol of the sequencing primer was added to the 
DNA. 8pl of Quickstart Reaction Mix (Beckman Coulter) was added to each 
reaction and the reactions were then incubated in the mastercycler PCR machine 
(Eppendorf) using the following amplification cycle:- 
Step 1: 96°C 20secs 
Step 2: 50°C 20secs 
Step 3: 60°C 4mins 
Step 4: Repeat steps 1-3 30 times
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2.2.12.2 Ethanol Clean-Up
5pl stop solution was added to each reaction (Appendix II),The mixture was 
vortexed and 60pl ice cold 95% ethanol added to each tube. The reactions were then 
centrifuged for 10 mins at 14,000 rpm, at 4°C and the resulting supernatant removed. 
200|li1 ice cold 70% ethanol was added to the pellet and the reaction was centrifuged 
at 14,000 rpm for 5 minutes to wash the pellet. This step was repeated and then all 
the supernatant was removed and the pellet allowed to air dry. Once dr y, each pellet 
was resuspended in 40pl sample loading solution, loaded onto the sequencing plates 
and covered with mineral oil.
2.2.12.3 Sequencing Reaction
The plates were loaded into the CEQ 8000 Sequencer (Beckman Coulter) and the 
reactions were run.
2.2.12.4 Analysis of Results
The sequencing data was exported into the DSgene sequencing software package and 
analysed.
2.2.13 Plasmid construction
The full-length FMDV infectious cDNA clone (pT7S3) of the OlKaufbeuren stiain 
(Ellard et al., 1999) was used as the template for PCR amplification of specific 
FMDV coding sequences.
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2.2.13.1 pQE30/3DP”‘
The coding sequence of the FMDV 3D^ °* was amplified in a PCR with primers 
3DFORBGL and 3DREVSPH, which contain Bglll and SphI restriction sites 
respectively (Appendix III), using Pfu DNA polymerase. The product was ligated 
into the pT7blue vector (Novagen) to produce pT7/3D*’°*, from this plasmid the 
Bglll-SphI fragment was excised and ligated into the bacterial expression vector 
pQE30 (Qiagen) previously digested with BamHI and SphI to produce pQE30/3D^°*. 
The vector adds an N-terminal hexa-His tag to the 3D*'°* coding sequence.
2.2.13.2 pQE30/3CDP"‘'(C163G)
The coding sequence of 3CDpro was amplified by PCR using oligonucleotides 
3CF0RBGL and 3DREVSPH with Bglll and SphI restriction sites respectively 
(Appendix III). The fragment was cloned in pT7 blue vector (Novagen) by blunt end 
cloning. pT7/3CD^‘^° containing the wild type sequence of FMDV 3CDpro was used 
as a template for modification of the codon (using primers C163FOR and C163REV, 
Appendix III) corresponding to cysteine 163 using the Quikchaiige site directed 
mutagenesis to a glycine codon as described previously (Grubman et al., 1995). The 
resulting plasmid was digested with Bglll and SphI and the modified fr agment was 
ligated between the BamHI and SphI sites of the pQE30 vector.
2.2.13.3 pQE30/3CP“’(C163G)
The coding sequence of O IK  3Cpro was amplified by PCR using oligonucleotides 
01K/3CF0R and 01K/3CREV with BamHI and Hindlll restriction sites 
respectively (Appendix III) using pQE30/3CD’'™(C163G) as a template. The 
fragment was cloned in pT7 blue vector (Novagen) by blunt end cloning. The
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resulting plasmid was digested with BamHI and Hindlll and the released 3C insert 
was ligated between the BamHI and Hindlll sites of the pQE30 vector.
2.2.13.4 pETll-M3C(C163A,C95K)R92S/R95S/R97S
pETl 1M-3C(C163G, C95K) plasmid was a gift from Dr. Stephen Curry (Imperial 
College, London) .The plasmid, under appropriate conditions expresses FMDV 
typeAlO 3C protein (Birtley et al., 2005). This plasmid was used as a template for 
modification of each of the arginine (R) residues at position 92, 95, 97 to serine 
residues by QuikChange site directed PCR mutagenesis using suitable primers 
(Appendix III).
2.2.13.5 pUb-SD""'
For unmodified FMDV 3Dpol expression, a foi*ward primer (Ub3DpolSacII) was 
designed with a SacII site, the coding sequence for the caiboxy terminus of ubiqutin 
followed by the first twenty one nucleotides of the 3Dpol sequence as described 
previously (Gohara et al., 1999). The reverse primer (Ub3DpolBglII) was designed 
such that it contained a Bglll site. The fragment was amplified and cloned into the 
blunt cloning site of the pT7 blue vector (Novagen). Modification of the internal 
SacII site within the FMDV 3Dpol sequence was carried out by using site directed 
mutagenesis kit using SacIImutFOR and SacIImutREV primers (Appendix III). 
Removal of the internal SacII site was confirmed by sequencing as well as by 
restriction digestion. The modified 3Dpol (OIK sti'ain) sequence was ligated 
between the SacII and BamHI site of the pET26b-Ub vector. The newly constructed 
plasmid was named as Ub-3Dpol.
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2.2.13.6 Ub-3B33C, Ub-3Bi233C
For expressing FMDV non-structural precursor proteins 3Bi3C 3Bi233C in the 
ubiquitin system, the respective DNA fragments were amplified by PCR using 
suitable primers (Appendix III) and cloned into pT7-blue blunt linearised vector. 
Mutations within the 3C protease at the Cysteine (Cys) residue to a Glycine (Gly) 
residue in pT7-3Bs3C, pT7-3Bi233C constructs were carried out using Quik-Change 
site directed mutagenesis protocol as described previously. The respective fragments 
were excised from pT7 blue clones using SacII and BamHI and cloned into similarly 
digested pET26b-Ub vector. All the desired mutations in the expression constructs 
were confirmed by sequencing.
2.2.13.7 pGC-cre (wt and mut forms)
The plasmid pGC was a gift fr om Dr Graeme Conn (University of Manchester), and 
contains the Hepatitis D virus (HDV) 5 ribozyme cDNA (Walker et al., 2003). 
Oligonucleotides T7creFOR and T7creREV (Appendix III) corresponding to the 
FMDV OVI cre/bus (Tiley et al., 2003) and preceded by a T7 promoter were 
annealed and ligated into this vector upstream of the ribozyme between EcoRI and 
Nhel sites to produce pGC-cre (see results). This plasmid can be used to produce, 
from a T7 promoter, RNA transcripts that correspond to the FMDV cre/bus. Shorter 
versions of the artificial cre/bus DNA constructs encompassing 37 and 31 
nucleotides respectively were generated using similar methods. The plasmid was 
modified using mutagenic primers (Appendix III) and a QuikChange mutagenesis kit 
(Stiatagene) to construct plasmids which can be tianscribed to produce mutant 
ti'anscripts with A to C substitutions at positions 1-3 within the conserved AAACA
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motif and also mutation in the stem (C47U) within the ere. All the desired mutations 
were verified by sequencing.
2.2.13.8 Generation of full-length infectious pT7S3 clones with cre/bus point 
mutations
Point mutations within the cre/bus in the first 3 ‘A’ residues was canied out using 
the Quik-change site directed mutagenesis protocol. Briefly, the pT7S3 infectious 
clone cDNA was digested with Spel and Notl to release a 3068 bp fragment which 
was ligated into similarly digested pGEM-5Z vector (Promega) to produce pGEM- 
5Z/SN. The newly generated clone was used as a template for modification of each 
of the first 3 ‘A’ nucleotide of the AAACA motif within the cre/bus using 
QuikChange site mutagenesis using OlKcremut primers listed in Appendix III. The 
modified fragments containing the required mutations were released from pGEM- 
5Z/SN derivatives and reconstructed back into the pT7S3 backbone. The respective 
mutations in the full-length cDNA were verified by sequencing.
To achieve a deletion of the AAA sequence from Üie AAACA motif, an overlap 
PCR mutagenesis protocol was performed using the OlKcreDel primers (Appendix 
III) with pT7S3 as the initial template. The external primers were designed to 
generate an amplified product (about 125Ont) that contained the naturally occurring 
Spel and Xbal sites of the pT7S3 infectious clone. The final product was digested 
with Spel and to generate a smaller 743 bp fragment which was ligated into the 
similarly digested pT7S3 backbone to produce pT7S3creDel. The presence of the 
required mutation in the cre/bus region in this plasmid was verified by sequencing.
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2.2.13.9 Generation of infectious pT7S3 clones with hammerhead ribozyme
Hammerhead ribozyme constructs were made using forward primer (pT7S3-Ribo- 
FOR) containing a Spe I  restriction site, T7 promoter, hammer-head ribozyme core 
sequence followed by the 5’ 17 nucleotides of the FMDV genome (FIG. 2.1). The 
reverse primer (pT7S3-Ribo-REV) was designed to include the natural Nhel site just 
upstream of the polyC tiact (Appendix III). The product was PCR amplified using 
Taq DNA polymerase (Invitiogen) and cloned into pT7-blue blunt vector (Novagen). 
The resultant clone was digested with Spel and Nhel to release a fr agment (469 bp) 
and ligated into the similarly digested pT7S3 infectious clone. Presence of the 
hammer-head ribozyme in the final constructs was verified by sequencing and also 
by in~viti^o transcription.
2.2.13.10 Construction of FMDV infectious cDNA clone with single amino acid 
substitution (arginine to serine at position 92,95 and 97) in the 3C protease
A PCR fragment (1750 bp) encompassing the FMDV 3C coding sequence along 
with the natural Bel I  and Bip I  restriction sites was amplified using primers 
OlKBclI and OlKBlpI (Appendix III) and ligated into the pT7-blue blunt end 
cloning vector. The newly constructed clone (pT7-BB) was used as a template for 
site directed mutagenesis using QuikChange mutagenesis kit (Stiatagene) to 
inti'oduce mutations in the codon for the amino acid arginine at position 92, 95 and 
97 to encode serines (for R92S, R95S, R97S mutagenic primers, see Appendix III). 
Positive clones were grown for midi-prep plasmid isolation using dam and dam' E  
coli stiains (ER2925 fr om NEB) and digested with Bel I  and Bip I  to release an insert 
of 1729 bp and introduced into similarly digested FMDV infectious c-DNA clone 
(with or without ribozyme).
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FMDV Ribozyme forward oligo
Spe /  T7 promoter_________ Base pair with FMDV 5’ terminus
TGGACTAGT TAATACGACTCACTATAGGG CCTTTCAA
Ribozyme core ^
CTGATGAGGCCGAAAGGCCGAAAACCCCGTATCCGGGGTTCaTTGA
17 nt at FMDV 5' terminus I---------------------------------------------------------------------------  Cleavage siteAAGGGGGCATTAG
/ • /  80c-
-u-
/
u
X  /
! Y
\ I
FIG.2.1. Designing FMDV ribozyme construct. Panel A. Shows the forward primer designed for 
FMDV ribozyme construct that contains the FMDV staffer sequence (with Spel restriction site), T7 
promoter sequence, and hammer-head ribozyme core sequence. Panel B. Secondary structure prediction 
of the above mentioned nucleotide sequence using M.Zucker RNA folding server.
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2.2.13.11 pSP64polyA/S-fragment. The nucleotide sequence of the FMDV S- 
fragment was amplified using oligonucleotides S-frag-FOR and S-frag-REV 
(Appendix III) with PstI and Xbal restriction sites respectively. The resulting 
fragment was cloned into pT7 blue vector by blunt end cloning and sub cloned into 
the corresponding sites of pSP64polyA vector (Promega). RNA transcripts 
coiTesponding to the S-fr agment were produced by in-vitro transcription using Xbal 
linearised pSP64polyA/S-fi'agment clone.
2.2.13.12 pT7-(PK+cre+IRES). The nucleotide sequence of the FMDV 5’ UTR 
encompassing the pseudoknots (PKs), cre/bus and 1RES was amplified by using 
oligonucleotides poly(C)-down-FOR and IRES/REV (listed in the Appendix III). 
The amplified PCR product was cloned in pT7-blue blunt end cloning vector as 
described previously.
2.3 RNA techniques
2.3.1 In-vitro transcription
Plasmids meant for in-vitro transcription were linearized with suitable restriction 
enzymes. The DNA was purified by phenol extraction and ethanol precipitation and 
then used as template for transcription reaction as follows using MEGAscript high 
yield transcription kit according to manufacturer instructions (Ambion)
2  pi ATP solution
2  pi CTP solution
2  pi GTP solution
2  pi UTP solution
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2  pi 
8  pi 
2  pi
1 0  X reaction buffers 
linear template DNA 
Enzyme mix
For shorter RNA tr anscripts {cre/bus) the reaction mixtures were incubated overnight 
at 37°C whereas for longer transcripts, reaction mixtures were incubated for 2-4 hrs 
(shorter duration) at 37°C. RNA transcripts were purified by phenol extraction and 
ethanol precipitation. The cre/bus RNA transcripts were analyzed by denaturing 
urea-PAGE and the longer transcripts were visualized by native TBE gel/ denaturing 
formaldehyde-agarose gels. The yield of the RNA transcripts was determined by 
spectrophotometry.
2.3.2 Urea-PAGE electrophoresis
Polyacrylamide urea gels (8 %) were used to analyze the in vitr o transcribed cre/bus 
RNA transcripts.
The following recipe were used for 10ml of gel solution
1.9ml 40% acrylamide bis-acrylamide
7.0ml lOM urea
1.0ml 1 OX TBE
0 .1ml 10% APS
5.0 pi TEMED
All the component were mixed quickly, poured into the gel apparatus and allowed to 
polymerize for at least Ihr. Gel wells were rinsed with TBE buffer prior to 
electrophoresis. The gel was run at 150-200v in IX TBE running buffer and stained
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with ethidium bromide at 0.5 pg/ml for 10-20 minutes and photographed under UV 
illumination (305nm).
2.3.3 Native agarose gel electrophoresis of RNA
To assess the overall integrity and quality of the larger RNA transcripts native 
agarose gel electrophoresis were carried out using 1% agarose gel in TBE. Usually 
Ipg of the RNA transcripts were loaded per well along with RNA molecular weight 
markers (Novagen) and visualized by ethidium-bromide (EtBr) staining.
2.3.4 Denaturing formaldehyde-agarose gel electrophoresis of RNA
For denaturing gel electrophoresis appropriate amounts of agarose, lOX FA gel 
buffer (Appendix II) and RNAse free water were mixed and boiled in a microwave. 
The molten agar then cooled to 65**-70**C in a hot water bath. After cooling, for 
100ml gel, 1.8 ml of 37% (12.3 M) formaldehyde and 5 pi of a lOrag/ml ethidium 
bromide were added in a flime hood. The gel was poured on to a gel tiay to a 
thickness of 3-5 mm. Combs were inserted immediately into the gel and allowed to 
set for at least 30 min. Electrophoresis tanks were treated with detergent solution 
(0.5 % SDS), rinsed with RNase-free water, and then rinsed with ethanol and 
allowed to dry. The gel was allowed to equilibrate with the FA running buffer 
(Appendix II) for 30 min prior to sample loading. The RNA samples were treated 
with denaturing sample buffer II (Appendix II) and heated for 10 min at 75**C. The 
denatmed samples were snap cooled in ice for 1 0  min and loaded into the gel which 
was allowed to mn for 2hr at 80V and RNA bands were visualized under UV.
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2.3.5 UV shadowing
Non-radioactive cre/bus RNA transcripts were mixed with 2X gel loading buffer II 
(Appendix II), heat denatured at 75**C for 2 min and snap cooled on ice for 5 min. 
Samples were loaded directly to freshly rinsed well of 8 % urea-PAGE gel and run at 
170V till the bromophenol blue (BPS) dye fr ont reached the bottom of the gel. The 
glass plate was carefrilly removed and the gel was covered with a thin saran wrap on 
both sides. The wrapped gel was placed over the top of a fluorescent thin-layer 
chromatogi'aphy (TLC) plate (the white side of the TEC plate faced the gel). RNA 
tianscripts corresponding to the cre/bus were visualized by a hand held UV light 
source (254 nm) as a purple band and marked with a marker pen over the saran wrap. 
The marked band was cut with a razor blade and put in RNA elution buffer (lOmM 
Tris, 0.1% SDS, ImM EDTA) overnight. The elution buffer was collected and the 
RNA was extracted with phenol: chloroform: isoamyl alcohol and subsequently 
precipitated with absolute ethanol.
2.3.6 Preparation of [^^P]-labeled RNA
Radioactive probes for UV-crosslinking were prepared by using Ambion’s maxi­
script kit. To generate probes with the highest specific activity [^^P]a-UTP were used 
as the limiting nucleotide without any cold UTP. The in-vitro transcription reactions 
were set up using linearised template DNA as follows.
1 pi lOmM ATP solution
1 pi lOmM CTP solution
1 pi lOmM GTP solution
5 pi [^^P]-UTP solution
2 pi 10 X reaction buffers
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8 pi linear template DNA
2  pi enzyme mix
The reaction mixture was incubated for 1-2 hr at 37°C and stopped by adding Ipl of 
0.5M EDTA. Residual DNA template from the reaction was removed by adding Ipl 
DNase I and incubated for 30 min at 37°C. An equal volume of 2X gel loading 
buffer was added, heated for 2  min at 75**C and loaded into the well of fr eshly rinsed 
8 % urea-PAGE gel. Electiophoresis was stopped once the bromophenol blue dye 
reached the bottom of the gel. The gel was covered with a saran wrap and an 
autoradiograph was developed by exposing the film for 30 sec-2 min. A dark band
on the autoradiograph was marked with a marker pen. The marked area on the
autoradiograph was excised using a sharp scalpel and again placed over the gel. The 
gel corresponding to the cut region was carefully removed and put in RNA elution 
buffer (lOmM Tris, IriiM EDTA, 0.2% SDS) overnight. The elution buffer was 
collected and treated with ammonium acetate and glycogen. The probe was 
recovered by phenol extraction and ethanol precipitation.
2.3.7 UV-cross linking
Approximately 50 pg of cell extracts (BHK SIO extracts (uninfected or infected), 
HeLa SIO extracts) or 0.5 pg of purified recombinant proteins (3CD, PCBPl, 
PCBP2) were incubated with uniformly radiolabeled probe (2x10^ cpni) in 20 pi of 
10 mM HEPES-KOH (pH 7.9), 25 mM KCl, 2mM MgCb, 10% glycerol, 0.05% NP- 
40, 0.5 mM DTT, 10 pg t-RNA. After 30 min incubation on ice, the reaction 
mixtures were UV cross-linked for 30 min on ice keeping the sample 10 cm fr om the 
UV source. The un-protected probes in UV-irradiated extracts were digested with 2
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pi RNase cocktail (Ambion) for 30 min at 37®C. The RNA-cross linked proteins 
were resolved in 10% SDS-polyacrylamide gels. After gel electrophoresis, the gels 
were stained in coomassie blue, destained, dried and ^^P-labelled complexes were 
visualized by autoradiography.
2.3.8 Electrophoretic mobility shift assay (EMSA)
Gel purified in vitio transcribed cre/bus RNA (50 pM) and FMDV AlO 3C proteins 
[(wt 3C or mutant 30 (R92S, R95S, R97S)] (20-250 pM) were incubated in a 20 pi 
reaction mixture in buffer conditions similar to the in vitio uridylylation assay (50 
mM HEPES, 8 % glycerol, 2mM MgCb) for 30 min at 30“C to allow complex 
formation. Samples were run on a 5% native polyacrylamide gel in 0.5X TBE buffer 
at room temperature for 2 hr. After electrophoresis the gel was stained in EtBr and 
visualised under UV. To visualise the 3C protein in the RNA-protein complex the 
gel was stained with coomassie brilliant blue.
2.3.9 Trizol extraction of RNA from tissue culture cells
Membrane fractions frrom FMDV infected BHK cells were treated with Trizol (500 
pi Trizol/ 50 pi of membrane fr action) and incubated for 5 min at room temperature. 
Subsequently 100 pi of chloroform was added, mixed well by vortexing and kept for 
another 3 min at room temperature. The samples were centiifuged at 12, 000 rpm for 
15 min at 4°C. Phenol and chloroform formed a lower organic red phase that 
contained all the protein and DNA. The upper clear aqueous phase containing RNA 
was collected carefully and this was precipitated by using 2pg glycogen and 250 pi 
of isopropanol at room temperature for 10 min. The samples were centi iftiged at 12, 
000 rpm for 10 min at 4**C. The pellet obtained was washed for 5 min at 12, 000 rpm
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by using 70% ethanol to remove any salt. RNA samples obtained were dissolved in 
RNA storage solution (Ambion) and stored at -70°C.
2.3.10 Electroporation of RNA into BHK cells
Fresh BHK cells were passaged the day before the electroporation to obtain 60%- 
70% confluency. Cells were split by tiypsinisation and resuspended in 10 ml of 
electroporation buffer (Appendix II). Viable cell counts were carried out and total 
cells were collected by centi'ifiigation at 200g for 3 min at 4°C. The cell pellet was 
resuspended at 2 xlO^/ml of electi'oporation buffer and 0 . 8  ml of the cells was 
transferred into an ice-cold electioporation cuvette. Approximately 4 pg of the 
FMDV RNA was added to the cuvette and shocked (0.75kV and 25pFD) using an 
electroporator (Bio-Rad). The cuvette was placed at room temperature for 10 min 
and cells were transferred to a 25cm^ culture flask containing 5ml of virus growth 
media. The flask was incubated overnight at 37**C in a CO2 incubator.
2.3.11 Plaque assay
Cells were seeded into 35 mm dishes, 16 hours prior to infection. Monolayers (-80% 
confluent) were washed with phosphate buffer saline (PBS) (pH 7.5 containing 2 
mM CaCb, ImM MgCb). Virus dilutions (200pl in PBS) were added to the cells for 
15 min at 37“C. The cell monolayers were then overlayed with 4 ml of molten Eagles 
overlay (Eagles medium supplemented with 0.6% indubiose, 5% tiyptone phosphate 
broth, 1% foetal calf serum, 100 SI Units/ml penicillin and 100 pg/ml streptomycin). 
Cells were then incubated at 37°C, 5% CO2 for 40-48 hours. Plaques were visualised 
by staining cell monolayers with methylene blue, 4% formaldehyde in PBS.
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2.3.12 Isolation of replication complexes from FMDV infected BHK-21 cells
BHK-21 cells were gi*own overnight up to 100% confluent in 175-cm^ flasks in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % PCS. The 
excess media was decanted leaving little residual media without making the 
monolayer dry. FMDV OIBFS virus was adsorbed onto the monolayer with or 
without the presence of guanidine hydrochloride (lOmM) and kept on a rocking 
platform at 37°C for 15 min followed by 15 min at 37®C incubator. An additional 25 
ml of DMEM media with 10% PCS was then added. The virus was allowed to grow 
till the CPE was observed in the infected cells. A mock infected BHK-21 monolayer 
was kept as a negative control. At about 3-4 hrs when the cells started rounding up 
(but had not detached from the plastic surface) the media was removed and the cells 
were washed with cold PBS. The cells were resuspended in 15 ml of fresh PBS and 
then pelleted at 500xg for 5 min at 4°C. The supernatant was discarded and the pellet 
was resuspended in 1 ml cold hypotonic TN buffer (Appendix II) and kept for 15 
min in ice. Cells were lysed with 30-40 strokes in a cold 15 ml glass Dounce 
homogenize!'. The lysate was tiansferred to 1.5 ml Eppendorf tubes and centrifuged 
for 5 min at 900xg at 4°C to remove any unlysed cells and nuclei. The supernatant 
was transferred to a fr esh Eppendorf tube and centrifriged for 20 min at 20,800xg at 
4°C. The resultant pellet (FMDV replication complexes (RCs) or mock RCs) was 
resuspended in 120 pi TN buffer with 15% glycerol and stored at -70°C.
2.3.13 In-vitro RNA replication assay
RNA replication assays were performed (as described by Green et al., 2003) using 
reaction mixtures containing 18 pi of FMDV RCs or mock RCs, 50mM HEPES (pH 
8.0), lOmM DTT, 3mM MgCb, 0.25 mM GTP, 0.25 mM CTP, 1.0 mM ATP, 0.04
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mM [a-^^P]UTP and unlabelled UTP, 10 pg/ml Actinomycin D, 25 pg/ml Creatine 
phosphokinase (CPK), 5mM Creatine phosphate, 800 U of RNasin/ml, 50 mM 
potassium acetate. Gu-HCl was added when required (at a final concentration 
lOniM) in the reaction mixture. Assays were carried out for 1 hr at 30°C. Reactions 
were stopped by adding 150 pi of TENSK at 37°C (Appendix II). RNA extinction 
was carried out using phenol: chloroform: isoamylalcohol (25:24:1). An aliquot of 
the extiacted RNA (usually 1/5 to 1/10 of the sample) was run in a native agarose gel 
at 100 volt for 2 hrs. The bottom of the gel was cut to remove any unincorporated 
nucleotide and gel dried under vacuum for 30 min without heat followed by drying at 
60°C for 30 min. The dried gel was exposed overnight for autoradiogiaphy.
2.3.14 RNaseA protection assay
In vitro RNA replication assays was performed as described above. The whole 
aliquot o f the reaction was centrifuged at 12,000 rpm for 5 min to pellet the entire 
membrane fraction. The supernatant was discarded that contained the unincorporated 
radiolabelled UTP. The membranous pellet was treated with Triton-X 100 in RNase 
A buffer to a final concentration of 0.1%. RNase A was added at the rate of Img of 
RNase A/ml of RNase A buffer containing 300mM NaCl and lOmM Tris (pH 7.8). 
A duplicate reaction was performed without RNaseA as contiol. The reaction 
mixture was incubated for 30min at 37**C. The RNA from the replication complex 
was isolated by Trizol (Invitiogen) as per the manufacturer’s instruction and run in a 
1% TBE agarose gel. The gel was diied and exposed.
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2.3.15 RNaseA sensitivity Assay
RNA replication assays were performed as described above and RNA was extiacted 
by Phenol:chloroforin:isoamylalcohol. An aliquot (1/5*'^ ) of the total RNA was 
dissolved in RNaseA digestion buffer with 300mM salt. The residual RNA was 
treated with RNaseA at the rate of 0.2 pg of RNaseA/ml of RNaseA buffer. The 
whole reaction mixture was incubated at 23^C for 15 min. Both RNaseA tieated and 
untreated samples were extracted with phenol:chloroform:isoamylalcohol and 
samples were analysed on a 1% TBE gel.
2.4 Protein techniques
2.4.1 Expression and purification of FMDV native 3Dpol
Protein expression and purification was carried out using the protocol described by 
Gohara et al., 1999. The plasmid Ub-3Dpol was transformed into BL21(DE3)pCGl 
cells for induction and expression of the protein. Briefly BL21(DE3)pCGl cells 
containing the Ub-3Dpol plasmid were gi'own overnight in 100 niL of NZCYM 
media supplemented with Kanamycin (25pg/mL), Chloramphenicol (20pg/mL), and 
0.4% glucose at 30®C. The overnight culture was used to inoculate IL of fresh 
NZCYM media supplemented with Kanamycin and chloramphenicol, and grown to 
ODeoo 1.0 at 37®C. The cells were cooled down to 28*^ C, induced with IPTG (final 
concentration of 500 pM) and grown for an additional 4 h at 28^C. The cells were 
harvested using a Soiwal GS-3 rotor at 6000 rpm for 15 min, washed once in 200 mL 
of TE (lOmM Tris, ImM EOT A). The cell paste obtained was weighed and stored at 
-70^C for future use.
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For protein purification, the fiozen cells were thawed in ice and suspended in lysis 
buffer (50mM potassium phosphate (pH 8.0), 500mM sodium chloride, 20% 
glycerol, lOmM mercaptoethanol, protease inhibitor cocktail set III , 0.1% NP40) 
using 5mL/g of cell paste. The suspended bacterial cells were fi ozen in liquid N2 and 
thawed in ice-cold water for 30 min. The thawed samples were lysed by sonication 
on ice. Protease inhibitor cocktail set III (Calbiochem) was added to a final 
concentration of ImM to inhibit any protease mediated protein degiadation after 
lysis. Precipitation of the nucleic acid was canied out by using polyethylenimine 
(PEI) to 0.25% (v/v). PEI was added drop by drop at 4®C for 30 min with constant 
stiiTing. The extiact was centrifuged for 30 min at 15, 000 rpm at 4^C to pellet the 
cellular debris and nucleic acid. The PEI supernatant was collected and solid 
powdered ammonium sulphate was slowly added upto 30%-40% saturation. The 
ammonium sulphate-precipitated material was then pelleted by centiifugation for 2 0  
min at 9,000 rpm at 4®C. The supernatant was decanted and the pellet was suspended 
in buffer A (50niM Tris, pH 8.0, 20% glycerol, 50mM sodium chloride, lOmM 
mercaptoethanol and 0.1% NP40) and dialysed overnight.
Subsequent purification of the native FMDV 3Dpol was canied out using an Akta- 
prime protein purification system hom Amersham Biosciences. The dialysed sample 
was loaded onto a 15mL phosphocellulose column (PI 1, Whatman) equilibrated 
with buffer A at a flow rate of 0.5 mL/min. The column was washed to baseline with 
buffer A containing 50mM NaCl and protein was eluted using a linear gradient (5 
column volume) fi'om 50mM to IM NaCl in buffer A. 1.5 mL hactions were 
collected and protein purity was analysed by Coomassie staining of the SDS-PAGE 
gel. Peak fiactions with 3Dpol protein were pooled and dialysed against buffer A
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with 50mM NaCl. The dialysed sample was loaded onto a buffer A equilibrated 1 
niL hi-tiap Q-sepharose column at 0.2 mL/min.The column was washed with buffer 
A with 50 mM salt and eluted with linear gradient (5 column volumes) from 50mM 
to 2.0M NaCl in buffer A. Pure 3Dpol fiactions were pooled and dialysed for 3 h 
against buffer A containing 50mM salt and further concentiated by loading onto a 
buffer A equilibrated 1 mL Heparin column and eluted using 2 column volumes of 
buffer A in a linear giadient from 50mM to 2.0M salt. The concentiated fraction was 
dialysed against buffer A (50mM salt) for 6 hrs and stored at -70^C.
2.4.2 Expression and purification of histidine-tagged 3DpoI, 3Cpro and 3CDpro
To express His-tagged FMDV O IK  3Dpol, 3Cpro and 3CDpro, the appropriate 
plasmids were transformed into Escherichia coli strain M15. Growth and induction 
of the cultures were done essentially as described for the native 3Dpol. For 
3Cpro/3CDpro, IPTG induction was earned out with 100 pM final concentiation of 
IPTG. His-tagged 3Dpol expression and purification was performed essentially as 
described above except the phosphocellulose column purified sample were directly 
loaded onto a 1-ml hi-trap His-column (Amersham Bioscience) and eluted by step 
elution using 500 mM imidazole. For 3Cpro/3CDpro purification 500 mM NaCl 
concentiation was kept constant throughout lysis, binding and for elution. The eluted 
3Dpol and 3Cpro/3CDpro samples were dialysed against Buffer A containing 50mM 
and 500 mM NaCl respectively.
2.4.3 Purifications of FMDV VPg precursor protein 3BC
Expression and purification of the native 3BC proteins (3Bi3C 3Bi233C) were 
performed essentially as described for native 3Dpol. The phosphocellulose column
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purified samples were directly loaded onto a 1-ml hi-trap SP sepharose column 
(Amersham Bioscience) and eluted by gradient elution using buffer A with 500-750 
mM salt.
2.4.4 Protein Dialysis
Purified protein samples were dialysed overnight using a ‘Slide-a-Lyser’ cassette 
(Pierce) with 7 kilo Dalton molecular weight cut off (7 IcD MWCO) against 1 litre of 
suitable buffers. The samples were collected, aliquotted and stored at -70°C.
2.4.5 Estimation of protein concentration
Protein concentiation was determined by using the following molar extinction 
coefficients: 1280 M'* cm'* (VPg 1 A^Pg2/VPg3), 51850 M'* cm'* (3Dpol), 61170 M' 
* cm'* (3CDpro), 9320 M'* cm'*(3Cpro), 10600 M'* cm * (3Bi3C) and 13160 M'* 
cm'*(3Bi233C). These values were determined by using protein parameters tool 
(ProtParam) on the ExPASy site (www.expasv.orgl. The absorbance values were 
measured at 280 nm in 6  M guanidine HCl (Gu-HCl), pH 6.5.
2.4.6 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
Protein samples were analyzed by SDS-PAGE. A 10% separating gel and 5% 
stacking gel containing 0.1% SDS was prepared (Sambrook and Russell 2001 3' '^ 
edition). The electrophoresis was canied out in Tris-Glycine buffer on a vertical slab 
gel electi'ophoresis system (Bio-Rad) using constant current of 40mA. Prior to 
loading, the samples were heated at 95°C for 5 minutes in 3X sample buffer (Bio- 
Rad). Gels were stained using Coomassie Brilliant Blue. Standard Pre-stained
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moleculai' weight markers (NEB) were used to determine the size of the protein 
samples.
2.4.7 Tris-tricine polyacrylamide gel electrophoresis
For separation and visualization of small VPg peptides (~2kD), the Tris-tricine gel 
electrophoresis system was used. To analyse the results of the in-vitio uridylylation 
assay, 14% Tris-tiicine gels were prepared using tiicine gel buffer (Appendix II), 
40% acrylamideibisacrylamide (29:1) and glycerol as follows:
Resolving gel stacking gel
Tricine gel buffer 5 ml 1.5 ml
40% acrylamide:bisacrylamide 5.3 ml 0.6 ml
Glycerol 2 g
mQ water up to 15 ml 6.0 ml
APS 100 pi and TEMED 15 pi
The gel was allowed to set for at least 1 hr. Samples were prepared by heating at 
95°C for 2 min in 3X tiicine sample buffer (Appendix II) and loaded on to a freshly 
rinsed well of the gel. Electrophoresis was carried out by using IX cathode buffer 
(Appendix II) at 150v till the dye front run off the gel.
2.4.8 Western blot
Cell lysates or purified proteins (approximately 100 ng) were resolved by 10% 
sodium dodecyl sulphate (SDS)-polyacrylamide gel electi'ophoresis (PAGE) using 
Tris-glycine running buffer as described above. Protein samples were transferred
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electrophoretically to nitrocellulose membrane (Immobilion) in a wet tiansfer tank 
(Bio-Rad). The membrane was then blocked overnight at 4**C with 5% blocking 
solution (skimmed milk powder in TBS-T) (TBS + 1% Tween, see Appendix II). 
The membrane was then incubated at room temperature with primary antibody 
(using a suitable dilution in blocking solution) for 1 hr. The membrane was washed 
extensively three times 5 min each using TBS-T. Subsequently the membrane was 
incubated with HRP conjugated secondary antibody (Amersham biosciences) diluted 
in blocking solution for 1 hr at room temperature. The membrane was then washed 
extensively as above and detection was achieved using the ECL plus system 
(Amersham Biosciences).
2.4.9 PolyU polymerase activity assays
PolyU polymerase assays were performed (as described by Gohara et al., 1999) in a 
total volume of 20 pi containing 50 mM HEPES buffer (pH 7.5), 10 mM 2- 
mercaptoethanol, 5 mM MgCb/MnCL, 60 pM ZnCh, 500 pM UTP, 0.2 pCi/pL [a- 
32p]0Tp, 1 ,8  pM dTis/0.15 pM poly(rA)5oo primer/template and IpM 3Dpol. 
Reactions were canied out at 30°C for 5 min followed by quenching with 0.5 M 
EDTA to final concentration of 100 mM. 10 pi of the quenched reaction was spotted 
onto DE81 filter paper discs and diied completely. The discs were washed three 
times for 5 min in 5% dibasic sodium phosphate and rinsed in absolute ethanol. 
Bound radioactivity was quantified by liquid scintillation counting in 5 mL of 
Escoscint scintillation fluid and the number of pmoles of UTP incorporated per pmol 
of 3Dpol/ min was measured.
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2.4.10 In vitro uridylylation assay
The synthesis of VPgp(U)pU was measured by using an assay similar to that 
described before (Paul et ah, 1998 and Goodfellow et ah, 2003). The reaction 
mixture in total volume of 20 pL contained 50 mM HEPES (pH 7.5), 8 % glycerol, 2 
mM MgCh, 12.5 pM VPg (any deviation in the VPg concentration is listed in 
appropriate figure legends), IpM cre/bus RNA transcripts, 0.75 pCi [a-^^P]UTP 
(100 pCi/ pL, Amersham Bioscience), 10 pM UTP. 1 pM 3CDpro [(C163G) with 
amino terminal His tag] and 1 pM 3Dpol were mixed together and added to the 
reaction. The final NaCl concentration in the reaction was kept at 6.25 mM. 
Reactions were carried out for 30 min at 30°C and stopped by addition of 10 pi of 
Tris-tricne loading dye. The samples were analyzed by Tris-tricine sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis with 14 % polyacrylamide. Gels were 
di'ied without fixing and autoradiographed. The reaction products were quantitated 
with a Phosphorlmager (Molecular Imager FX, BIO-RAD) by measuring the amount 
of [^^P] UMP incorporated. VPgpU(pU) refers to the sum ofVPgpU and VPgpUpU.
To determine the differential efficiency of uridylylation of each VPg(l-3) peptides, 
standard reactions were assembled as described above with varied concentrations of 
VPg 1-3 ranging from 1 pM to 10 pM for 10 minutes. The samples were analysed by 
using a bigger Tris-tricin gel. The purpose is to separate three radiolabeled band that 
is end-labeled cre/bus RNA products, VPgpU(pU) and the unincorporated hot UTP. 
The gel was caiefrilly removed and covered with a saran wi'ap. The radioactivity of 
each band was quantified without diying the gel by Phosphorlmager and the 
percentage of [^^P] UMP incorporated into each VPg was determined.
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CHAPTER THREE 
Development of a foot and mouth disease virus VPg uridylylation 
assay
Recent studies on the mechanisms of replication initiation of PV and HRV RNA 
have established the requirements for in vitro uridylylation of VPg to be: VPg, 3D^“*, 
3 CD, RNA tianscripts containing the ere plus UTP and divalent metal ions, either 
Mn^^ or Mg^^ (Gerber et al., 2001a, b; Paul et al., 2000, 2003a,b). To establish a 
similar assay system for the FMDV it was necessary to generate the equivalent 
reagents.
3.1 Recombinant protein production
3.1.1 Expression and purification of histidine tagged FMDV 3D‘’“‘
The coding region for FMDV 3D^ ®* was amplified using a PGR and inserted into the 
bacterial expression vector pQE30 (Qiagen). An N-terminal His-tagged form of 
3D^ °* was efficiently expressed fiom this vector in E. coli M l5 (FIG. 3.1, Lane 2) 
and purified using Hi-Trap His-column (Amersham Biosciences) to near 
homogeneity as judged by coomassie blue staining and immunoblotting using anti- 
3D antibodies (FIG. 3.2, Panel A and Panel B)
3.1.2 Expression and purification of histidine tagged FMDV 3CD'”^®
cDNA encoding the FMDV 3CD precursor protein was amplified by PCR. Within 
the FMDC 3C, His-46, Cys-163, Asp-84 ar e part of the catalytic triad and His-181 is 
part of the binding pocket (Grubman et al., 1995). The catalytic activity of the 3C 
protease was blocked by modification of the cysteine codon (TGC) at residue 163 to 
a glycine (GGC) codon (FIG. 3.3, Panel A). This modification was verified by DNA
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è è
62kD
48kD
3CDpro
3Dpol
FIG.3.1.SDS-PAGE analysis of un induced and induced M15 cells harbouring pQE30-3Dpol and pQE30-3CDpro 
plasmids. Expressiai of 3Dpoi and 3CD proteinase (proteolytically inactive) was achieved as described in the materials 
and methods.0.5 mi o f the sample was pelleted and suspended in 90 pi o f PBS. 30pl o f 3X loading dye (Bio-Rad) 
was added, heated for 5 min at 95°C and loaded onto an 10% SDS PAGE gel. The gel was stained with Coomassie 
brilliant blue R-250 and subsequently destained. Lane 1, uninduced M15 cells harbouring pQE30-3Dpol, lane 2,
M15 cells harbouring pQE30-3Dpol and lane 3, M15 cells harbouring pQE30-3CD after 4-h induction.
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FIG.3. 2. Gel analysis of FMDV 3Dpol, His-3D, 3CD, and VPgl to 3. Purified recombinant 
His-tagged 3D (termed His-3Dpol), His-tagged 3CD(CI63G) (termed His-3CD), and the untagged 
3D (3Dpol) were analyzed by SDS-PAGE and either stained directly with Coomassie blue (A) or 
transferred to an Immohilon membrane and detected using an anti-3D monoclonal antibody 
(kindly provided by E. Brocchi) with peroxidase-labeled goat anti-mouse immunoglobulin and 
chemiluminescence reagents (B). (C) Synthetic peptides (10 nmol [lanes a], 20 nmol [lanes b], or 
30 nmol [lanes c]) corresponding to 3B1, 3B2, and 3B3 were analyzed on Tris-Tricine gels 
(16.5% acrylamide) and stained with Coomassie blue. Lane M contains a molecular weight marker 
(175,000 to 6,000; New England Biolabs).
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sequencing and the mutant 3CD coding sequence was inserted into pQE30 as above. 
The His-tagged 3CD(C163G) was also efficiently expressed in E. coli Ml 5 (FIG. 3. 
1, Lane 3) and purified to near homogeneity as detected by coomassie blue staining 
and immunoblotting (FIG 3.2, Panels A and Panel B). As expected, the 3CD 
migrated more slowly than the 3D^ °* confirming that the modification of the 3C 
sequence blocked its proteolytic activity.
3.1.3 Expression and purification of native FMDV 3D^ "*
To express the FMDV 3D^ °* without any additional sequences, the 3D^ °* cDNA was 
amplified using a PCR, modified to remove an internal SacII site, and inserted into 
the vector pET26-Ub as described (Gohara et al., 1999, FIG. 3.3, Panel B) to 
generate pUb3D^°*. This plasmid efficiently expressed a ubiquitin-tagged FMDV 
3D^ °* in E. coli and when co-expressed with the ubiquitin-specific protease Ubp2, by 
co-transformation of E. coli BL21 (DE3) with pUb3D^°* and pCGl, cleavage 
occurred to liberate the untagged FMDV 3D^ °* (FIG. 3.4, Panel A). It was observed 
that even after 4 hrs of co-expression the processing of the ubiquitin-tagged 3Dpol to 
native 3Dpol was incomplete (FIG. 3.4, Panel A). However during the course of the 
purification, the ubiquitin-tagged 3Dpol was completely processed (FIG. 3.4, Panel 
B) during the ammonium sulphate precipitation step (Materials and Methods).The 
native FMDV 3D^ °* was then purified to near homogeneity using phosphocellulose, 
anion exchange and heparin chromatography (FIG. 3.5, Panel A, Panel B and Panel 
C respectively). This untagged FMDV 3D^ °* migiated slightly faster on SDS-PAGE 
than the His-tagged 3D^°' (FIG. 3.2, Panels A).
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3CDP"“
3D
H46 D 8 4 H 1 8 1
B Sac II 
1
Bam HI
r R FMDV 3DP»'
T7p
SacII
Sac II Bam HI
%
CTCCGCGG TGGA-GGGTTG
G G G L
Cleavage junction
pET26b-Ub-3D
F M I)\ 31)'-' MCR 
Bgll/BamHI
GACGCGTAA AGATCC 
Stop
FIG.3. 3. Strategy for production of proteolytically inactive 3CD and authentic 3Dpol. Panel A. 
To generate intact BDpoI precursor protein 3CD, QuikChange site directed mutagenesis protocol 
was followed to mutate the amino acid codon for Cysteine 163 to a Glycine within the 3C coding 
region (shown with star in panel A). This mutation was intended to completely block the protease 
activity of the 3C to produce uncleaved 3CD in the bacterial expression system. Panel B. To produce 
unmodified FMDV 3Dpol the internal Sac II site was modified by QuikChange site directed 
mutagenesis protocol without changing the arginine amino acid (shown with delete mark) and the 
Bam HI site was made irrelevant by introducing a Bgl II restriction site in the reverse primer.
Panel B depicts the diagrammatic representation of the overall strategy followed for native FMDV 
3Dpol expression using the system as described in Gohara et al., 1999. The cleavage junction between 
ubiquitin and FMDV 3Dpol cleaved by the ubiquitin protease is indicated.
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s
4 uncleaved 3Dpoi
<4------- native 3Dpol
FIG. 3. SDS-PAGE analysis of uninduced and induced BL21DE3(pCGl) cells harbouring Ub-3Dpol plasmid.
Unmodified 3Dpol was expressed as described in the Materials and Methods. Lane 1 represents the uninduced 
B121DE3(pCGl) harbouring Ub-3Dpol plasmid. Lane 2, lane 3, lane 4 and lane 5 corresponds to B121DE3(pCGl) 
harbouring Ub-3Dpol plasmid induced with IPTG (final concentration 0.5 mM) for 1-hr, 2-hr, 3-hr and 4-hr respectively.
B
62kD
#48kD
uncleaved 3Dpol 
native 3Dpol
FIG. 3. SDS-PAGE analysis of Ubiquitin-tagged and fully cleaved native 3Dpol protein. Lane 1, represents the 
induced BL21DE3 cells harbouring the Ub-3Dpol plasmid. Lane 2 represents ammonium sulphate precipitated fi-action 
o f the native 3Dpol as mentioned in the Materials and Methods section. As expected ubiquitin-tagged 3Dpol migrated 
slower compared to the fully cleaved 3Dpol.
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P hosp h o ce llu lo se  (P11) colum n purification 
^  I f  to  9 ,
3DP°*
B HiTrap™  Q S e p h a ro se  XL colum n purification
IÇ lb i r  n  4P ai ^
HiTrap™  H eparin HP colum n purification
3DP°*
FIG.3.5. Ion exchange chromatography purification of FMDV 3Dpol enzyme. Ammonium 
sulphate precipitation fraction of the FMDV 3Dpol (FIG. 3.4, Panel B ) was loaded on to a 
phosphocellulose column to remove any nuclease contamination (Panel A). Subsequently 
3Dpol sample was purified by Q column anion exchange chromatography (panel B) and 
heparin column chromatography (panel C). Fraction 25, 26 and 27 were pooled together and 
dialysed against bufferA containing 50 mM salt (see Materials and Methods section).
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3.2 Synthesis of synthetic peptides corresponding to VPgl, VPg2, and VPg3.
Synthetic peptides corresponding to the individual FMDV VPgl, VPg2, and VPg3 
peptides and a modified version containing a single-amino-acid substitution (Y to F) 
were produced by Lawrence Hunt (Institute for Animal Health, Compton Lab) and 
purified by high-performance liquid chromatography. Aliquots were analysed in 
Tris-ti'icine gel (14%) and stained with coomassie brilliant blue (FIG. 3.2, Panel C).
3.3 Production of wild-type and mutant FMDV crelbus transcripts.
The plasmid pGC-cre (wt) and the various mutants were used as templates for 
production of RNA transcripts (FIG. 3.6 and FIG. 3.7). Plasmid DNAs were 
linearized with D m  I  and purified by phenol extraction and ethanol precipitation, and 
RNA was produced using a MEGAscript high-yield tianscription kit according to the 
manufacturer's instructions (Ambion). The products were tieated with DNase I and 
purified using urea-polyacrylamide (8%) gel electrophoresis to recover the cre/bus 
transcripts only. The transcripts were detected by UV shadowing, eluted in EDTA (1 
mM) and sodium dodecyl sulfate (SDS, 0.5%), and isolated by phenol extraction and 
ethanol precipitation. The purified RNA transcripts were analysed using 8% 
polyacrylamide-urea gels and were stored at -70°C.
3.4 PolyU polymerase activity assays
The fimctional activity of the three purified proteins (His-3Dpol, native 3Dpol and 
His-3CD) were tested using an in vitro RNA polymerase assay (Gohara et al., 1999) 
using poly(A) as template. The His-tagged 3D^ °* and the His-tagged 3CD(C163G) 
exhibited little or no RNA polymerase activity in the presence of Mg^^ but both 
proteins displayed significant activity in the presence of Mn^^ (FIG. 3.8 Panel A and
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FIG.3. 6. Production of FMDV cre/bus transcripts. Panel A, represents the cloning strategy 
of the FMDV cre/bus to produce the pGC-cre plasmid. Panel B represents the in vitro transcription 
o f the linearized pGC-cre plasmid (cut with Dra I) to generate cre/bus transcripts and the 
self-cleaved ribozyme.
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FIG.3. 7. Diagrammatic representation of the wild type and mutant ere. Mutations were introduced 
within the AAAC A motif o f the loop region of the cre/bus by QuikChange site directed mutagenesis as 
per the manufacturer's instructions.
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Panel B). This result should be compared with the complete lack of RNA polymerase 
activity exhibited by the PV 3CD (Thompson et a l, 2004). Indeed the complete 
inactivity of the PV 3CD was confirmed in our assays (data not shown). There is 
conflicting evidence about the ability of different picomavirus 3D^ °* molecules with 
some form of N-terminal extension to function as an RNA polymerase. The PV 3D*’°* 
poorly tolerates even a single extra amino acid (Gohara et a l, 1999) whereas the 
3D^“^ from HRV2 within a GST-3D^°* fusion protein exhibited similar RNA 
polymerase activity to the untagged 3D^ °^  (Gerber et a l, 2001a, b). The native 
FMDV 3D^ °* exhibited high RNA polymerase activity using poly(A) as a template 
(FIG. 3.8, Panel A). This activity was also markedly gi'eater in the presence of Mn^^ 
compared to Mg^^ (compare FIG. 3.8, Panel A). It is noteworthy that the 
incoiporation of UMP by the unmodified 3D^ °* in the presence of Mg^^ is 
comparable to that achieved by the His-tagged 3D^°’ and the His-3CD in the 
presence of Mn^ .^ The specific activity of the unmodified FMDV 3D^ °* in the 
presence of Mn^ "^  was 247pmol/min/pg whereas in the presence of Mg^ "^  it was 15 
pmoFmin/pg.
3.5 In vitro uridylylation assay
Standard in vitro uridylylation assays were performed (Materials and Methods) 
using RNA transcripts corresponding to the FMDV cre/bus with the FMDV VPg 
peptides, (FIG. 3.8, panel C and Panel D). No uridylylation of the peptides was 
observed using the His-tagged 3D^ °^  in the presence of Mg^ "^  (FIG. 3.8, panel C). 
Reactions were then performed to analyze the ability of the untagged FMDV 3D^ °^  to 
uridylylate the FMDV VPgl peptide. Under these conditions efficient VPgl 
uridylylation was obseiwed (FIG. 3.8, Panel C and Panel D). It was found that the
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FIG.3.8. In vitro RNA synthesis and VPgl uridylylation by FMDV 3Dpol. (A and B) In vitro 
RNA synthesis assays using a poly(rA)5QG (0.15 pM) template and dTl 5 (1.8 pM) primer were 
performed with the His-tagged 3Dpol (1 pM), His-tagged 3CD (1 pM), and un tagged 3Dpol (1 pM) 
as indicated in the presence of Mn^  ^(5 mM) (A) or Mg^^ (5 mM) (B). The incorporation of [32PJUMP 
(from UTP) was measured at 5 min when the assays were within a linear range, and the reactions for 
panels A and B were performed in parallel. (C) In vitro 3B uridylylation assays were performed using 
the 3B1 peptide (12.5 pM) with [a-32P]UTP in the presence of Mg^  ^(2 mM) with His-tagged 3CD 
(1 pM), the crelbus RNA transcripts (1 pM), and either the untagged 3Dpol or the His-tagged 3Dpol, 
as indicated. The uridylylated 3B1/VPglproduct, termed VPgpU(pU), is indicated. (D) In vitro 3B 
uridylylation assays were performed as described for panel C, and the individual components of the 
uridylylation reaction were separately omitted, as indicated. +, present; -, absent.
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production of [^^P]-uridylylated VPgl required the presence of the 3CD(C163G)
precursor and an RNA transcript (56nt) corresponding to the FMDV cre/bus. |
Omission of this short RNA transcript, or His-3CD(C163G), or 3D*’‘^* totally |
I
abrogated uridylylation of VPgl (FIG. 3.8, Panel D). To achieve the standard VPg I
uridylylation assay optimisation of each and individual components were carried our |
as summarized below. !
3.6 Optimization of the in-vitro uridylylation assay
3.6.1 Stoichiometry of 3CD
To find out the stoichiometiy of the 3 CD concentration for optimal VPg 
uridylylation, in viti*o uridylylation assays were carried out using IpM 3Dpol, IpM 
cre/bus RNA transcripts, 10 pM VPgl and varied concentrations of 3CD protein. It 
was observed that IpM of purified 3CD is optimal for the reaction and any 
concentration above or below is suboptimal in this conditions (FIG. 3.9). Henceforth 
all the future experiments were carried out using IpM 3CD.
3.6.2 Optimum VPg concentration for the uridylylation assay
To titrate the optimum VPg concentiation, uridylylation assay was carried out using 
IpM 3Dpol, IpM cre/bus RNA transcripts, IpM 3CD and different concentiation of 
VPg peptides (VPgl-3) ranging from 1-100 pM. Incorporation of UMP residues in 
the VPg to form VPgpUpU was measured by phosphorimaging and the values 
obtained were plotted against the different VPg concentiations. The three VPgs were 
uridylylated with slightly different efficiencies. The optimal reaction was observed at 
6.0 or 12,5 pM VPg but higher concentrations inhibited the reaction (FIG. 3.10). All 
the future experiments were performed at 12.5 pM VPg concentration.
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FIG.3. 9. Uridylylation of VPgl in vitro using cre/bus as a template with varied concentration 
of 3CD. The production of VPglpUpU was measured as described in the Materials and Methods 
using IpM 3Dpol,lpM cre/bus, 10 pM VPgl and different concentration of 3CD as indicated in 
the Panel A. The optimal concentration of 3CD required for the in vitro uridylylation assay was 
determined from the graph depicted in Panel B.
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FIG J .10. In vitro uridylylation assays using varied concentrations of VPg. Optimal concentration 
of VPg required for the uridylylation ofVPgl-3 were determined using IpM 3Dpol, IpM cre/bus, 
IpM 3CD and VPgl-3 peptide ranging from IpM- lOOpM for 20 min at 30°C (Panel A). The 
synthesis of VPgpU(pU) for each peptide was quantified using a phosphoroimager (Bio-Rad). The 
range of VPg concentrations that supports the linear range of VPgpU(pU) synthesis in the in vitro 
reaction was determined from the graph depicted in Panel B.
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3.6.3 Titration of divalent cations/cofactors
The effects of divalent cations and on uridylylation activity of the
polymerase enzyme were assessed by using IpM 3Dpol, IpM cre/bus RNA 
tianscripts, IpM 3CD and 12.5 pM VPgl with varied ion concentiations as indicated 
(FIG. 3.11 and FIG. 3.12). Production of VPgpUpU was quantified by 
phosphorimaging. For both magnesium chloride (MgCb) and manganese acetate {
(MnOAc), the optimum concentrations were found to be 2mM.
3.6.4 Determination of optimum temperature
To determine the optimum temperature for VPg uridylylation, uridylylation reactions 
were assembled as above using 2mM Mg^ "^  and incubated at different temperatures 
for 1 hr as indicated (FIG. 3.13). The optimum temperature was found to be 30°C- 
37°C. At 42°C, the reaction was greatly inhibited.
3.6.5 Optimization of time of incubation i
VPg uridylylation assays were assembled and carried out as above for different |
durations as indicated (FIG. 3.14). The linearity of the reaction was determined from !
the plotted values and 30 min incubation time was found to be optimum for the j
reaction. '
3.7 The role of the cre/bus in the uridylylation of the FMDV VPg peptides
To study the effects of mutations in the loop region of the FMDV cre/bus in the VPg 
uridylylation assay, mutant cre/bus plasmids were generated. The first A residue in 
the conserved A^A^A^CA motif from the PV ere acts as the template for the addition 
of two U residues to the VPg peptide primer, the second and third A residues
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F IG J .ll. Effects of magnesium ion (MgClj) on VPg uridylylation. Panel A. Standard VPg 
uridylylation assays were assembled as described in the Materials and Methods except for the 
varied magnesium ion concentration as indicated. Panel B. The production of VPglpU(pU) was 
measured and plotted as a function of Mg^^ concentration. Optimal quantity of Mg^^required for 
uridylylation of VPgl was determined.
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FIG.3.12. Effects of Manganese ion (MnOAc) on VPg uridylylation. Panel A. Standard VPg 
uridylylation assays were assembled as described in the Materials and Methods except for the 
varied manganese ion concentration as indicated in the legend. Panel B. The production of 
VPglpU(pU) was measured and plotted against the Mn^+ concentration . Optimal quantity of Mn^^ 
required for uridylylation of VPgl was determined.
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FlG.3.13.Effects of tem perature on VPgpU(pU) synthesis. Standard assays were carried out as 
indicated in the Materials and Methods except for the varied temperature ranging from 23°C to 42°C. 
The rate of VPgpU(pU) formation by the FMDV 3Dpol (Panel A) at different temperatures 
at the indicated time points was measured and plotted on a graph (Panel B). The optimal 
incubation temperature corresponds to the maximum VPgpU(pU) formation.
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FIG.3.14. Uridylylation assay time course experiments in the presence of 2mM MgCij. Panel A. 
Standard uridylylation assays were carried out using IpM 3Dpol,lpM cre/bus, IpM 3CD and 
12.5 pM VPg 1 using Mg^^ (2 mM) as a cofactor at 30°C for varied times as indicated . Panel B.
The incorporation of UMP into the VPg to form VPgpU(pU) was plotted against Y-axis as function 
of time of incubation. The linearity o f the reaction was determined from the graph.
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modulate this process (Paul et al., 2003). Mutations (A to C) were inti'oduced in the 
FMDV cre/bus at the A \ A^, A  ^ positions individually and a fourth mutant was 
made with mutations at both the A' and A  ^ positions (FIG. 3.7). RNA transcripts 
were prepared firom each of these plasmids and their ability to support the 
uridylylation of FMDV VPgl was tested in the presence of Mn^ "*" or Mg^ "^  ions (FIG
3.15, Panels A and Panel B). In the presence of each of the divalent metal ions, the 
wt cre/bus tianscript supported very efficient uridylylation of VPgl. However, 
substitution of A* alone or A' and A  ^ together in the cre/bus tianscripts completely 
blocked the reaction. In the presence of Mg^^ ions (FIG. 3.15, Panel A and Panel B), 
the A  ^and A  ^point mutants were also inactive but, in the presence of Mn^^ ions, low 
level uridylylation of the VPgl peptide was also observed using the A  ^ and A  ^
mutant transcripts as template (FIG. 3.15, Panel A).
3.8 Uridylylation of the three different FMDV VPg peptides
Uniquely, FMDV encodes and uses three distinct forms of VPg (3B) which differ in 
size and sequence (FIG. 3.16, Panel A). Each of the different forms of FMDV VPg 
has been found to be associated with genomic RNA and hence all must be functional 
(King et al., 1980). The activity of the three different peptides in the in vitro 
uridylylation assay was compared (FIG. 3.16). It was appaient that each of the VPg 
peptides could be uridylylated in vitro by the untagged 3D' °^' in the presence of the 
cre/bus transcripts and His-3CD. However, VPg3 was a better substiate in this assay 
than VPg2, which in turn was also better than VPgl. It was also apparent that the 
uridylylation reaction occuned with similar efficiency in the presence of Mn^^ or 
Mg^ "^  (FIG. 3.16) and the relative efficiency of uridylylation of the different VPg 
peptides was the same with each divalent metal ion. Each of the VPg peptides
1 1 0
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FIG3.15. Critical role of the AAACA motif within the FMDV crelbus for in vitro uridylylation 
of FMDV 3B1. In vitro uridylylation assays using the FMDV 3B 1 peptide were performed using wt 
or mutant FMDV cre/bus RNA transcripts as indicated in the presence of Mn^^ (A) or Mg^ "^  (B) 
with FMDV 3Dpol and His-3CD. Reaction mixtures were incubated at 30°C for 30 min. +, present.
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FIG.3.16. In vitro uridylylation of all three FMDV 3B peptides. Panel A. Comparison of VPg 
sequences from FMDV(01 Kaufbeuren) and PV (type 3). The conserved Tyr (Y) (residue 3) 
is the site of uridylylation. Panel B. In vitro uridylylation assays were performed in the presence 
of purified FMDV components 3Dpol (1 pM), His-3CD (1 pM), crelbus RNA transcripts 
(1 pM), and either Mn^ "^  (2 mM) or Mg^^ (2 mM), as indicated, using each of the FMDV 
3B peptides (12.5 pM). Products were analyzed on Tris-Tricine gels. Panel C. Incorporation of 
[a-32P]UMP into VPgpU(pU) was quantitated for each peptide using a phosphorimager.
Panel D. The time course of uridylylation of V Pgl, VPg2, and VPg3 was determined in parallel. 
Reactions were performed as described for Panel B with Mg^^ (2 mM), and each VPg peptide 
was used at 1 pM. The time points were 30 s (A), 1 min (B), 2 min (C), 5 min (D), and 10 min 
(E). Panel E. The incorporation of UMP in the reactions shown in panel D was quantified using a 
phosphorimager.
1 1 2
CHAPTER THREE FMD V VPg URIDYL YLA TION ASSA Y
migi'ate slightly differently on the Tris-tricine gels (FIG. 3.16, Panel B).Thus, 
although VPgl is one amino acid shorter than VPg2 and VPg3 (FIG. 3.16, Panel A), 
it migi'ates at an intermediate position and VPg3 migrates the fastest (FIG. 3.16, 
Panel B). To confirm the differences in efficiency of uridylylation, we determined 
the rate of UMP incoiporation in a time course assay for each VPg in parallel (FIG.
3.16, Panel D and Panel E). Consistent with the results shown in FIG. 3.16, Panel B , 
Panel C and Panel D the rate of VPg3 (3B3) uridylylation was the fastest, while that 
for VPgl (3B1) was the slowest and VPg2 (3B2) was intermediate (FIG. 3.16, Panel 
E).
3.9 Differential uridylylation efficiency of VPgl, VPg2 and VPg3.
To determine more accurately the differential ability of each copies of the VPg to 
undergo uridylylation, the incoiporation of [^^P]-a UTP into VPg-pUpU was 
monitored by a Tris-Tricine gel and buffer system. Tlie uridylylation of each VPg 
was caiTied out with different concentrations for a fixed time period of 10 min. Both 
VPg-pU(pU) and the unincoiporated labeled UTP were separated, and the band 
intensity quantified by phosphorimager (FIG. 3.17). The uridylylation efficiency of 
each peptide was determined fiom the % incorporation of UTP into VPgpU(pU) 
(FIG. 3.18). Consistent with earlier results % incoiporation of UTP into VPg3 was 
highest (~ 4%) followed by VPg2 (~ 3%) and VPgl (~2%).
3.10 Specificity of VPg recognition in the uridylylation assay. The linkage of VPg 
(3B) to RNA occurs through the hydroxyl gioup on a Tyr residue. To confirm that 
the uridylylation reaction observed with the FMDV components was dependent on 
the presence of the Tyi' residue, a variant of the VPg3 peptide was synthesized in
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2 2 s S S 5 S 53. 3. 3. 3. 3. 3. 3. 3.O in o m o in p OT- ni ni CO CO iri
■VPg1pU(pU)
unincorporated  [a-^^P]UTP
FIG.3.17. Differential uridylylation efficiency of VPgl. Standard uridylylation assay reactions 
were set up with a range of VPg concentrations as indicated in the figure legend. The incubation 
temperature was set for 10 min to measure the incorporation of [^^P] UTP when the reaction is 
within the linear range. Band intensities were quantified for VPglpU(pU) and unincorporated UTP 
for each concentration of VPg in each lane and the incorporation percentage of UTP was calculated. 
Similar reactions were set up for VPg2 and VPg3 and the relative efficiency of uridylylation of each 
VPg peptide was determined.
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[VPgl]
(pM)
VPglpU(pU) Unincorporated
UTP
VPglpU(pU)+
unincorporated
UTP
% incorporation of 
UTP iiitoVPglpUfpU)
1.0 12762 810477 823239 1.55
1.5 15745 797504 813250 1.93
2.0 17474 790814 808289 2.16
2.5 18472 772881 791354 2.33
3.0 17970 753035 771005 2.33
3.5 19997 783024 802971 2.48
[VPg2]
(pM)
VPg2pU(pU) Unincorporated
UTP
VPg2pU(pU)+
unincorporated
UTP
% incorporation of 
UTP in toVPg2pU(pU)
1.0 25491 673969 699460 3.6
1.5 26115 710873 736988 3.54
2.0 28183 738300 766483 3.67
2.5 27947 731228 759175 3.68
3.0 29308 747383 776691 3.77
3.5 29278 734384 763662 3.83
[VPg3]
(pM)
VPg3pU(pU) Unincorporated
UTP
VPg3pU(pU)+
unincorporated
UTP
% incorporation of 
UTP in to VPg3pU(pU)
1.0 23077 790146 813224 2.83
1.5 31955 767190 799146 3.99
2.0 34498 773963 808462 4.26
2.5 34019 769413 803433 4.23
3.0 35432 780505 815937 4.34
3.5 38584 801116 839700 4.59
FIG.3.18. Tabular presentation of the differential uridylation efficiency of the FMDV VPg peptides
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which the Tyr was replaced by a Phe residue (which lacks the hydroxyl gi'oup). This 
peptide was inactive in the uridylylation reaction, as anticipated (FIG. 3.19, Panel A).
3.11 Compatibility between FMDV and PV uridylylation assay system 
Poliovirus is able to utilize as a substrate, in addition to its own VPg, the VPg 
of HRV14 when either poly(A) or cre(2C) RNA is used as a template. In contrast to 
HRV14 VPg, the VPgs of HRV2 and HRV89 have hardly detectable substrate 
activities on both templates (Paul et al., 2003). Based on those observations we 
analysed the activity of poliovirus polymerase, PV VPg and PV ere within the 
FMDV uridylylation assay system and vice versa. PV VPg is significantly different 
in sequence from each of the FMDV VPgs (FIG. 3.16, Panel A). Suiprisingly, the 
PV VPg was very efficiently uridylylated using the FMDV components (FIG. 3.19, 
Panel B). However none of the rest of the PV components was recognised in the 
FMDV uridylylation assay system using Mg^^ as a cofactor. In contiast, use of the 
PV uridylylation assay system showed high specificity for the PV components and 
none of the FMDV components were able replace the PV components (FIG. 3.19, 
Panel C).
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FMDV cre/bus + +
FMDV 3CD + +
FMDV 3Dpol + +
FMDV VPg3 + -
VPg3(Y3F) - +
VPgpU(pU)
B
FMDV system PV system
êc80)>+
>
I
CVJ COD ) D ) O Î 2? Q2 CL CL CL Q CJ
Q c > > > Ü CO CO
a? Q O 8
<D>
> > > > > >o CO CO o Q Q Q Q Q
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#  # VPgpU(pU)
FIG.3.19. Specificity of the VPg uridylylation reaction. (A) In vitro uridylylation assays were 
performed with [ a-32P]UTP using the FMDV crelbus RNA transcript in the presence o f Mg^^ 
with FMDV 3Dpol and His-3CD with either the FMDV VPg3 peptide or the VPg3(Y3F) peptide, 
as indicated. The latter peptide has the Tyr (Y) residue replaced by a Phe (F) residue. (B) In vitro 
uridylylation assays were performed using the FMDV assay system where each o f the FMDV 
components was separately replaced with PV components as indicated. (C) In vitro uridylylation 
reactions were performed using PV assay system where each and single component was replaced 
separately with FMDV components as indicated.
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3.12 Discussion
The studies that have been performed here have shown for the first time the 
mechanism by which the FMDV 3Dpol selects its viral RNA structure as a template 
for uridylylation of the genome linked short peptides VPg to form VPgpU(pU), a 
primer for viral RNA synthesis. This has been demonstiated in vitro by using 
defined purified components. In picornavirus VPgs, the tyiosine residue at position 3 
is found to be conserved. The importance of this residue in RNA replication has been 
well known. In recent times the exact function of this residue has become clearer 
when it was established that this residue participates in a nucleophilic attack on the 
a-phosphate of UTP to fomi VPgpU(pU) in vitro (Paul et al., 1998, 2003). In our 
study we have shown that in addition to UTP (with divalent metal ions) and a FMDV 
VPg peptide, this uridylylation reaction required RNA transcripts containing the 
crelbus^ the untagged 3D^ °*, and the 3CD precursor. Each of the three distinct FMDV 
VPg peptides is an efficient substrate in this reaction, although the VPg3 showed the 
highest activity. Within the RNA, the AAACA motif within the crelbus was shown 
to be the sole or primai-y motif for activity.
3.12.1 An authentic N-terminus of the FMDV 3Dpol is a pre requisite for 
efficient RNA polymerisation and VPg uridylylation activity
The synthetic activity of PV and HRV 3Dpol in vitio has been well studied (Paul et 
al., 2000; Gerber et al., 2001). The ti'anscription activity of the enzyme is required 
for complementary strand synthesis. The nucleotidylation activity is required for 
formation of a covalent linkage between a nucleotide(U) and the hydioxyl group of 
tyrosine. Both these activities aie required for the synthesis of a protein primer and 
subsequent positive and negative strand synthesis. Both types of synthetic activities
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are quite similar to the activities of some of the double stranded linear DNA viruses 
with a genome linked protein including phage 29, PRDl (a lipid-containing double 
stranded DNA bacteriophase), and adenoviruses (see Introduction),Within the 
picoraaviruses the first amino acid glycine in 3Dpol is absolutely conserved. Recent 
studies have suggested that PV 3Dpol undergoes an elegant proteolytic processing- 
dependent allosteric switch for polymerase activation that involves burying the N- 
terminal glycine residue in a pocket at the base of the fingers domain. The buried N- 
terminus is also involved in positioning Asp238 in the active site (Thompson and 
Peersen 2004). The replacement of the glycine with an alanine significantly reduces 
the polymerization activity of the enzyme (~54% of the wt) whereas replacement 
with a serine almost completely destroyed the enzymatic activity (1.6% activity of 
the wt) (Thompson and Peersen 2004). The presence of an extia -CH3 group in the 
alanine pushes the N-terminus out of its binding pocket by ■^ 0.9 Â compared to the 
native Glyl residue. These studies indicate that a clear coiTelation exists between 
enzymatic activity and the positioning of Asp238 for the interaction with the 2' OH 
of the incoming NTP.
The importance of the native N-terminus in polymerase enzyme activity has also 
been reported for other vimses like Sindbis virus, a prototype alpha-virus, in which 
an authentic amino terminus is essential for minus stiand synthesis (Lemm et al., 
1994). Similarly, the coxsackie virus A21 is only active in an untagged form (Gerber 
et al., 2001), whereas in contiast, the 3D‘^ °' from HRV-2 displayed similar activity in 
both oligo-dT primed polyU synthesis and uridylylating VPg in an untagged form or 
as part of a glutathione 6"-tiansferase fusion protein. In studies shown here the 
activity of FMDV 3D^ °* is clearly severely affected by the presence of the N-terminal
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His tag or by the presence of 3C sequences and has little or no activity in the 
presence of Mg^^ in the standard RNA polymerase assay. However, these proteins do 
display significant activity in the same assay with Mn^ "^ . The structure of the native 
FMDV 3D^“* has recently been published (Ferrer-Orta et al., 2004). It was found that 
the N-terminal region of the protein encircles the enzyme active site; hence, it is 
perhaps not very suiprising that the presence of an N-terminal His tag perturbs the 
activity. It is clearly possible, however, for the presence of the tag to differentially 
affect the RNA polymerase activity compared to the uridylylation reaction.
3.12.2 FMDV 3Dpol uridylylates VPg efficiently in presence of either Mg^  ^ or 
Mn^+
All known DNA and RNA polymerases require divalent cation cofactors for optimal 
activity. Because of relatively higher concentration of magnesium (Mg^^) in vivo in 
comparison to Mn^ "^  it is considered that Mg^^ is the true physiological cofactor 
inside the cell. Evidence has been presented that besides Mg^^ and Mn^^ other 
divalent cations like Co^^ and Zn^^ also stimulate the PV VPg uridylylation reaction 
(Paul et al., 2003). However other divalent cations like Ca^^, Fe^’*' and N f^ are 
inactive in VPg uridylylation. The activity of the 3D^°' from PV and HRV-2 have 
both been shown to be much (10- to 100-fold) higher in the presence of Mn^^ than in 
the presence of Mg^^ (Arnold et al., 1999; Gerber et al., 2001). The FMDV 3D^ °* 
was also much more active (over 10-fold) with Mn^^ in the RNA polymerase assay. 
Within cells, the enzymes presumably function with Mg^ "*". Studies suggest that the 
specificity of these RNA polymerases is relaxed in the presence of Mn^ "^  compared to 
Mg^^, and this can lead to a higher level of misincorporation of nucleotides (Arnold 
et al., 1999). The ability to use mutant forms of the short FMDV crdbus tianscripts
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in the uridylylation assay was also enhanced in the presence of Mn^ "^ , but there was 
little difference in the activity observed with each of these divalent metal ions when 
the wt crelbus was used as a template with each of the VPg peptides (FIG. 3.16). 
These results closely match observations made with the PV 3D^ °^  (Paul et al., 2003; 
Dr. Ian Goodfellow, personal communication).
3.12.3 Loss of virus viability due to VPg3 deletion could be due to loss of primer 
function
It is noteworthy that the uridylylation ability of the FMDV 3Dpol reduces 
significantly at concentiations of VPg above 10 pM (FIG. 3.10). However this is not 
ti'ue for PV 3Dpol. PV 3Dpol can uridylylate PV VPg very efficiently well above 
100 pM (Pathak et al., 2002). It is also interesting that the FMDV VPg3 peptide was 
the most efficient substrate for uridylylation by the FMDV 3D^ °^  (FIG. 3.16). This 
was further confirmed by quantification analysis of the UTP incoi*porated in to each 
of the VPgs during a fixed period of time and at a fixed concentiation (FIG. 3.17 and 
FIG. 3.18). So the ability of the FMDV 3Dpol to recognise and uridylylate FMDV 
VPg3 more efficiently might suggest that FMDV 3Dpol forms a more stable 
complex with VPg3. It is also possible that since VPg3 is closer to the 3D and 3C in 
the polyprotein, the availability of VPg3 being selected for uridylylation is greater 
than VPg2 and VPgl. In addition, 30 or 3CD is also a prerequisite for the VPg 
uridylylation, this leads to the possibility that VPg/3B along with the 30 as precursor 
protein (3B0) might also serve as a substrate for uridylylation (see Chapter 4). 
Deletion of the individual VPg sequences fiom within FMDV RNA transcripts had 
shown that only the VPg3 sequence was essential for viability (Falk et al., 1992). 
However, this was attiibuted to a defect in proteolytic processing that was observed
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using in vitro translation reactions of the mutant tianscripts. Recently it has been 
reported that amongst the three different copies of the VPg, the amino acid sequence 
of the VPg3 is most conserved among all FMDV isolates known to date compared to 
VPg2 and VPgl (Carrillo et al., 2005). VPgl and VPg2 have been implicated in the 
broad host range of the virus (Pacheco et al., 2003) milike that of the VPg3. It can be 
suggested that VPg3 might have a conserved fiinction in all hosts that is solely in 
RNA replication. In addition, since VPg3 also seems to be the most efficient 
substrate for in vitro uridylylation, it may be that the loss of this sequence may also 
have a deleterious effect on RNA replication, especially at the early stages of 
infection when the VPg peptides will be present at low levels. On the other hand, 
there was apparently little difference in the efficiency of virus rescue from the three 
different mutant transcripts in which two of the three 3B tyi osine (Y) residues were 
changed to phenylalanine (F). However, no sequence analysis of the rescued viruses 
was reported and each rescue was about 100-fold-less efficient than that of the wt 
(Falk et al., 1992).
3.12.4 FMDV 3Dpol uses a mechanism of VPg uridylylation that is consistent 
with a ‘Slide-Back’ mechanism proposed for poliovirus 3Dpol
Mutagenesis of the AAACA motif within the FMDV crelbus showed that the A* 
nucleotide is critical for the uridylylation reaction (FIG. 3.15). This result is 
consistent with studies using a FMDV replicon containing modifications in this motif 
(Mason et al., 2002). Modification of the A  ^and A  ^nucleotides within this motif also 
greatly depressed viral RNA replication, and it is now shown that the in vitro 
uridylylation of VPg is also severely inhibited by these mutations in the crelbus. 
Thus, the results on the requirements for the crelbus in a FMDV replicon (Mason et
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a l, 2002) closely match the in vitro studies on the uridylylation of VPg presented 
here. Furthermore, they are in accord with previous results on the role of the 
AAACA motif obtained in previous studies on the PV and HRV ere structures (Paul 
et a l, 2003a; Yang et a l, 2002). These results lead to the hypothesis that the first A 
nucleotide within this motif acts as the template for the addition of both the first and 
second U to 3B/VPg using a "slide-back" mechanism (Paul et a l, 2003b) as has been 
suggested for nucleotidylation reaction observed in adenoviruses and phage 29. Our 
results are also consistent with a slide-back’ back mechanism of VPg uridylylation 
by FMDV 3Dpol.
3.12.5 Amino acid composition of the VPg peptides might be responsible for 
3DpoI recognition
The ability of the PV VPg to act as a substrate in the FMDV uridylylation assay was 
quite surprising considering the fact that PV VPg peptide is significantly different in 
sequence from each of the FMDV VPgs (FIG. 3.16). In contrast, FMDV VPg could 
not replace PV VPg in the PV uridylylation assay (FIG. 3.19). Similar studies using 
HRV2 has shown that the 3Dpol can efficiently uridylylate PVl VPg, HRV 14 VPg 
and HRV89 VPg in the HRV2 uridylylation assay (Gerber et a l, 2001). Conversely 
PV 3Dpol could not utilise HRV2 and HRV 89 VPg in the PV uridylylation assay 
(Paul et a l, 2003a). Botli HRV2 and HRV89 are closely related and contain two 
negatively charged glutamic acid residues which are absent in polioviruses. It is 
believed that the negatively charged amino acids in the HRV2 and HRV89 VPgs 
make them incompatible substrates in the PV uridylylation assay. Similarly all the 
three FMDV VPgs also contain two negatively charged amino acids, this may 
explain why they ar e unsuitable substrates for the PV uridylylation assay.
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In the VPg of many enterovimses, Tyiosine (positions), Glycine (position 5) and 
Arginine (position 17) are found to be conserved. The tyrosine residue is absolutely 
critical for the replication of the virus. A mutant PV VPg peptide with mutation at 
position 3 (T3Y4) where tyrosine at position 3 was replaced with threonine (an 
amino acid residue that contains free -OH group like tyrosine) and the amino acid at 
the fourth position was replaced with a tyrosine has been found to be completely 
inactive in the uridylylation reaction suggesting the high degiee of specificity of the 
PV SDpol enzyme for the identity and location of the tyiosine in the VPg peptide 
(Gerber et a l, 2001). As expected, mutation at the position 3 (Y3F) of the FMDV 
VPg completely abolished the uridylylation of the VPg. In addition in PV, 
replacement of die positively charged aiginine (residue 17) with a negatively 
charged glutamic acid, produced a mutant peptide that was completely inactive in the 
uridylylation assay (Paul et a l, 1998; Paul et a l, 2000). Thus it is not too surprising 
that all the FMDV VPg peptides with two negatively charged glutamic acid in them 
are completely inactive as a substrate in the PV system. Furthermore in the 
compatibility experiments between FMDV and PV, none of the ere transcripts could 
replace the function played in the homologous system. However it is noteworthy that 
HRV14 ere is a very good template in the PV uridylylation assay system and was 
stimulated by the addition of PV 3CD (Paul et a l, 2000). From this point of view it 
is quite intriguing, how 3C of PV could complement the function of HRV 3C in the 
PV uridylylation system. So it seems that the specificity of the VPg uridylylation 
reaction provided by the 3 C/3 CD in the in-vitr o uridylylation assay is due to non­
specific structure based RNA binding activity rather than any sequence specific 
recognition of the 3 C/3 CD protein. This argument could be further substantiated, for 
example a PV chimeric ere structure in which the entire sequence of the stem was
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replaced with an artificial sequence of similar stability supported 3CD dependant 
VPg uridylylation very efficiently (Goodfellow et ah, 2003). In the FMDV 
uridylylation assay PV 3C could not complement the function of the FMDV 3C or 
vice versa. Recently it has been proposed that the base of the loop and upper stem in 
the ore determines the 3C binding site (Yin et ah, 2003). It is interesting, however, 
that the FMDV crelbus does not contain the consensus sequence derived fiom the 
PV and HRV ere sequences, ^GXXXAAAXXXXXXA’"', or even the more relaxed 
version, RXXXAAAXXXXXXR. In the FMDV sequences studied, nt 14 is a C (see 
references Mason et ah, 2002; Paul et ah, 2003b; and Tiley et ah, 2003).
3.12.6 FMDV 3CD protein provides specificity to VPg uridylylation assay 
The uridylylation ability of the FMDV 3Dpol was stimulated up to 80-100 times in 
the presence of 3CD (FIG. 3.8, Panel D). This suggests that 3CD provides a high 
degree of specificity to this reaction when the ere/bus is used as a template either by 
recruiting the 3Dpol or 3Dpol/VPg complex on the ere/bus template. Another 
possibility is, 3CD might provides a great degree of stability to the ere/bus RNA 
structure because of its RNA binding activity providing an optimum orientation of 
the AAACA motif in the ere/bus for it to act as a template. In PV it has been shown 
that the RNA binding activity of the 3CD/3C is required for the stimulation of the 
uridylylation activity of the 3Dpol (Gerber et ah, 2001). To date the 3C recognition 
motif in the ere/bus has not been identified. In addition, the structure-function 
analysis of the cre-3C complex and its relevance in VPg uridylylation assay has not 
been established. Recently the structure of the HRV ere has been determined by 
NMR (Thiviyanathan et al., 2004) which suggests that the adenosine residues 
(AAACA) in the ere loop are oriented towards the inside of the loop. But it was
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suggested that the loop was twisted in a spiral fashion such that sufficient space was 
provided for two uridine residues to base-pair with the loop without significant 
disruption of the structure. However the stimulation of VPg uridylylation by 
addition of the 3C miglit be because the RNA binding activity of the 3C produces 
some conformational changes in the overall configuration of the ere structure that 
could present the loop in such a manner that the adenosine residues are more 
exposed and accessible to stimulate VPg uridylylation.
Studies on the PV system have found that the PV 3C alone can replace 3 CD (Pathak 
et al., 2002). There are significant differences between the properties of the PV 3C 
and 3CD. Both proteins are active proteases, but the PV 3CD is required for 
processing of the capsid precursor PI (Leong et al., 2002), whereas in contiast, the 
FMDV 3C is able to achieve all capsid processing by itself (Ryan et al., 1999). 
Hence, it will be interesting to determine whether the role of the FMDV 3CD in VPg 
uridylylation can also be replaced by 3C.
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CHAPTER FOUR 
Characterisation of RNA elements and proteins required for FMDV 
replication
All picornavirus RNA replication follows a similar strategy, where the viral genome 
is first ti'anscribed into a negative stiand, which in turn is used as a template for 
synthesis of positive sense progeny genomes. We have shown in the previous chapter 
that the viral protein 3B (VPg) serves as a source of primer for replication to be 
initiated. Considering the fact that during polyprotein synthesis VPg/3B is 
synthesized within precursor proteins the exact source of the VPg to acts as a primer 
is still not known. Furthermore for poliovirus RNA synthesis to occur the formation 
of a ternary ribonucleoprotein (RNP) complex is necessary in which both the viral 
proteins as well as host proteins participate (Andino et al., 1990, 1993; Herold and 
Andino 2001), The negative-stiand synthesis of poliovirus is initiated within the 
poly(A)-tail of the genomic RNA (Herold and Andino 2001). The viral protein 3CD 
binds to the 5’-end of the genomic RNA and reaches its site of action within the 
poly(A)-tail of the genome via circulai’ization of the genomic RNA using an RNA- 
protein-protein-RNA-bridge that involves two cellular factors, PCBP and PABPl 
(Herold and Andino 2001). This type of RNA-protein interactions necessary for PV 
RNA replication have not yet been shown for any other picornaviruses including 
FMDV. In addition it is important to mention that the RNA stiuctures that are 
involved in PV replication within the 5’ UTR are different from the RNA structures 
present in the FMDV genome. Therefore we have attempted to look at the 
requirements of both RNA stiuctures within the FMDV genome and non-stiuctural 
proteins that play important roles in FMDV RNA replication.
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4.1. Determination of RNA sequence required for FMDV VPg 
uridylylation
4.1.1 A functional AAACA motif of the cre/bus within the FMDV full-length 
RNA is required for efficient VPg uridylylation
In the previous chapter, a small RNA transcript including the FMDV cre/bus 
sequence was used as the template in the uridylylation assay. Clearly, this element 
normally has to function in the context of a full-length (FL) viral RNA and secondly 
it is possible that uridylylation of VPg may also occur on the poly(A) tail at the 3’ 
terminus of the viral RNA. To investigate this, plasmid pT7S3 (containing a fiill- 
length infectious c-DNA of FMDV) and its derivatives with point mutations in the 
A l, A2 and A3 positions within the AAACA motif of the cre/bus or with complete 
deletion of the A1A2A3 residues were linearized downstream of the poly(A) tail at a 
unique Hpal site and used for the production of frdl-length RNA transcripts as 
described in the Materials and Methods. The transcripts were purified by phenol 
extraction and ethanol precipitation and quantified using a spectrophotometer. 
Truncated transcripts lacking the poly(A) tail or the entire coding sequence were 
generated in the same way but using templates that had been linearized with EcoNI 
or Xbal, respectively, as indicated in the figure legends.
Uridylylation reactions were performed using 3D^°\ His-3CD, VPg3, and RNA 
transcripts corresponding to the wt FL RNA. Efficient uridylylation was observed in 
the presence of all of these components but omission of any one of them blocked the 
reaction (FIG.4.1, panel A). A very low level of product was observed in the absence 
of His-3CD but this was over 100-fold less abundant. When mutant FL transcripts 
were used in which the cre/bus sequence was modified or deleted, it was found that
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modification of the position within the AAACA motif of the cre/bus or deletion 
of A \ A  ^and A  ^(as in the creDel transcript) completely blocked activity but a weak 
signal (about 1% of wt) was observed in the presence of Mg^^, when À} or A  ^ alone 
were modified (FIG. 4.1, Panel B). The overall pattern of these results closely 
matches those observed with the short cre/bus transcripts (Chapter 3) but it is 
apparent that the FL transcripts with A  ^ or A  ^ modified were more active than the 
short cre/bus tianscripts containing these modifications. In the absence of a 
functional AAACA motif within the FL RNA no uridylylation of the VPg3 occuixed 
indicating that the poly(A) tail was not functional in this assay (FIG. 4.1, Panel B). 
RNA transcripts corresponding to the FMDV 5’UTR down to an Xbal site (about 
40nt downstream from the cre/bus within the FMDV 1RES) were also very efficient 
as templates for the uridylylation o f VPg3. Indeed, since within this assay the 
various RNA ti’anscripts were used at the same molar concentiation, it is apparent 
that the full-length RNA and the truncated 5 ’UTR were significantly better templates 
than the cre/bus element alone (FIG. 4.1, Panel B). In previous studies (Paul et al 
2000), it has been shown that the PV 3D^ °* can generate VPgpU(pU) using a poly(A) 
template in the presence of Mn^ "^  and this occurs most efficiently in the absence of 
3CD. These results were reproduced using PV 3D^ '^ * (FIG. 4.1, Panel C). However, in 
contiast, no significant uridylylation of FMDV VPg3 was observed using FMDV 
3D’’°* with a poly(A) template in the presence of Mg^ "*", but a very weak signal was 
observed, on long exposure, in the presence of Mn^^ (FIG. 4.1, Panel C).
4.1.2 Context of the RNA template determines uridylylation efficiency.
The above results suggested that 5 ’ UTR RNA tianscripts lacking most of the 1RES 
element is about as good a template as the full-length FMDV RNA for VPg
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FIG. 4.1. The cre/bus is required for FMDV 3B3 uridylylation and the context of this 
structure influences the efficiency of the reaction. Panel A. In vitro uridylylation assays 
were performed with [a-^^P]-UTP in the presence of using the purified components VPg3 
(12.5pM), 3Dpol (IpM ), His-3CD (IpM ) with full-length (FL) wt FMDV RNA transcripts 
(25nM) as indicated. Panel B. Uridylylation assays were performed with [a-^^P]-UTP in the 
presence of Mg^^ using the purified components VPg3 (12.5pM), 3Dpol (IpM ), His-3CD 
(IpM ) using the different RNA transcripts indicated. Each transcript was used at the same 
concentration (25nM). The full-length (FL) RNA transcripts (wt or mutant as indicated) were 
derived from Hpal linearized plasmid DNA. Alternatively, truncated transcripts were produced 
following linearization with EcoNl which removes the 3 ’ UTR plus the coding sequence for the 
C-terminus of 3Dpol or linearization with Xbal which removes all o f the coding sequence plus 
most of the 1RES but the transcript still includes the S-ffagment and the cre/bus. The uridylylated 
VPg (VPgpU(pU)) product is indicated. Panel C. Uridylylation reactions were performed using 
FMDV or PV components (as indicated, in the absence of 3CD) with poly(A) as the RNA template. 
Reactions were performed in the presence of Mg^^ or Mn^^ for 30min (a) or 60 min (b) as shown.
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uridylylation and both were much better template than the cre/bus transcript alone. 
This interesting observation raised the possibility that larger RNA transcripts 
improved the uridylylation efficiency. However evidence of a lack of functionality of 
the polyA tail in the uridylylation assay suggested that the sequences required for 
optimal VPg uridylylation reside solely in the 5’ UTR. In addition, the significant 
improvement in the uridylylation efficiency using the 5’ UTR tianscripts lacking the 
1RES compared to the cre/bus transcripts indicated that RNA sequences within the 5’ 
UTR sequence other than the 1RES element are also involved in modulating the 
uridylylation efficiency (FIG. 4.1, Panel B). In order to investigate the possibility 
that distinct stiuctures within the FMDV 5’ UTR (FIG. 4.2, Panel A) might be 
required for determining the optimum template efficiency for VPg uridylylation, a 
number of different RNA transcripts were made as described in the figure legends 
(FIG. 4.2, Panel B). VPg uridylylation assays using such transcripts showed that the 
complete FMDV 5’ UTR transcripts is better than the FMDV 5’ UTR lacking most 
of the 1RES. However an RNA transcript that contains PK+cre+IRES is the best 
template in the assay and was much better than RNA tianscripts that contain only the 
PK+cre RNA sequence. This result suggests that 1RES RNA stiucture also 
influences this reaction by enhancing the production of VPgpUpU in viti'o. It has 
been demonstrated earlier that distinct structural domains of the FMDV 1RES 
undergoes long-range RNA interaction in optimum conditions of magnesium and 
potassium (Ramos and Salas 1999).To investigate the possibility of similar RNA- 
RNA interactions within the FMDV 5’ UTR that might influence FMDV VPg 
uridylylation, trans stimulation experiments were carried out using two separate 
RNA tianscripts in the same uridylylation assay each at 35 nM concentiation. It is 
very interesting to observe that addition of 1RES transcripts in trans stimulated the
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VPgpUpU production about ten fold in the presence of PK+cre RNA tianscripts 
(FIG. 4.3, Panel A). However in similar experiments the 1RES RNA transcripts 
could not produce any significant trans stimulation in the presence of the FMDV 5 ’ 
UTR RNA transcripts lacking most of the 1RES RNA sequence except for the first 
40 nt (FIG. 4.3, Panel B, Panel C). This finding suggests that either some signals 
located in the S-fragment or polyC tract or both interfere with RNA-RNA interaction 
seen between PK+cre and 1RES transcripts or the RNA sequence required for 
interaction between the PK+crc and 1RES is determined by the first 40 nt of the 
1RES element. It was also observed that the 1RES could not stimulate significantly in 
trans when cre/hus alone is used as a template (FIG. 4.3, Panel C). This result 
showed that the RNA sequence present within the PK+cre+IRES contain almost all 
the signals required for most optimum FMDV VPg uridylylation (FIG. 4.2). Since 
the 1RES has been well characterised to be involved in RNA translation we also 
suggests that there might be some overlapping sequence present within the 1RES 
that interacts with cre/bus when in the context PK+cre. In addition since the PK+cre 
is a better template when compared to cre/bus transcripts alone, it indicates that the 
RNA sequence present immediately upstieam (PK) and downstream (1RES) of the 
cre/bus are involved in stabilisation of the shorter cre/bus tianscripts enabling it to 
act as a better template compared to cre/bus or PK+crc tianscripts alone.
4.1,3 The cre/bus derived from a temperature sensitive mutant of FMDV (ts303) 
is a less efficient template in VPg uridylylation
Previous studies (Tiley et al., 2003) have suggested that a temperature sensitive 
mutant of FMDV (ts303) could not grow at the non-permissive temperature (42°C), 
however it has a wild type giowth phenotype at 37°C. The lesion that resulted in
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FIG. 4. 2. The minimal and optimal sequences required for FMDV VPg uridylylation is 
located within the 5’ UTR. Panel A. Secondary and tertiary folding of the FMDV 5’ UTR 
region. Panel B. In vitro uridylylation assays were carried out using VPg3 as a substrate and 
RNA transcripts of different length from the 5’ UTR as depicted in the figure legend. The reactions 
were carried out for 30 min in presence of Mg^^ and the production of VPgpUpU was measured.
All the reactions were carried out using the same concentration (35 nM) of RNA including that 
of the cre/bus transcripts.
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FIG.4.3. RNA sequences within the FMDV 5’ UTR complement in trans in VPg uridylylation.
To detec t any specific R N A -R N A  interaction betw een FM D V  1RES and o ther secondary structures 
w ithin the FM D V  5 ’ U TR , that m ight contribute to the increased efficiency o f  V Pg uridylylation, 
standard in vitro uridylylation assays w ere carried  out using separate transcrip ts in equim olar ratio 
in the sam e in vitro reaction as show n in the figure legend. The production o f  V PgpU pU  was 
m easured by phosphoroim aging and plotted as bar diagram s.
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such a phenotype has been attributed to a single point mutation (C47U) in the stem 
of the cre/bus. It was suggested that this mutation reduced the stability of the cre/bus 
compared to the wild type. To test the hypothesis that such a cre/bus template is also 
weaker in the VPg uridylylation reaction, the same mutation was introduced into the 
stem of the cre/bus by QuikChange site directed mutagenesis (FIG. 4.4, Panel C) and 
RNA ti'anscripts were made using the Megascript kit. Uridylylation assays using 
such mutated transcripts resulted in reduced production of VPgpUpU compared to 
the wild type cre/bus transcripts at different temperature points under similar in vitro 
conditions (FIG. 4.4, Panel A and Panel B). The difference in VPg uridylylation is 
more marked at temperatures above 34°C but the reaction was inhibited for both 
wild type and mutant cre/bus transcripts at 42°C.
4.1.4 Shorter cre/bus transcripts do not support VPg uridylylation
In human rhinovirus 14 (HRV 14) although the full length ere is about 6 6  nt, the 
minimum optimal ere sequence required for VPg uridylylation is 34 nt 
(Thiviyanathan et al., 2004). To determine whether smaller cre/bus sequence would 
function in the FMDV VPg uridylylation assay shorter cre/bus (cre37 and cre31) 
constructs were made by oligonucleotide ligations (see Materials and Methods). The 
deletions were introduced into the stem of the cre/bus with a few nucleotide changes 
(C44U in cre/bus37 and U42C, U43C in cre/bus31) as shown in the FIG. 4.5, Panel 
B and panel C. These changes were designed to stabilize the stem of the cre/bus 
stmcture. VPg uridylylation assays using such modified transcripts resulted in very 
limited production of VPgpUpU in the reaction when compared to the wild type 
cre/bus {ere 54) (FIG. 4.5, Panel D).
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FIG . 4.4. T he cre/bus stability  de term ines the efficiency o f FM DV VPg3 uridy ly lation . Panel A. 
Standard in vitro VPg uridylylation assays were performed in the presence o f  Mg^^ using wild type 
(wt) cre/bus or mutant (mt)(ts303) cre/bus transcripts at temperatures ranging from 30°C to 42°C. 
The production o f  VPgpUpU in the reactions was measured at each temperature point and plotted 
as a graph. Panel B. M easurement o f  VPg3 uridylylation using wt and m t cre/bus transcripts at a 
narrower range o f  temperature starting from 35.1°C to 42.3°C.
136
CHAPTER FOUR ANAL YSIS OF FMDV RNA AND PROTEINS
/
\  /  ® 202oi»C _ A -Cxï.
v4 /V*9 ^ 9   ^ 2040 p\
{•V \  y
T T 10 6«S
•c ^  ù«^
0 . Ï  Y 'Y  30
C
à*
4
•u /
• V•u9*A«
c * 0  è»V
u#A  G»c cre/bus 3 \1 I “
AG=-15.2 U42C, U43C
cre/bus 37 "8.5
cre/bus 54  AG=-10.9
C44U
s
sU)3.O
2Ü
E E
CO CO
(/} (/)3 3.O JO
2 2Ü Ü# -VPgpUpU
FIG . 4 . 5. D eletions in cre/bus stem  has deleteriou s e ffects on V P g uridyly lation . Uridylylation 
assays were carried out using the wild type and modified cre/bus transcripts (cre37/cre31 ) under 
similar conditions. The synthesis of VPgpUpU in the reactions were monitored by tris-tricine gel 
electrophoresis and autoradiography. The precise yield of the VPgpUpU in all the three reactions 
could not be compared due to the large difference in their uridylylation efficiency (over 100 fold).
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4.2 Determination of protein requirements for FM DV VPg uridylylation
As discussed earlier, for PV replication to occur, a complex web of interactions must 
be established that includes interaction of viral RNA along with both viral and 
cellular proteins. The importance of the viral protein 3CD in PV RNA replication is 
well known. However the properties and function of the PV 3CD and FMDV 3CD 
are not similar. In FMDV, the 3C protease can carry out all the polyprotein 
processing and the role of the 3 CD in FMDV replication or polyprotein processing is 
not clear. Therefore it is interesting to see whether FMDV 3 CD and 3C possess 
similar properties to that of the PV in the uridylylation assay.
To observe the suitability of 3C in FMDV VPg uridylylation instead of 3CD, it was 
necessary to express the relevant recombinant proteins in the E coli system. In 
addition mutations were introduced within the 3C protein in the predicted RNA 
binding domain to see the effects on VPg uridylylation and RNA replication.
4.2.1 Expression and purification of FMDV OIK 3C protein
The coding region for FMDV O IK  3C was amplified using a PCR using pQE- 
3CD(C163G) (described in chapter 3) as a template and inserted into the bacterial 
expression vector pQE30 (Qiagen). An N-terminal His-tagged form of 3C(C163G) 
was efficiently expressed fi'om this vector in E. coli M15 and pmified using Hi-Trap 
His-column (Amersham Biosciences) to near homogeneity as judged by coomassie 
blue staining (FIG. 4.6)
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4.2.2 FMDV AlO 3C proteins and its derivatives
The plasmid pETmll-3C, that encodes the 3C(C163A) protease from FMDV AlOei 
was a generous gift from Dr Stephen CuiTy (Imperial college, London). This plasmid 
was used as a template to generate modified 3C plasmids with amino acid changes 
fr om arginines (R) to serines (S within the puiported RNA binding motif of 3C by 
QuikChange site directed mutagenesis. C-terminal His-tagged form of AlOôi 
3C(C163A) and its derivatives that contain mutations in each of the arginine 
residues to serines at 92, 95 and 97 positions respectively were efficiently expressed 
in E. coli BL21DE3pLysS as described in Birtley et a l, 2005, Purification of the 
proteins were carried out using Hi-Trap His-column (Amersham Biosciences) to near 
homogeneity as judged by coomassie blue staining (FIG. 4.6).
4.2.3 FMDV 3C can substitute for FMDV 3CD for the uridylylation of FMDV 
VPg
In Chapter 3, it was shown that the uridylylation of FMDV VPgs required UTP plus 
Mg^^ (or Mn^^) and was also dependent on the presence of each of the following 
FMDV components: 3D^ °* and 3CD plus an RNA template including the cre/bus. 
Recently Pathak et a l, 2002 have demonstrated that the role of PV 3CD in this 
reaction can be achieved by 3C alone. It was decided to determine whether the 
FMDV 3C protein could replace 3CD in the FMDV VPg uridylylation assay. The 
results obtained using the cre/bus tianscript as template showed that the 3C protein 
derived from both serotype O (OIK) and A (AlOei) can each substitute for 3CD in 
this assay (FIG. 4.7). However the reaction is significantly less efficient than 
achieved with 3CD (FIG. 4.8). The production of VPgpUpU was steadily increased 
with increased concentration of 3C protein, albeit at lOpM 3C, the level of VPg
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FIG. 4.6. Purification of the His-tagged 3C proteases by Ni-NTA affinity chromatography.
Proteolytically inactive AlO 3C(C163A) and mutant versions of this protein were grown, induced 
and expressed in BL2 lDE3pLysS cells as described by Birtley et al., 2005. OIK version 3C(C163G) 
protein was expressed in M15 cells. All the proteins were purified using a similar protocol as described 
for His-tagged 3CD protein in Chapter 3 using Hi-Trap His-tagged column (Amersham biosciences). 
The purity of the proteins were judged to be more than 90% from the coomassie blue staining.
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FIG. 4.7. The factor that contributes to the stimulatory activity of the 3CD in VPg uridylylation 
resides in 3C. Standard VPg uridylylation assays were carried out (see Materials and Methods) 
except that the 3CD protein was replaced with 3C protein. To observe if there is any significant 
differences in the ability to stimulate VPg uridylylation in vitro, 3C(C163A) or 3C(C163G) 
proteases o f both type AlO and type OIK were expressed and purified using similar protocols 
and equal amount of proteins were used in the assay (lpM-2.5 pM) under similar conditions. 
Formation of VPgpUpU in vitro was measured by phosphorimaging as shown in the graph above.
141
CHAPTER FOUR ANALYSIS OF FMDV RNA AND PROTEINS
I II
3 C D 1 | j M  3 C 1 u M  3 C 2 . 5 u M 3 C 5 . 0 u M  3 C  I O u M
■4— VPgpUpU
B
6 0 0
5 0 0
4 0 0
3 0 0
200
100
0 I I
3CD 3 C 1 mM 3C 3C 3C
I p M  2 . 5 ]j M  5 . 0 [ j M  1 0 [ j M
# #  #  #  * "VPgpUpU
FIG. 4.8. 3CD mediated VPg uridylylation in vitro is much more efficient than 3C protein 
alone. In vitro VPg uridylylation assays were carried out using both BCD and 3C at different 
concentrations as depicted in the figure legends either using cre/bus (1 pM) (Panel A) or 5’ UTR 
RNA transcripts (25 nM) (Panel B) as templates. Reactions were carried out for 30 min at 30°C 
and production of VPgpUpU was quantified and depicted as bar graphs.
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uridylylation was only about 25% of that achieved with IpM 3CD (FIG. 4.8, Panel 
A). In contrast when the cre/bus transcripts was replaced by the FMDV 5’ UTR as a 
template the reaction was inhibited with 3C concentration above 1-2 pM (FIG. 4.8, 
Panel B).
4.2.4 Identification of a putative RNA binding site on the surface of FMDV 3C 
protein
In certain picomaviruses the ability of the 3C or its precursor 3CD to bind cloverleaf 
RNA at the 5’ end of the genome is well established (Andino et al., 1990, 1993; 
Kusov et al., 1997; Walker et al., 1995). In PV 3C, the individual residues that 
contribute to this RNA-protein interaction have been identified (Andino et al, 1993). 
A consensus motif that includes the amino acid sequence KFR '^^DI^  ^ is found to be 
conserved among enteroviruses, rhinoviruses and hepatovirus (Andino et al., 1993; 
Mosimann et al., 1997; Bergmami et al., 1997). For the PV 3C protein, residues R84 
and 186 within this motif were found to be critical and modification of R84 blocked 
the ability of the PV 3CD to support VPg uridylylation (Paul et al., 2000). In FMDV 
the analogous motif is K^^VRDI (AlO) or R^^VRDI (OIK and Type C) (FIG. 4.9). In 
addition among the picomaviruses mentioned excluding the HAV other viruses also 
showed the presence of a conserved amino acid arginine corresponding to residue 
92 of FMDV 3C (R79 in PV) (FIG. 4.10). It should be noted that the arginine residue 
at the 84 position (R84) in PV corresponds to the arginine residue at position 
97(R97) in FMDV. Since the structure of the FMDV 3C protein has been determined 
recently (Birtley et al., 2005) it is possible to locate this motif and residue R97, in 
particular, on the surface of 3C. Consistent with obseiwations on the PV and HAV 
3C proteins, this motif on the FMDV protein is located on the opposite face of the
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FIG.4.9. Sequence alignment of the 3C proteases from three FMDV serotypes.
Multiple sequence alignment o f the 3C protein derived from three different serotypes of the 
FMDV (A, O, C) using DS gene software. The high degree of consensus among the three 
different serotypes is presented in the figure legend. The solid-line box represents the absolute 
conserved nature of the predicted RNA binding site o f the three different FMDV serotypes.
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FIG.4.10. Sequence alignment of the 3C proteases from multiple picomaviruses. Amino acid sequences 
of the 3C protease derived from three different FMDV serotypes (O, A, C) and other picomaviruses including 
enteroviruses (PV), rhinoviruses ( HRV 14) and hepatovirus (HAV) were aligned using the programme 
BIOEDIT. The residues marked with red star were the position where mutations were introduced in the 
AlO 3C expression constructs by QuikChange site-directed mutagenesis (see Materials and Methods).
In all cases the positively charged arginine residues were mutated to a neutral amino acid serine.
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FIG.4.11. Three dimensional x-ray crystallographic structure of 3C pro tease depicting the 
basic surface opposite to the protease active site Panel A. Surface representation of the 3C 
protease coloured by electrostatic potential. The positively charged residues (blue) are indicated 
with single amino acid letter code. Panel B. secondary structure showing the positions o f the 
mutated arginine residues to serines on the 3C surface. Panel C. The 90° vertical rotation of the 
3C structure in Panel B showing the catalytic triad of the 3C protease just opposite to the predicted 
RNA binding site. The asterisk C l63* represents the mutation in the cysteine to an alanine within 
the active site of the AlO 3C protease.
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protein from the protease active site (FIG. 4.11, Panel C). It is apparent that other 
positively charged residues are close to R97 on the surface of the FMDV 3C, thus 
residues R92 and R95 together with R97 form a cluster of positively charged 
residues that may bind to RNA. In addition since the amino acid sequence alignment 
of tliree different serotypes of the FMDV showed a high degree of similarity among 
them (FIG. 4.9) and the AlO 3C stmcture has been solved (FIG. 4.11) we have used 
the AlO 3C protein for further analysis of this protein.
4.2.5 Analysis of putative RNA binding residues in FMDV 3C.
In order to test the role of these basic residues for the uridylylation function, 
mutations were inti’oduced into the 3C sequence individually to change residues 
R92, R95 and R97 to an uncharged serine (S) residue in each case. The mutant His- 
tagged 3C proteins were each expressed in E. coli and purified to near homogeneity. 
Equal amounts of each of these proteins were then tested in uridylylation assays in 
conjunction with 3D^°’ and either the cre/bus transcript (FIG. 4.12, Panel A) or with 
the entire FMDV 5’UTR (FIG. 4.12, Panel B). Very similar results were obtained 
with each template. The R97S mutant was almost completely inactive in these 
assays, similaiiy the R92S mutant was also severely defective but a low level of VPg 
uridylylation was observed. In contrast, the R95S mutant displayed about 25% of wt 
activity. Competition experiment using such mutant proteins demonstrated that these 
proteins do not compete with wt 3C protein for VPg uridylylation (FIG. 4.13).
4.2.6 Electrophoretic mobility shift assay (EMSA)
To confirm that the stimulatory properties of the FMDV 3C protein in the VPg 
uridylylation assay is due to the RNA binding activity, gel shift assays were
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FIG. 4.12. Modification of the positively charged arginine residues to serines in 3C protein 
influences VPg uridylylation. In vitro uridylylation assays were carried out using VPg3 as a 
substrate in the presence of either 3C(C163A) or 3C(C163A) with mutations in arginines to serines 
at position 92, 95 and 97 respectively either using cre/bus (Panel A) or 5’ UTR RNA (Panel B) 
as templates. Equal amount of the proteins were used in each reaction those were detected 
by western blotting (Panel A). The amount of VPgpUpU synthesized in Panel A and Panel B were 
quantified and depicted in bar graph.
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A- 2.5 pM 3C(C163A)
B- 5.0 pM 3C(C163A)
C- 2.5 pM 3C (C 163A )+ 2.5  pM 3C(R92S) 
D- 2 .5  pM 3C(C163A)+ 2 .5  pM 3C(R95S) 
E- 2 .5  pM 3C(C163A)+ 2 .5  pM 3C(R97S)
-VPgpUpU
FIG.4.13. Mutant 3C proteins do not compete with wt AlO 3C(C163A) protein for VPg 
uridylylation. To test the ability of the mutant 3C protein (R92S, R95S and R97S) to inhibit 
wt 3C(C163A), VPg uridylylation assays were carried out using 2.5 pM VPg3 and 2.5 pM 
3C(C163A) in all reactions with further addition of 2.5 pM 3C (wt/mut) as indicated in the 
figure legend. Production of VPgpUpU was measured and showed as a bar diagram.
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FIG.4.14. Electrophoresis mobility shift assay of recombinant 3C(C163A) with FMDV cre/bus. 
Panel A. FMDV cre/bus RNA transcripts (100 pM) were incubated with 3C(C163A) (20pM-250pM) 
at 30“C in reaction conditions similar to that o f the in vitro VPg uridylylation assay (see Materials and 
Methods) for 20 min and run in a 8% TBE-polyacrylamide gel. RNA was stained with ethidium- 
bromide and visualized using UV light. Arrow on the left represents the free RNA and on the right 
Present the RNA-protein complex. Panel B. Coomassie brilliant blue staining of the ethidium 
bromide stained polyacrylamide gel to visualize the position of the 3C(C163A) in the gel.
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performed to determine the ability of the 3C protein to foim complexes with cre/bus 
transcripts. Essentially reaction conditions of the binding buffer were set similar to 
that of VPg uridylylation assays containing the cre/bus RNA with 3C(C163A) 
protein. By Et-Br staining it was found that in the presence of 3C, the mobility of the 
cre/bus tianscript was greatly impaired, consistent with the formation of an 
RNA/protein complex (FIG. 4.14, Panel A).
4.2.7 Generation of FMDV full-length RNA transcripts with authentic 5’ end
To establish whether there is any connection between the ability of the 3C to support 
VPg uridylylation in vitro and its importance in RNA replication in vivo we 
inti'oduced the same mutations into the FMDV infectious clone (Materials and 
Methods). Such mutations were inti'oduced into the infectious cDNA clone pT7S3 
and pT7S3-Ribo (contains a hammer head ribozyme upstream of the 5’ end of the 
virion cDNA). Wild type RNA transcripts generated from these clones were 
electroporated into BHK 21 cells and plaque assay was carried out. A direct 
comparison of the infectivity of both type of transcripts showed that wild type 
FMDV RNA transcripts without ribozyme is slightly better than that of the wild type 
transcripts with ribozyme (FIG. 4.15)
4.2.8 FMDV S-fragment interacts with a cellular protein p48
To detect any interactions between the S-fragment and viral and cellular proteins UV 
cross linking experiments were carried out (Materials and Methods) using ^^P- 
labelled S-fragment RNA. It was observed that neither the recombinant viral protein 
(3 CD) nor cellular proteins (PCBPl and PCBP2) showed any evidence of RNP
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pT7S3(wt) pT7S3Ribo(wt)
(48)
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FIG. 4.15. Plaque assay using pT7S3(wt) and pT7S3Ribo(wt) RNA transcripts in BHK 21 cells.
Wt RNA transcripts (with or without ribozyme) were electroporated with BHK 21 cells. After 8 hr 
incubation the virus was harvested and 200 pi of the neat or diluted virus was added to fresh BHK 21 
cells (60%-70% confluent) in soft agar. Staining of the petridishes were carried out after 48 hr 
incubation at 37°C. The number of plaques at each dilution were counted as above and compared.
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FIG.4.16. Interaction of the S-fragment with viral and cellular proteins. Panel A. UV cross- 
linking experiments were carried out using radiolabeled S-fragment probe in the presence of either 
purified recombinant proteins (3CD, PCBPl, PCBP2) or cell extract (BHK SIO) following protocol 
as described in the Materials and Methods. Reaction samples were mixed with 3X sample loading 
buffer (BioRad), boiled for 5min at 75“C and run in a 10% SDS-PAGE gels. The gel was stained with 
coomassie brilliant blue for 15 min, destained for 30 min and dried for 1 hr at 68°C and gel was 
exposed over night for autoradiography. Panel B. The specificity of the UV-cross linking experiment 
was checked by titrating the competitor t-RNA in the reaction. Panel C, demonstrates the interaction 
of the radiolabeled S-fragment and PK+cre+IRES probes using cell extracts derived from unifected 
(BHK SIO, HeLa SIO) and FMDV infected BHK extracts.
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complex foraiation (FIG 4.16, Panel A). However FMDV S-fragments specifically 
interacted with a 48 kDa cellular protein (p48) both in BHK cell extracts and HeLa 
cell extracts (FIG 4.16, Panel A, Panel B). However a similar interaction was not 
detected with radiolabelled probe comprising the FMDV pseudoknots, cre/bus and 
1RES together (PK+cre/ôw^+IRES) indicating the specificity of this interaction (FIG 
4,16. Panel B, Panel C).
4.2.9 3B precursor proteins can be a substrate in the FMDV uridylylation assay 
For PV it has been suggested that VPg containing precursor proteins like 3AB, 
3ABC, 3ABCD and 3BC could be substi'ates in the uridylylation assay. To 
investigate this possibility for FMDV, native protein expression and purifications of 
the non-structural proteins 3BCi233C and 3Bs3C were carried out using ubiquitin 
vector system (FIG. 4.17, Panel A) as described in the Chapter 3. Purifications of the 
untagged version of the 3BCi2s3C and 3Bg3C were carried out by ion exchange 
chromatography (Materials and Methods) (FIG. 4.17, Panel B). In vitro uridylylation 
assays using these purified proteins resulted in efficient uridylylation of these 
precursor proteins in vitro. It was found that that both the precursor proteins can be 
uridylylated in viti'o in the absence of 3CD (since they each contain 3C), but the 
reaction was stimulated in its presence (FIG. 4.18, Panel A and Panel B). However it 
should be noted that uridylylation of the 3BCi2s3C resulted in the formation of some 
radiolabelled breakdown product that was again enhanced by the presence of the 
3CD protein (FIG. 4.18, Panel B). Treatment of the 3BCi233C uridylylation assay 
products with RNase A and Proteinase K resulted in complete disappearance of the 
breakdown products indicating their protein nature (FIG.4.18, Panel C). At the 
present time the explanation of this phenomenon is not known.
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FIG.4.17. Expression and purifications of FMDV non-structural precursor proteins. Panel A. 
Coomassie brilliant blue staining of the un tagged recombinant proteins expressed in E coli cells 
(total cell extracts). Panel B. Purification of the native VPg precursor protein 3B,2]3C and 3B^3C. 
Expression of the native VPg precursor proteins 3B,233C and 3 B33C were carried out as described 
for of the native 3Dpol protein in Chapter 3. Purification of the proteins were carried out by 
ion-exchange chromatography using PI 1 (phosphocellulose) and High-Trap SP sepharose column. 
Purity of the proteins were judged by coomassie brilliant blue staining.
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FIG. 4.18. Precursor protein 3BC can be a substrate in FMDV uridylylation assay. In vitro 
uridylylation assays w ere carried out using VPg precursor proteins SB^^gSC and SBjSC as 
substrates using cre/bus  as a tem plate. Panel A. FM D V  uridylylation assays w ere carried out using 
varied concentrations o f  SB^SC with or w ithout 3CD. Panel B. 3B ,2]3C uridylylation assay in 
presence or absence o f  3CD. Panel C. D epicts the effects o f  RNase A (lane b) and proteinase K 
(lane c) in separate in vitro reactions at 37“C on the 2.5 pM 3B]2g3C uridylylation products.
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4.3 Discussion
4.3.1 The FMDV cre/bus could be the primary template for VPg uridylylation
In the previous chapter the requirements of the FMDV uridylylation assay in vitro 
were described in which cre/bus acts as a template. However an important question 
remaining to be answered is how the cre/bus functions in vivo when it is in the 
context of the full-length FMDV RNA. Within the 5’ UTR of the FMDV genome, 
besides the cre/bus there are other important structures which are present including 
the S-fiagment, internal ribosome entry site (1RES), pseudo knots (PKs) and the 
polyC tract (FIG. 4.2, Panel A).Therefore at this juncture it could not be ascertained 
whether the cre/bus alone or any other RNA stmctme within the 5’UTR participates 
in RNA replication. Previously it has been suggested for PV that the polyA tail at the 
3’ end of the genome primes VPg uridylylation internally (Paul et al., 1998). To 
investigate these possibilities for FMDV, in viti'o uridylylation assays were canied 
out using RNA transcripts with an intact polyA tail but with point mutations in each 
of the first 3 ‘A’ residues within the AAACA motif of the cre/bus. To our surprise 
any mutations that debilitated the VPg uridylylation using cre/bus as a template (as 
in Chapter 3) also showed similar results with tlie same mutations within the cre/bus 
in the context of the full-lengtli FMDV RNA. This indicates that the polyA tail is an 
inefficient template for VPg uridylylation in vitro in the presence of magnesium. 
This is in agreement with a recent report on poliovirus where mutation in the first 
‘A’ residue within the AAACA motif blocked the production of VPgpUpU using a 
cell-fi'ee reaction (Murray et al., 2003). Therefore we suggest that at least for FMDV, 
cre/bus is the primary template for VPg uridylylation in vitro and it might be 
possible that cre/bus dependent VPg uridylylation primes both positive and negative 
strand synthesis. It was also found that wild type full-length FMDV RNA is a
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significantly better template for VPg uridylylation in comparison to cre/bus alone 
(FIG. 4.1, Panel B).
4.3.2. RNA-RNA interactions in the FMDV 5’ non-coding region influence VPg 
uridylylation
It is noteworthy that the stability of the PV ere as a template also determines the 
uridylylation efficiency in viti'o (Goodfellow et al., 2003). We assume that when the 
FMDV cre/bus is within the full-length FMDV RNA the overall stability and tertiary 
folding is significantly influenced by the neighbouring structures either by direct 
contact with nearby structure or some type of long distance kissing interactions. 
Since we know that the poly A tail is an insignificant template in VPg uridylylation, 
the enhanced ability of the FL-FMDV RNA to support VPg uridylyaltion is most 
likely determined by the 5’ UTR structures. To test this hypothesis a series of 
truncated FMDV 5’ UTR RNA transcripts were used which showed that RNA 
transcripts encompassing the PK+cre+IRES are the most efficient template in the 
reaction (FIG. 4,2). This result suggested that neither tire S-ffagment nor the polyC 
tract is involved in any sort of stabilization of the cre/bus structure. However it was 
evident from the RNA trans complementation experiments that RNA-RNA 
interactions exists among the secondary and tertiary structures of the PK, cre/bus and 
1RES which supports VPg uridylylation as a single template most efficiently than 
any other structures present in the 5’ UTR (FIG. 4.2, FIG. 4.3). In addition a 
comparison of the uridylylation efficiency of the cre/bus alone and that of the full- 
length FMDV RNA and 5' UTR FMDV RNA (FIG. 4.1 and FIG. 4.2) showed that 
the ability of the FMDV 5’ UTR and FMDV full-length RNA to support VPg
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uridylylation is very similar suggesting that the optimal sequences for uridylylation 
reside solely in the 5 ’ UTR.
4.3.3 The FMDV cre/bus derived from a temperature sensitive mutant is 
defective in VPg uridylylation
In foot and mouth disease virus temperature sensitive mutants have been identified in 
which the virus could not gi*ow at the non-permissive temperature (42°C). For one 
mutant (ts303) this defect was attributed to a lesion in the stem of the cre/bus (Tiley 
et al., 2003). Based on this information we generated the cre/bus transcripts with a 
mutation at position 47 of the stem from a cytosine residue to a uracil residue (FIG. 
4.4). The ability of this transcript to support VPg uridylylation was measured in 
vitro. It was found that this mutated cre/bus transcript could not support VPg 
uridylylation to similar extent as that of the wild type cre/bus transcripts under 
similar conditions of temperature and time. Analysis of the secondary structure of 
the wild type and mutant FMDV cre/bus RNA sequence using mfold RNA 
prediction server rhttp://bioinfo.math.n3i.edu/Mnfoldl showed that the stability of 
this mutated cre/bus RNA is reduced because of the mutation (AG value -15.2 to - 
13.5). In addition the effect of this mutation on virus growth was only observed at 
elevated temperature in vivo but not at the permissive temperature of 37°C. Our in 
vitro data suggested that the defects in VPg uridylylation in vitro using mutated 
cre/bus as a transcript was observed throughout the temperature range of 30°C to 
42°C (FIG. 4.4, Panel B). The difference in sensitivities between the in vivo data and 
in vitr o data could be attributed to the relative stability of the cre/bus transcripts 
alone in vitr o compared to that of the cre/bus element in the context of full-length 
FMDV RNA. These results suggested that the temperature dependence of the cre/bus
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in VPg uridylylation coiTesponds to the stability of the cre/bus structure. It is also 
being reported that the stern of the PV ere provides the stability to the loop for VPg 
uridylylation (Goodfellow et al., 2003). Recently it has been shown that although 
HRV14 ere is about 66nt in length the minimal functional sequence required for VPg 
uridylylation in vitro is 34 nt (Thiviyanathan et a l, 2004). To explore the minimal 
sequence for FMDV cre/bus we generated two shorter version of the cre/bus with 31 
and 37 nt respectively. In vitro uridylylation assay using these shorter cre/bus 
transcripts resulted in very little VPg uridylylation compared to the wild type cre/bus 
(54 nt) (FIG. 4.5). This suggests that the minimal optimal sequence for VPg 
uridylylation in FMDV is more than 37 nucleotides.
4.3.4 The FMDV 3C protein can replace 3CD in VPg uridylylation assay 
We have shown in the previous chapter that 3 CD is a pre-requisite for the VPg 
uridylylation in vitro. Earlier studies with PV have shown that the RNA binding 
activity of the 3C domain within the 3 CD is responsible for the stimulation of the 
VPg uridylylation (Pathak et al., 2002). To explore the possibility that FMDV 3C 
also possesses similar' properties, we replaced the FMDV OIK 3CD with 3C proteins 
of AlO and OIK serotypes in the uridylylation assay. We found that 3C alone can 
replace the 3CD in the uridylylation assay (FIG. 4.7) but it is less efficient than 3CD 
(FIG. 4.8). In addition we also found that the OIK and AlO 3C protein possess 
similar activity in the uridylylation assay. A titration experiment showed that even at 
10 pM 3C concentration, efficiency of VPg uridylylation was only about 25% of the 
level observed in the presence of 1 pM 3CD (FIG. 4.8, Panel A). This suggests that 
3CD is more specific for the uridylylation of the VPg than the 3C alone. However 
there was a shar p contrast in the extent of stimulation of VPg uridylylation using the
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3C protein with respect to RNA template. There was steady stimulation of VPg 
uridylylation by 3 C in the presence of cre/bus as template, whereas the reaction was 
inhibited beyond 1 pM 3C in the presence of the 5’ UTR (FIG. 4.8, Panel B). This 
phenomenon could be explained on the basis that there was a great difference in the 
concentration of RNA in the two systems. 5 ’ UTR transcripts were used 40 times 
lower compared to the cre/bus transcripts in similar assays. It is possible that the 
excess 3C protein to template ratio could block the accessibility of the template 
thereby causing non-specific inhibition of the reaction.
4.3.5 The RNA binding activity of the FMDV 3C protease could be responsible 
for stimulatory effects in VPg uridylylation
Recently the crystal structure of the FMDV (AlO) 3C protease has been solved 
(Birtley et al., 2005) which showed a region of the 3C that is rich in positively 
charged amino acids on the opposite face fiom the protease active site (FIG. 4.11), 
This region was hypothesized to be the RNA binding region of the FMDV 3C 
protein. Based upon the sequence alignment with other picornaviruses (FIG. 4.10) 
we predicted that arginine residues at position 92(R92), 95(R95) and 97(R97) might 
be involved in RNA binding properties of the FMDV 3C protein. We mutated the 
positively charged arginine residues at positions 92, 95 and 97 to serine residues. 
Replacement of the wild type 3C protein with mutant proteins resulted in varied 
degiees of VPg uridylylation. Substitution of the arginines at 97 and 92 almost 
completely inhibited the reaction; whereas mutation in the arginine 95 residue 
resulted in 75% reduction in VPg uridylylation (FIG. 4.12). Since it has been 
suggested that the RNA binding activity of the 3C contributes to the stimulation of 
uridylylation, we explored this possibility by electrophoretic mobility shift assay
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(EMSA). Initial experiments suggest that wild type 3C protein binds to the cre/bus in 
a dose dependant manner (FIG.4.14). The binding activity of the mutant 3C proteins 
is the focus of current investigation. In addition, studies on PV have shown that 
modifications of the 3C protein at the arginine residue at position 84 which 
corresponds to the FMDV arginine 97 inhibits RNA replication by disrupting the 
ternary complex formation between clover leaf and 3CD protein (Andino et al., 
1990, 1993). To date no such studies has been carried out to find out the role of 3C 
or 3CD in FMDV RNA replication. Fur thermore a defined role of the S-fragment in 
FMDV RNA replication has not yet been established.
The formation of a ribonucleoprotein complex between 3 CD and clover leaf RNA of 
poliovirus and its significance in RNA replication is long established (Andino et al., 
1990). In addition there is str ong evidence of linkage between the ability of the ere to 
support VPg uridylylation in vitio and its effects on RNA replication (Yang et al.,
2002). At this juncture we have little information regarding either the biological 
relevance of the RNA binding activity of the FMDV 3 C/3 CD in RNA replication or 
formation of any ribonucleoprotein complex formation between the FMDV 3 C/3 CD 
to any RNA structure at the 5’ UTR. Based upon the band-shift assay (FIG. 4.14) we 
assume that the RNA binding activity of the 3C is also required for FMDV VPg 
uridylylation. However we do know that mutations in the arginine residues in 3C at 
92, 95 and 97 positions affect FMDV VPg uridylylation, thus it may be expected that 
such mutations will affect RNA replication. Hence it makes sense to carry out further 
experiments to elucidate the role of 3 C/3 CD in FMDV RNA replication by 
introducing these mutations into the full-length FMDV infectious clone and 
analysing their effects on RNA replication by introducing such full-length modified
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RNA into BHK cells. It is well established that transcripts generated by in viti’o 
transcription reaction using T7 RNA polymerase adds two non-viral GG residues at 
the beginning of the transcripts that delays the onset of RNA replication in 
transfected cells until the ends are corrected (Herold and Andino 2001). To avoid 
such problems we introduced sequence encoding a ribozyme into the infectious 
cDNA clone of the FMDV and a direct comparison was carr ied out using transcripts 
with or without ribozyme. Unexpectedly we found the transcripts generated in vitro 
without ribozyme was slightly better when compared to transcripts with the 
ribozyme with respect to the number of plaques formed on BHK cells under identical 
condition (FIG. 4.15). Similar observations were made during the course of 
development of a cell-free replication system for FMDV using BHK 21 extracts 
(Data not shown). This discrepancy might be attributed to the fact that the in vitro 
condition at present for RNA transcription may not be ideal for the optimal cleavage 
of the ribozyme from the 5’ end of the FMDV transcripts.
4.3.6 The FMDV S-fragment interacts with a cellular protein (p48)
We have suggested earlier (see Introduction) that if PV and FMDV follow a similar 
replication str ategy then the FMDV 3 C/3 CD may be expected to interact with the S- 
fragment, which is considered to be the counterpart of the cloverleaf RNA to form a 
ternary ribonucleo-protein complex. To investigate this hypothesis we carried out the 
UV-cross linking experiment using ^^P-labelled S-fragment probe in the presence of 
both cellular and purified recombinant proteins including FMDV 3CD, PCBPl, 
PCBP2 and BHK and HeLa cell extracts. It was found that S-fragment does not 
participate in the formation of RNP complex either with viral protein 3CD, or with 
the cellular proteins PCBPl and PCBP2 (FIG. 4.16, Panel A). These findings
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suggested that FMDV S-fragment did not interact with any of those proteins stated 
above individually. It might be possible that 3C or 3CD together with other viral or 
cellular proteins interacts with the FMDV S-fragment. Since FMDV replicates in 
BHK 21 cells and all positive strand RNA viruses utilises host components for RNA 
replication it was quite obvious to try out the BHK cell extracts to detect any RNA- 
protein interactions. It was observed that the S-fragment specifically interacts with a 
cellular protein p48 (ca.48 kDa) even in the presence of competitor RNA (FIG. 4.16, 
Panel B). To exclude the possibility that this interaction might be due to a RNA 
binding protein La (an autoantigen required for translation of many positive strand 
RNA viruses including PV and HCV which has a general RNA binding activity) we 
used another radiolabelled probe that contains the FMDV PK+cre+ 1RES sequence. 
UV cross linking with such a probe resulted in interaction with a much larger protein 
(~ 100 kDa) but not the p48 (FIG. 4.16, Panel C). Similar observations were also 
made using HeLa cell extiacts and infected BHK 21 cells extracts (FIG. 4.16, Panel 
C). The identity of this protein (p48) remains to be elucidated.
4.3.7 Non-structural precursor protein 3BC is a good substrate in FMDV 
uridylylation assay
In this chapter we have also explored the possibility of using non-structural precursor 
proteins as a subsfrate for FMDV uridylylation assay. It has long been believed that 
either 3AB or 3AB containing precursors are the source of VPg for uridylylation. 
Since 3 A and 3AB both remain attached to the membrane (Towner et al., 1996) it is 
likely that 3AB undergoes cleavage in the presence of 3CD to produce VPg 
molecules for primer formation required for both negative and positive stiand 
synthesis. It is also possible that the uncleaved form of the 3B and 3C (3BC) might
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also acts as a substrate for VPg uridylylation in the presence of 3D. It was found that 
both forms of the 3BC precursor proteins either 3Bi233C or 3Bs3C are good 
substrates for VPg uridylylation with or without the presence of 3CD (FIG. 4.18).
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CHAPTER FIVE
Characterisation of foot and mouth disease virus replication 
complexes (RCs) in vitro
All positive stiand RNA viruses replicate inside the cells in association with 
cytoplasmic membranes (Salonen et al., 2005). Previous studies on poliovirus 
(Takeda et al., 1986) and recent studies on other positive stiand RNA viruses like 
hepatitis C virus (HCV) (Ali et al., 2003; El-Hage and Luo 2003) and feline 
calicivirus (FCV) (Green et al., 2002) have also shown a requirement for membrane 
associated replication complexes (RCs) in RNA replication. To date no such studies 
have been undertaken to characterise the replication complexes in FMDV infected 
cells in vitio. In addition, a cell-free system capable of replicating FMDV RNA in- 
vitro has not been developed so far. Such a system could greatly contiibute to our 
understanding of the RNA replication mechanism of FMDV. It would be possible to 
analyse individual steps in RNA replication and clarify some of the other individual 
processes like the requirement for replication factors and also the effects of inhibitors 
of RNA replication like guanidine in vitro. In the present studies we have been able 
to develop an in viti'o RNA replication assay system using a membrane fraction from 
FMDV infected BHK 21 cells that faithfully synthesizes frill length FMDV RNA 
molecules along with intermediate RNA species.
5.1 Features of the FMDV in vitro replication assay system 
Based upon the observations with some positive strand RNA viruses that a 
membrane fraction obtained fr om cells infected with these viruses is fully capable of 
synthesizing virion RNA in vitro (Takeda et al., 1986; Green et al., 2002; Ali et al.,
2003) we envisaged developing a homologous system for FMDV. Like other
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positive stiand RNA viruses, FMDV assembles replication complexes using 
membranes derived from the vesicle structures inside the cytoplasm (Monaghan et 
a l, 2004). In this context we have prepared a post nuclear, crude membrane fraction 
from FMDV infected BHK21 cells (see Materials and Methods) which was 
supplemented with an ATP regenerating system using creatine phosphate as a 
substrate and creatine phosphokinase (CPK from rabbit muscle) as an enzyme. 
Addition of all the 4 rNTPs along with ^^P-aUTP in to the system resulted in 
synthesis of FMDV RNA that included single stranded RNA (ss RNA), double 
stranded RNA replicative form (dsRNA RF) and partially double stianded replicative 
intermediate (dsRNA RI) molecules (FIG. 5.1, Panel B). To observe the effects of 
guanidine on RNA synthesis, BHK21 cells were treated with this inhibitor (lOmM 
concentration) prior to virus infection and cmde membrane fractions obtained from 
these cells were incapable of synthesizing RNA (FIG. 5.1, Panel B). Ethidium- 
bromide staining of RNA isolated fr om the in vitro RNA replication assay showed 
that RNA synthesis was only observed when the BHK cells were infected with virus 
in the absence of guanidine (FIG. 5.1, Panel A). In all cases the membrane fraction 
was found to be associated with similar' levels of 18S and 28S ribosomal RNA.
5.2 Association of FMDV specific structural and non-structural polypeptides 
with the crude replication complexes
In poliovii'us infected cells, RNA translation, vesicle assembly and RNA replication 
are coupled processes (Egger et a l, 2000). Similarly we may expect that all the non- 
structural proteins required for FMDV RNA replication and the stiuctmal proteins 
required for virus capsid assembly will also be present in the FMDV crude 
replication complexes (CRCs). In order to investigate this possibility we analysed for
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FIG. 5. 1. RNA synthesis from membrane fraction of FMDV infected BHK cells. In
vitro RNA replication assays were carried out using RC isolated from mock, guanidine 
treated and FMDV infected BHK cells using ^^P-aUTP at 30°C. Panel A. RNA synthesized 
in this assay was extracted using phenol: chloroformiisoamyl alcohol and analysed by 
ethidium-bromide staining using a 1% native agarose gel. The first lane contains in vitro 
transcribed full-length (FL) viral RNA as a marker. Second and third lanes contain RNA 
synthesized from mock and FMDV infected BHK cells with prior treatment with guanidine 
hydrochloride (10 mM) respectively. Lane four shows the synthesis of FL FMDV RNA 
within the RC. 18S and 28S r-RNA appeared in all lanes as indicated. However presence 
of the FL FMDV RNA was only observed in the fourth lane. Panel B. Ethidium-bromide 
stained gel was dried under vacuum without heat for 30 min followed by drying at 60°C 
for an hour on the gel dryer. The dried gel was exposed to x-ray film for Ihr and image was 
developed using a Compact X4 X-Ograph.
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the presence of both non-structural and stiuctural proteins in these replication 
complexes isolated at different time points post infection. Western blot analysis of 
these membrane fractions using anti-3C, anti-3D monoclonal antibody revealed that 
non-sti'uctural precursor polypeptides appeared at around 2hr post infection (FIG.
5.2, Panel A and Panel B) and by 3hr most of the non-structural proteins including 
both precursor and mature proteins were present (FIG. 5.2, Panel A and Panel B). As 
expected the membrane preparations from mock infected and guanidine tieated 
FMDV infected cells did not show any detectable protein synthesis in western blot 
(FIG. 5.2, Panel A and Panel B). Similar experiments using polyclonal serum raised 
against the capsid protein of O IK  virus also revealed the appearance of the structural 
proteins in the CRCs isolated from FMDV infected cells (FIG. 5.3).
5.3 Synthesis of peptide primer VPgpUpU within the CRCs
In picornavirus RNA replication, synthesis of the peptide primer VPgpUpU is the 
primary step in both positive and negative strand synthesis. To analyse whether time 
RNA replication initiation takes place within these replication complexes, in vitro 
replication assay was carried out as described in the Materials and Methods. 
VPgpUpU synthesis within these replication complexes was analysed using methods 
described by Vartapetian et al., (1984) (see Materials and Methods). Earlier work 
using poliovirus has suggested that VPg bound to the short oligonucleotides 
partitioned to the organic phenol phase, whereas the virion RNA is sequestered to the 
aqueous phase (Ambrose and Baltimore 1978; Vartapetian et al., 1982). Our 
preliminary experiments using FMDV CRCs in the RNA replication assay showed 
similar results with two ^^P-aUTP labelled products were being present in the phenol 
phase (FIG. 5.4) which are interpreted as VPgpU(pU).
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FIG. 5. 2. Analysis of non-structural proteins associated with RC isolated from mock and 
FMDV infected BHK cells with anti-3C Mab. Panel A. Monoclonal antibody raised against 
the 3C protein was used to detect the RC proteins during the course of FMDV infection. The 
appearance of 3C along with its precursors 3BC, 3CD and larger precursors are marked by 
arrows. A non-specific band of approximately 50 kDa appears in every lane irrespective of virus 
infection. The values in the left are molecular sizes in kilodalton. Panel B. The same sample were 
analysed using a monoclonal antibody raised against the 3D polymerase. The appearance of 3D 
and its precursor 3CD and larger 3D containing precursors are indicated.
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FIG. 5. 3. Analysis of structural proteins associated with the RC from mock and FMDV 
infected BHK cells. Proteins synthesized during the course of in vitro assays were transferred to a 
nitrocellulose membrane and analysed using guinea pig serum raised against FMDV. Appearance 
of the VP3, VP2/VP1 and VPO was indicated by an arrow.
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FIG. 5. 4. De novo synthesis of VPgpUpU in the FMDV crude replication complexes (CRCs).
Standard in vitro RNA replication assays were performed as described previously. The samples 
were solubilised with SDS (final concentration of 1%) and extracted with chloroform/methanol 
(2:1, v/v). The aqueous phase was again extracted with phenol:chloroform:isoamyl alcohol (25:24 
:1). Products in the organic phenol phase were precipitated with 4 volume of acetone and production 
in the aqueous phase were precipitated with 2.5 volume of ethanol. The samples were dissolved 
in tris-tricine dye and analysed using 14% tris-tricine gel electrophoresis.
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5.4 FMDV RNA synthesis in crude replication complexes (CRCs)
The ability of the FMDV CRCs to synthesize RNA was analysed by isolating the 
membrane fractions from the FMDV infected BHK21 cells at different times post 
infection starting from Ihi' to 3.5 hrs. In vitro RNA replication assays were 
performed (see Materials and Methods) to detect the synthesis of the viral RNA. It 
was found that CRCs isolated as early as 2hr post infection (FIG. 5.5) were 
sufficiently active enzymatically to synthesize full-length virion RNA, which closely 
matched the results of the western blot analysis with appearance of the replication 
proteins like 3D polymerase (FIG. 5.2). However CRCs isolated at 3 hr post 
infection were most active in synthesizing virion RNA (FIG. 5.5) when there is 
gieatest abundance of the mature and precursor forms of the non-structural proteins 
(FIG. 5.2). The 3.5 hr CRCs were also active in synthesizing virion RNA though less 
efficiently compared to the 3hr CRCs.
5.5 Time course of RNA synthesis in CRCs
The accumulation of FMDV RNA in the replication complexes was analysed by 
using the 3hr post infection membrane fr actions in an in vitro RNA replication assay. 
A master mix reaction was assembled and aliquoted in to 7 tubes for 7 different time 
points. At each time point the reaction was stopped by adding the TENSK solution 
(see Appendix II). Analysis of the RNA extiacted from these replication complexes 
showed that viral RNA synthesis could be detected as early as 5 min (FIG. 5.6) and 
gradually increased until it reaches maximum at Ihr time point (FIG. 5.6).
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}■ RI+RF
 dsRNA
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FIG. 5. 5. Analysis of RNA synthesis in RC isolated from FMDV infected BHK cells at 
different time points. BHK cells were infected with 01 BPS virus at high MCI to observe more 
than 95% of cell infection. Replication complexes (RCs) present in the membrane fraction were 
isolated at Ihr, 2hr, 3hr and 3.5 hr post-infection. The ability of these RC to synthesise 
full length (FL) virion RNA were assessed by in vitro RNA replication assay. Newly 
synthesized RNA were extracted using phenol: chloroform: isoamyl alcohol followed by ethanol 
precipitation. Subsequently the RNA pellets were dissolved in RNA storage solution (Ambion). 
1/10"' of the aliquot was treated with non-denaturing orange dye and run on a 1% native agarose 
gel at 80 volts for 3hrs. The gel was dried for 30 min under vacuum without heat followed by 
drying at 60®C for another hour. The dried gel was exposed to Biorad X-ray film for approximately 
1 hr and image was developed using Compact X4 X-Ograph.
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FIG. 5. 6. Time course of RNA synthesis in vitro using 3hr replication complexes. RNA
replication assays were carried out in seven individual tubes at 30®C for the indicated times. 
RNA was extracted from each tube and run on a 1% native agarose gel. The gel was dried and 
exposed to film.
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5.6 Effect of guanidine on RNA synthesis in vitro
To determine the effects of the guanidine in vitro, this inhibitor (lOmM) was added 
to the reaction mixture at the beginning of the RNA synthesis. The idea was to detect 
the action of the guanidine at the very early stage of the initiation of viral RNA 
synthesis within these replication complexes to observe the effects on negative 
strand synthesis. For this, CRCs isolated from BHK 21 cell infected with FMDV in 
the absence of guanidine at different time point were used in the reaction either with 
or without guanidine. Earlier it has been reported using poliovirus that guanidine 
inhibits the synthesis of negative sh ands in a reaction using pre-initiation replication 
complexes (PIRC) isolated from a cell-free in vitro tianslation-replication reaction. 
However guanidine did not have any effects on positive strand synthesis (Barton and 
Flanegan 1997). In FMDV the reaction mixtures containing guanidine were partially 
inliibited in their ability to support RNA synthesis (approximately 50%) compared to 
CRCs without guanidine (FIG. 5.7). This suggested that within this system true 
initiation of negative strands occurred.
5.7 Analysis of RNA species synthesized within the FMDV CRCs
To determine the nature of the RNA species synthesized within the FMDV CRCs, 
total RNA was isolated fr om the in vih o replication assay by phenol extraction and 
ethanol precipitation and subsequently treated with RNase A under high salt buffer 
conditions. High salt buffer conditions are supposed to keep the double stranded 
RNA intact (and hence resistant to RNase A) compared to the low salt buffer 
condition that allows the relaxation of the double stranded RNA interaction. 
Analysis of the RNA sample in a native agarose gel after the digestion showed that 
the single stranded RNA species is completely degraded by RNase A, whereas the
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FIG. 5. 7. Effects of guanidine hydrochloride on RNA synthesis in vitro. To observe the effect 
of guanidine hydrochloride on RNA synthesis, in vitro RNA replication assays were carried out 
using RC isolated from FMDV-infected BHK cells at different time points. In all reactions the final 
concentration of the Gu-HCl was lOmM. Reactions were carried out for a period of Ihr at 30°C with 
or without Gu-HCl as indicated and stopped by adding TENSK buffer and the RNA was extracted. 
1/10'^ of the total aliquot of the RNA was run on a 1% native gel. Subsequently the gel was dried and 
exposed to film.
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RNase A buffer + +
RNase A -  +
dsRNA
ssRNA
FIG. 5. 8. Double stranded RNA species are synthesized in the RC. RNA replication assays 
were performed, the product RNA were extracted with phenol.chloroform-isoamyl alcohol and 
precipitated with ethanol. One quarter o f the isolated RNA was kept untreated and the rest of the 
sample were digested with 0.2 pg o f RNase A per ml in 0.3 M NaCl for 15 min at 23°C. The 
RNA samples were separated by gel electrophoresis using a native 1% TBE-agarose gel.
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double stranded RNA (RF) along with some of the replicative intermediate (RI) 
RNA species are resistant (FIG. 5.8).
5.8 All RNA species synthesized within the FMDV CRCs are protected from 
RNase A
To determine whether FMDV RCs remained inside or outside of the vesicle 
membrane structure, membrane fractions containing CRCs were treated with RNase 
A either with or without detergent treatment. As indicated in FIG.5.9, in the presence 
of detergent TritonX-100, the RNA was completely accessible to RNase A thus this 
treatment resulted in complete digestion of the bound RNA within the replication 
complexes. However in the absence of TritonX-100 nearly all RNA was protected 
indicating that the RNA synthesized within the replication complex was tightly 
bound inside the membrane vesicles (FIG. 5.9).
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FIG. 5. 9. Effects of Triton X-100 on RNA synthesis in vitro. In vitro RNA replication assays 
were carried out for one hour as described for FIG. 5.8. The total reaction mixture was spun down 
for 3 min at maximum speed. The supernatant containing un-incorporated nucleotide was discarded. 
The remaining membranous pellet was resuspended in 40 pi of RNase A digestion buffer by gentle 
pippeting. The resuspended pellet was treated with or without Triton X-100 as indicated and 
RNase A to a final concentration of 0.1 % and 1 mg/ml respectively. The reaction mixtures were 
incubated at 37°C for 30 min. RNA was extracted by Trizol method. 1/10* aliquot of the total 
RNA isolated was run in a native agarose gel .dried and exposed to a x-ray film.
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5.10 Discussion
The studies that have been performed here show for the first time the complete RNA 
replication events in vitro within the crude replication complexes (CRCs) isolated 
fi'om FMDV infected BHK21 cells. These events include the formation of the 
functional peptide primer VPgpUpU and subsequent positive and negative stand 
synthesis. In the absence of an authentic cell fr ee replication system for FMDV, this 
system mimics the replication events inside the cells and allows the dissection of 
individual steps in RNA replication. Usually an authentic cell fi'ee system is supplied 
with a saturating amount of virion RNA to initiate the complete replication cycle in 
vitro. However the current system described in this chapter utilises both de novo 
peptide primer (VPgpUpU) and endogenous virion RNA as a source of template 
RNA to initiate the replication cycle.
5.10.1 The production of VPgpUpU in vitro suggests true initiation of RNA 
synthesis
It has been demonstrated that FMDV is capable of utilising all the three copies of 
VPg/3B peptides as primer for RNA replication. This was achieved in viti'o using 
defined purified components as described in Chapter 3. As a matter of fact, the 
CRCs contain all the replication protein required for RNA replication including VPg, 
3Dpol, and 3CD. The presence within these CRCs of these non-structural proteins 
was established by western blot analysis of the membrane fraction using specific 
monoclonal antibodies directed against 3C and 3D protein (FIG. 5.2). So it should be 
able to synthesize the VPgpUpU using endogenous RNA template and VPg/3B 
peptide without any exogenous subsfrate. Indeed it was found that supplementation 
of these CRCs with an ATP generating system resulted in hue synthesis of
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VPgpUpU in vitro though in limited quantities (FIG. 5.4). However due to 
unavailability of specific antibodies against FMDV VPgl, VPg2 and VPg3 true 
identification of the copies of VPg that were uridylylated could not be ascertained.
5.10.2 The FMDV in vitro RNA replication assay support positive and negative 
strand synthesis
In the case of a complete RNA replication cycle within the cells negative strand 
synthesis follows VPgpUpU synthesis and subsequently the negative strand acts as 
template for the synthesis of positive strands. Previous studies have shown that 
within this system the majority of the RNA strands synthesized are of positive 
polarity (Takegami et al., 1983). We also suggest that most of the RNA synthesized 
in the FMDV in vitro replication assay could be of nm-off transcripts but de novo 
initiation of positive and negative stiand synthesis could not be ruled out. In the 
present system the experiment we have conducted is not capable of determining the 
polarity of RNA synthesis within this system. However evidence that supported the 
true initiation of negative sti and synthesis within this system was obtained and these 
could have been used as template for positive strand synthesis. The use of guanidine, 
a reversible inhibitor of picornavims RNA replication, in this system resulted in 
approximately 50% reduction in RNA synthesis suggesting that there are true events 
of initiation of negative strand synthesis. The fact that guanidine does not have any 
effects either on positive strand synthesis or elongation of the aheady initiated 
nascent negative strand synthesis support our conclusion that de novo initiation of 
negative and positive sti'and synthesis does occur in this system. Time course 
experiments of the 3hr CRCs showed that RNA synthesis could be detected as early 
as 5 min with the appearance of partially double stianded RNA molecules and
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mature single stranded RNA molecules (FIG. 5.6). The RNA synthesis reached a 
maximum at about 1 hr. We assume that within this time period there is initiation of 
negative strand synthesis that lead to appearance of RI and RF and mature positive 
strand synthesis. In fact we validated the presence of RI and RF by treating the total 
RNA isolated from these replication complexes with RNase A. As expected all the 
single stranded RNA molecules were completely degraded whereas all the double 
stranded (RI) and partially double stranded was resistant (FIG. 5.8).
5.10,3 The FMDV CRCs contain both structural and non-structural proteins
Analysis of the protein components of the CRCs showed the presence of non- 
structural proteins, both mature and precursor polypeptides, and also the presence of 
all the capsid proteins. This suggests that assembly of provirions and mature virions 
also takes place within the replication complexes once the positive sense progeny 
virion RNA molecules are formed. One of the interesting observations is the 
detection of 3BC protein in the membrane preparation with 3C monoclonal antibody 
which has been found earlier to be a precursor protein that undergoes uridylylation to 
form SBCpUpU (Chapter 4). At this stage we cannot say whether this uridylylated 
precursor is a cleavage product of the 3 ABC that is subsequently auto-processed to 
generate VPgpUpU, the true primer for RNA replication. Another important 
observation is, by 3.5 hrs of infection in the BHK21 cells, the structural capsid 
protein synthesis is at maximum (FIG. 5.3), this may explain the reduced RNA 
synthesis hom the 3.5 hi' CRCs preparation (FIG. 5.5) compared to the 3hr 
replication complex (FIG. 5.5). It appears that at three hours post infection the RNA 
replication is at a peak but by 3.5 hr the RNA production has decreased.
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5.10.4 The synthesis of FMDV RNA takes place inside of the replication 
complexes
Studies conducted on poliovirus have shown that replication-complex associated 
membrane stiuctures closely protect the replication intermediates (RI) rendering 
them resistant to the action of RNase A. However, the single stianded mature RNA 
molecules are located outside of the replication complex and are susceptible to the 
action of RNase A (Bienz et al., 1992). In contrast, similar' studies on hepatitis C 
virus (HCV) have suggested that the majority of the RNA remained protected against 
the action of the RNase A in the absence of detergent within the replication 
complexes (El-Hage and Luo., 2003). Addition of detergent resulted in solubilization 
of the replication complexes both with PV and HCV thereby rendering them 
susceptible to the action of RNase A (Bienz et al., 1992; El-Hage and Luo 2003). 
Our present work using FMDV CRCs showed that the single stranded, partially 
double stianded (RI) and double stranded RNA (RF) species synthesized within this 
system are completely resistant to the action of the RNase A in the absence of 
detergent TritonX 100 (FIG 5.9). High resolution autoradiography and in situ 
localisation studies have suggested that PV RNA synthesis proceeds on the outer 
surface of the vesicles and both positive and negative stiand RNA are found to be 
attached to the vesicular membrane (Bienz et al., 1987; Bolten et al., 1998). To date 
no such studies in FMDV have been carried out. Such studies might help in 
understanding the location of the RNA synthesis within the vesicular structures in 
the FMDV infected cells and may shed light into the completely resistant nature of 
the FMDV RNA.
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In summary, the ability of this system to support de novo synthesis of VPgpUpU 
followed by both positive and negative strands synthesis is promising with respect to 
studying FMDV replication in viti'o. This information should contribute to the 
development of a FMDV cell free system using RNA from infectious cDNA clones 
to recover infectious virions which will help in dissecting individual steps in FMDV 
RNA replication in vitro.
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CHAPTER SIX 
FINAL DISCUSSION
Foot and mouth disease is probably the most contagious disease of cloven footed 
livestock and wild mammals. The disease has the potential to spread very quickly 
with severe economic consequences. The replication of the virus is remarkably 
efficient and one of the most important aspects of FMDV is its ability to infect a 
wide range of hosts. In the recent past a great deal of importance has been given to 
looking at the epidemiology, pathogenesis and vaccine development. Very little 
attention has been paid to study the replication mechanism of the virus. In this 
project the emphasis has been to look specifically at the mechanism of replication at 
the molecular level.
In the picomavirus lifecycle during the course of RNA replication both positive and 
negative str ands are linked to the viral encoded peptide VPg (Paul 2002). In addition, 
in poliovirus infected cells, uridine linked VPg (VPgpUpU) is found in the 
cytoplasm (Ambrose and Baltimore 1978). This observation led to the impression 
that VPg peptide acts as a primer for both positive and negative strand synthesis. 
However only recently this became clearer when Paul et al (1998) showed, for the 
first time, that VPg peptide can be linked to uridine residues (a process called 
uridylylation) in vitro by the PV polymerase in the presence of poly(A) template. 
Subsequently it was shown that the cis-acting replication element {ere) acts as a 
better template for VPg uridylylation which provided fiirther validation for the role 
of the ere in RNA replication in vivo. In 2002, Mason et al demonstrated that for 
FMDV the ere is located in the 5’ non-coding region. No further work has been 
pursued since to elucidate the role of ere in priming the replication mechanism. In
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this chapter the replication mechanism of the FMDV RNA will be discussed 
including the identification of non-structural proteins and RNA elements that play 
important roles in FMDV replication along with the characterisation of the stiuctural 
and functional aspects of the replication complexes (RCs) that provide a platform for 
replication to occur.
6.1 VPg uridylylation and RNA polymerisation are two distinct functions of the 
FMDV polymerase enzyme (3Dpol)
Previous work with FMDV has shown that all the three copies of the FMDV VPgs, 
which are non-identical to each other, can be linked to the 5’ end of the RNA at 
almost equal frequency (King et al., 1980). Therefore it appears that all the three 
copies of VPg must be able to form phosphodiester bond with the terminal uridine 
residue of the viral RNA. It also generates the question whether all the three copies 
of VPg can be uridylylated in vitro with equal efficiency. To address these questions 
we developed an in vitro assay that measures the production of uridylylated form of 
the VPg peptide (VPgpUpU) using an un-tagged FMDV polymerase enzyme. It is 
interesting to mention that picomavirus polymerases constitute a class of polymerase 
in which the N-terminal segment forms an important component of the active site of 
the enzyme. It is now known that in the unmodified polymerase enzyme the N- 
terminus is buried in a pocket that encircles the active site (Hobson et ah, 2001; 
Ferrer-orta et ah, 2004). This interaction of the N-terminus with the active site 
determines the polymerisation activity. This is very much consistent with our 
observation that the N-terminal His-tagged version of the FMDV polymerase lacks 
the ability to uridylylate VPg in vitro. Whereas using an unmodified polymerase
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enzyme uridylylated VPg was produced very efficiently under identical conditions. It 
is noteworthy that although the N-terminal His-tagged polymerase enzyme is devoid 
of the uridylylation activity it still retains some RNA elongation activity. The native 
polymerase enzyme differed hugely in polymerization activity in response to the 
presence of divalent metal ions (Mg^VMn^" )^ in the polyU polymerisation reaction. 
The same enzyme showed no significance difference in the uridylylation ability in 
the presence of these different cations. These findings suggest that the RNA 
polymerisation activity and uridylylation activity are two distinct fiinctions of the 
enzyme perhaps conti'ibuted by different domains of the polymerase enzyme. The 
uridylylation activity is more likely to be dependent on additional interactions with 
other cofactors (eg. 3C) along with the catalytic activity of the enzyme.
6.2 Importance of VPg in RNA replication
In the FMDV uridylylation assay it was established that all the three copies of VPg 
can be uridylylated efficiently, though VPg3 was found to be the best substrate. 
Surprisingly, although PV VPg has little similarity with the three FMDV VPgs, it 
was still efficiently recognised as a substrate in the FMDV uridylylation system. In 
contrast, using the PV uridylylation system it was not possible to replace the PV VPg 
with FMDV VPg, This phenomenon was explained on the basis of the presence of 
negatively charged glutamic acids in the FMDV VPgs. Therefore it can be suggested 
that the overall charge of the VPg is also crucial for polymerase recognition and 
VPg-polymerase complex formation. It also makes sense to argue that amongst the 
VPgs, VPg3 is the best recognised substrate with formation of most stable complex 
with FMDV polymerase. This might be linked with the genetic evolution of the virus
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in which VPg3 is the closest in proximity to 3C and 3D the two essential viral 
proteins for VPg uridylylation and viral RNA replication. Therefore the earlier report 
of the loss of viability (Falk et al., 1992) of the vims with the deletion of the VPg3 in 
the viral genome which was explained as a consequence of a defect in polyprotein 
processing may also have resulted from the lack of primer function.
6,3 Precursor proteins could be a source of VPg for RNA replication
In all picornaviruses, polyprotein processing generates mature and precursor 
polypeptides that serve distinct functions in the virus life cycle (Leong et al., 2002). 
One of the important questions that arises is whether VPg needs to be cleaved from 
its precursor for uridylylation or whether the precursor form can first undergo 
uridylylation and then subsequent cleavage to liberate the uridylylated form of the 
VPg. It has long been suggested that 3AB might serve this frmction by acting as a 
source of VPg (Towner et al., 1996). 3CD brought about the cleavage of the 3AB 
thereby releasing 3B for uridylylation. We have shown for the first time that both 
precursor forms of the VPg (3 B3C and 3Bi2]3C) and VPg alone can be uridylylated 
in viti'o. Therefore we hypothesize that precursor proteins like 3AB, 3 B3C and 
3Bi233C, 3ABC, 3BCD might be source of VPg for uridylylation instead of 3AB 
alone.
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6.4 The cre/bus supported VPg uridylylation could be the source of VPgpUpU 
for both positive and negative strand synthesis
iI
!
At this juncture it is hard to explain how the entire process of VPg uridylylation I
occurs inside the cells. It appears that the poly(A) tail is not the primary template for
FMDV VPg uridylylation. The poly(A) segment might be involved in stabilization i
Iof the viral RNA inside the cell against the action of exonucleases by forming a
icomplex with polyA-binding protein (PABP). It is also possible that polyA-PABP j
RNP complex is involved in genome circularisation of the FMDV RNA by 
interacting with the 5’ end. Unlike other picornaviruses, the cre/bus is located in the 
5’ UTR and the accessibility of this template for VPg uridylylation is not defined.
One hypothesis could be that once the VPg-3Dpol complex forms, it translocates to 
the 5’ UTR for uridylylation. Another possibility is that, by long distance 
interactions, either by RNA-RNA or RNA-protein bridges, the cre/bus template is 
brought into close proximity with the VPg-polymerase complex. It can also be 
suggested that once a pool of VPgpUpU forms inside the cell this may be used for 
both positive and negative strand synthesis (summarized in FIG.6.1). This could 
explain the ability of the FMDV cre/bus to act in trans (Tiley et al., 2003). It was 
also determined that the sequences required for optimal FMDV VPg uridylylation 
reside solely in the 5’ UTR region.
6.5 FMDV S-fragment forms a binary complex with a cellular protein p48
In the FMDV uridylylation system the efficiency of the reaction was enhanced by 
100-fold when 3CD was added to the reaction. Similar observations have been
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FIG.6.1. Proposed model for FMDV RNA replication. The FMDV RNA once released into the cytoplasm 
the 5’end terminal VPg is cleaved by the cellular VPg unlinkage enzyme. Translation of the viral RNA 
produces the proteins that are required for RNA replication and capsid assembly. The FMDV cre/bus is 
functional in positive sense polarity and the anti-sense cre/bus is non-functional for priming VPg for 
uridylylation. The cre/bus in positive sense primes VPg uridylylation that generates a pool of VPgpUpU 
inside the cells. This VPgpUpU translocates to the 3’end of the viral RNA to form hydrogen bonds with 
the proximal 3’ end of the poly(A) tail to initiate nascent negative strand synthesis. The VPgpUpU from 
the cellular pool also primes the 3’end of the negative sense RNA by forming hydrogen bond with the 
terminal AA- residues to synthesize the nascent positive strand.
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reported in other picornaviruses including PV and HRV. The role of 3CD as an 
efficient cofactor in this reaction has been attributed to its RNA binding activity. It 
also seems that in FMDV system the RNA binding activity of the 3 CD/3 C 
contributes to this effect. Mutations of the arginine residues that are predicted to 
form the RNA binding motif of the FMDV 3C severely debilitated the uridylylation 
reactions. In PV, 3CD also forms a component of the biologically relevant ternary 
ribonucleoprotein (RNP) complex with the cloverleaf RNA that participates in PV 
RNA replication. The striking difference between FMDV and PV is the lack of a 
cloverleaf RNA in FMDV; instead a larger S-fragment is present at the 5’ end of the 
RNA. A definitive function for the S-fiagment in FMDV RNA replication has not 
been established. It has been hypothesized that the S-fragment at the 5’ end may 
prevent the degradation of the viral RNA through the action of exonucleases; a 
similar function has been assigned to the PV cloverleaf (Murray et al., 2001). 
However no supportive evidence has been presented in this regard for FMDV S- 
fragment. Our experiments suggest that FMDV S-fragment does not interact with 
FMDV 3CD or the polyC binding protein (PCBP1/PCBP2), these are the two factors 
that bind to the PV cloverleaf for negative stiand synthesis (Herold and Andino 
2001). However it is interesting to mention that FMDV S-fragment interacts with a 
cellular factor of molecular weight approximately 48 kilo Dalton (p48). Further 
identification and chai acterisation of this factor needs to be done.
6.6 FMDV replication complexes (RCs) are enzymatically active
Like other picornaviruses FMDV replicates inside the cell using membrane fractions 
derived fr om vesicular structures like the ER and Golgi (Moffat et al., 2005). A post-
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nuclear membrane fraction containing crude replication complexes (CRCs) derived 
fr om BHK 21 infected cells efficiently synthesized both positive and negative sense 
RNAs including replicative form (RF) and replicative intermediates (RI). The 
production of the functional peptide primer VPgpUpU was also detected in this 
system. These findings suggested that all the replication events can be mimicked 
using these replication complexes in vitro. It should be noted that unlike with PV 
(Bienz et al., 1992), FMDV crude replication complexes (CRCs) efficiently protect 
the newly synthesized virion RNA fr om the action of RNase A. This in viti’o RNA 
replication system can be a useful tool to dissect the individual steps in FMDV RNA 
replication in the absence of a true cell-fr'ee system for virus production as described 
for PV and EMCV (Molla et al., 1991; Svitkin and Sonenberg 2003).
6.7 Future directions
At present the above findings contributed to further understanding of the molecular 
biology of FMDV and more specifically of the RNA replication mechanism at the 
molecular level. At the same time still there are lot questions remaining to be 
answered.
6.7.1 Functional dissection of cre/bus RNA and poly(A) tail in FMDV RNA 
replication
It is interesting to mention that for FMDV, the poly (A) tail is an inefficient template 
for VPg uridylylation in the presence of Mg^^ in vitio. Since Mg^^ is the tiue 
physiological cofactor it could be the same phenomenon in vivo. Other findings like
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the replication of mutant PV lacking poly(A) tail, and the inability to detect
polymeric VPg species (VPgpUpUpUpUpUpU ) in the cytoplasm of the
picomavirus infected cells support the hypothesis that the poly (A) tail might not be 
the template for VPg uridylylation. On the contrary internal priming on the poly(A) 
tail could be the case where abortive VPg uridylylation takes place but terminating 
once two uridine residues added to the VPg (VPgpUpU) thereby allowing for the 
accumulation of VPgpUpU inside the cell. This might be an intrinsic property of the 
VPg-3Dpol complex to allow addition of only two uridine residues. If this is the case 
then there might be other cellular* mechanisms involved in this process as well. For 
instance if internal priming of the VPg takes place on a poly(A) template then there 
is every possibility of having shorter poly(U) tail in the negative stiand and 
consequently shorter poly(A) tail in the mature positive strand. However a definite 
length of the poly(A) tail is maintained in a particular virus during a particular virus 
life cycle. Hence the role of the poly(A) polymerase (PAP) a cellular enzyme come 
in to picture. These hypotheses could be fiirther clarified by using a cell-free 
replication system for FMDV. The role of the cre/bus in positive and negative stiand 
synthesis can be studied by using FL FMDV RNA with mutations or complete 
deletion of the cre/bus (A1A2A3) and further detecting the effects on positive and 
negative strand synthesis. If cre/bus is required for both positive and negative strand 
synthesis such mutations in the cre/bus should block the formation of VPgpUpU in a 
cell-free system. In addition the role of the poly(A) polymerase (PAP) in maintaining 
the length of the FMDV poly(A) tail and in RNA replication could be determined by 
depleting the PAP in a cell-free system with specific antibodies or siRNA approach.
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6.7.2 Defining the role of S-fragment in FMDV RNA replication
The FMDV S-fragment that forms the 5’ terminal 371 nt of the FMDV RNA is 
predicted to fold into a single haiipin stmctiire. The equivalent region in PV and 
HRV form the cloverleaf that folds into 4 domains and each domain has an important 
role in RNA replication including interactions with cellular protein (PCBP) and viral 
protein (3CD). For FMDV, the relevance of the specific interaction of a 48 kDa 
cellular protein (p48) to the S-fiagment in RNA replication needs to be investigated. 
For this identification of the protein (p48) need to be earned out. Once the 
identification is done it will be possible to clone and express the protein. Specific 
antibody could be raised against the protein to deplete the cell-fr ee system and which 
could then be programmed with FMDV RNA to see the effects. It will also be 
interesting to see if any specific interaction exists between FMDV 3 ’ UTR with any 
cellular protein in BHK SIO extiacts. The identification of such RNA-protein 
interactions at the 5’end and 3’end of the viral RNA will fiirther enhance the 
understanding of the role of cellular proteins in FMDV RNA replication and might 
also shed information regarding the interaction between 5’end and 3’end of the 
FMDV RNA a mechanism that has been proposed for replication o f PV.
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BUFFERS, SOLUTIONS AND REAGENTS
II.l Solutions for DNA Preparations and Analysis
LB Broth
Bacto-tiyptone lOg
Bacto-yeast extracts 5 g
NaCl lOg
dHzO 950ml
Adjust to pH 7 with 5M NaOH 
Adjust volume to IL
20% LB Glycerol
80ml LB 
20ml Glycerol 
Autoclave for 1 hour
TAE (50X) Buffer
242g Tris
57ml Glacial Acetic Acid 
100ml 0.5M EDTApH 8.0
Make up to 1L with dH20
Agarose Gel (1%)
Ig Agarose (Gibco) 
2ml TAE (50X) buffer 
98ml ddH20 
lOjal EtBr
LMP Agarose gel (0.5%)
0.5g LMP Agarose (Gibco) 
48ml ddH20 
1ml TAE (50X) buffer 
5 pi EtBr
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TFBl for making competent cells
30mM KO Ac 
50mM MnCla 
lOOmM KCl 
lOmM CaCl2 
15% Glycerol 
H2O to a volume of 50ml
TFB2 for making competent cells
lOmM Na-MOPS 
75mM CaCl2 
lOmM KCl 
15% Glycerol 
H2O to a volume of 50ml
TCM (I.IX)
IM Tris (pH 7.0) 11 pi
IM MgCl2 11 pi
IM CaCl2 11 pi
dH2Ü 967 pi
SOB medium
20g Bacto-tryptone 
5g Bacto-yeast extiact 
0.5g NaCl
Dissolve in 1 litre of water adding KCl to 2.5niM and adjust pH to 7.0 with NaOH, 
autoclave to sterilize and add sterile MgS0 4
SOC medium
SOB
20 mM Glucose
Ampicillin Stock (lOOmg/ml)
2g AMP (GniBH)
10ml H2O
10ml 100% Eton
Use at a concentiation of lOOpg/ml
X-Gal stock (80mg/ml)
Ig X-GAL (Roche)
12.5ml Dimethylformamide 
Use at a concentration of 40pg/ml
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Sequencing Stop Solution
1 OOmM EDTA (pH 7.0) 20pl
3M NaOAc 20pl
Glycogen (20mg/ml) lOpl
XIII Marker
XIII marker (500pg/ml) 2.5pl
6x load dye lOpl
dHzO 46.5pl
Run 5pl
II.2 Solutions for RNA Analysis 
lOX TBE
121 g Tris (Trizma base)
62g Boric acid 
18.6g EDTA
Make volume upto 1 liti'e with deionised water
lOM urea
Dissolve 60.06 gi’ams of urea in 100 ml of dH20
HEPES (IM)
Dissolve 1.191 giams in 5ml dH20, adjust the pH to 7.5
Gel Loading Buffer II
95% Formamide 
0.025% Xylene cyanol, 
0.025% Bromophenol blue 
18Mm EDTA 
0.025% SDS
FA gel buffer (lOX)
41.9 g MOPS
6.8 g Na-acetate,3H20 
20 ml 0.5 M EDTA
Adjust pH to 7.0 with NaOH
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FA gel running buffer (IL)
100 ml lOX FA gel buffer 
20 ml 37% (12.3M) formaldehyde 
880 ml RNase-free water
Electroporation buffer
21 mM HEPES, pH 7.0 
137 mM NaCl
5.0 mMKCl
0.7 mMNa2HP04
6.0 mM Glucose
Solution was prepared in RNase free water and filter sterilised
Probe/RNA elution buffer
0.2% SDS 
10 mM Tris 
1 mM EDTA
TN hypotonic buffer
10 mM Tris, pH 6.8 
10 mM NaCl
TENSK
100 mM NaCl 
10 mM Tris pH 8.0 
0.1 mM EDTA 
0.5% SDS
10 pg/ml Proteinase K
Low salt RNase A digestion buffer
10 mM Tris, pH 7.8 
5 mM EDTA 
100 mM NaCl
High salt RNase A digestion buffer
10 mM Tris, pH 7.8 
5 mM EDTA 
300 mMNaCl
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5% TBE-PAGE gel
1.7 ml 30% acrylamide:bisacrylamide
500 pi 1 OX TBE
Irai Glycerol
6.8 ml Deionised water
100 pi 10% APS (Ammonium per sulphate) 
5 pi TEMED
3X UV-cross linking buffer (1 ml)
30 pi IM HEPES 
105pl IMKCl 
6 pi IM MgCl2 
300 pi Glycerol 
15 pi 10% NP-40 
1.2 pi 1.25MDTT 
543 pi RNase free water
EMSA binding buffer (1 ml)
50 pi IM HEPES 
2 pi lMMgCl2 
80 pi Glycerol 
868 pi RNase free water
II.3 Media and solutions for Protein expression, purification and 
Analysis
NZCYM broth
Tryptone lOg
Yeast extract 5 g
Casamino acid Ig
NaCl 5g
MgS04 Ig
Dissolve 22.0 grams per liti'e of dH20 and autoclave
Lysis Buffer (for protein purification)
500 mMNaCl
50 mM Potassium phosphate, pH 8.0 
10 mM mercaptoethanol 
20% glycerol
40pi of Protease inhibitor cocktail (Calbiochem) 
0.1%NP40
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Buffer A (for protein purification)
50 mM Tris 
20% Glycerol 
10 mM pME 
0.1%NP40
10% running gel (20ml)
6,7ml Acrylamide (Sigma)
5.0ml 1.5MTris pH 8.8
7.9ml ddH20
200pl 10% SDS
200|il 10% APS
lOpl TEMED
5% stacking gel (5ml)
0.83ml Acrylamide (Sigma)
0.63ml IM Tris pH 6.8
3.4ml ddH20
50^1 10% SDS
50^1 10% APS
lOpl TEMED
SDS-PAGE running buffer
2&8g Glycine
6g Tris
2g SDS
Make final volume upto 2L witli dH20
Coomassie Brilliant Blue
Brilliant Blue G 5g
Destain 15 ml
Coomassie Brilliant Blue Destain Solution
Methanol 400ml
Glacial acetic acid 150ml
dHzO 1450ml
IPTG Stock (lOOmM)
IPTG 1.2g
dHgO 50ml
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Tricine gel buffer 0.5 litre (3M tris, 0.3% SDS, pH 8.45)
181.65g Tris
1.5 g SDS (adjust pH to 8.45 using HCl) 
mQ H2O up to 500 ml
Tricine cathode buffer 0.5 litre (lOX) (IM  tris, IM  tricine, 1% SDS)
60.55 g Tris
89.60 g Tricine
5.0 g SDS/50 ml 10% SDS
mQ H2O up to 500 ml
Tricine sample buffer
200 mM Tris-HCl (pH 6.8)
2% SDS 
40% Glycerol
0.04% Coomassie Brilliant Blue G-250
Western Blot Running Buffer
Glycine 28.8g
Tris base 6g
SDS 2g
dHzO 2L
Western Blot Transfer Buffer
Glycine 2 8.8 g
Tris base 6g
dHsO 1600ml
Metbanol 400ml
lOx TBS-0.1%Tween
Tris base 48.4g
NaCl 160g
dH2 0  1800ml
Adjust to pH to 7.6 witb HCl 
Tween-20 20ml
Make up to 2L witb dH20 
Dilute to Ix before use
Blocking Buffer
Marvel Milk 5 g
1X TB S-Tween 10 0ml
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Name Sequence (5’-3’)
3DFORBGL CCAGATCTGGGTTGATTGTGGACACCAGAGAT
3DREVSPH CCGCATGCCGCGTCACCGCACACGGCGTTCAC
3CFORBGL CCAGATCTAGTGGTGCCCCACCGACCGACTTG
C163FOR CACCAAGGCTGGTTACGGCGGAGGAGCCGTTC
C163REV GAACGGCTCCTCCGCCGTAACCAGCCTTGGTG
SacRmutFOR CAGGGTAAACGCCGTGGCGCGCTCATCGAC
SacIImutREV GTCGATGAGCGCGCCACGGCGTTTACCCTG
Ub3DpolSacII GCGCCGCGGTGGAGGGTTGATTGTGGACACCAGA
Ub3DpolBgHI GCGAGATCTTTACGCGTCACCGCACACGGCGTT
GC-cremut“FOR(Al-C) GAGGAGGACTTGTACCAACACGATCTAAACAG
GC-cr emut-RE V (A 1 -C) CTGTTTAGATCGTGTTGGTACAAGTCCTCCTC
GC-cremut-FOR(A2-C) GAGGAGGACTTGTACACACACGATCTAAACAG
GC-cremut-REV(A2-C) CTGTTTAGATCGTGTGTGTACAAGTCCTCCTC
GC-crenmt“FOR(A3-C) GAGGAGGACTTGTACAACCACGATCTAAACAG
GC-cremut-REV(A3-C) CTGTTTAGATCGTGGTTGTACAAGTCCTCCTC
GC-cremut-FOR(AlA2-C) GAGGAGGACTTGTACCCACACGATCTAAACAG
GC-cremut-REV(AlA2-C) CTGTTTAGATCGTGTGGGTACAAGTCCTCCTC
TTcreFOR AATTCTAATACGACTCACTATAGGGTCGCTTGAGGAGGAC
TTGTACAAACACGATCTAAACAGGTTTCCCCAACTGACCC
G
TTcreREV CTAGCGGGTCAGTTGGGGAAACCTGTTTAGATCGTGTTTG
TACAAGTCCTCCTCAAGCGACCCTATAGTGAGTCGTATTA
G
OlKcremut FOR(AIC) GAGGAGGACTTGTACCAACACGATCTATGCA
01Kcremut-REV(AlC) CTGCATAGATCGTGTTGGTACAAGTCCTCCTC
01Kcremut-FOR(A2C) GAGGAGGACTTGTACACACACGATCTATGCAG
01Kcremut-REV(A2C) CTGCATAGATCGTGTGTGTACAAGTCCTCCTC
01Kcremut“FOR(A3C) GAGGAGGACTTGTACAACCACGATCTATGCAG
01Kcremut-REV(A3C) CTGCATAGATCGTGGTTGTACAAGTCCTCCTC
F-OlKcreDEL GATTGTACTGAGAGTGCACCATATCGACGC
R-OlKcreDEL GTTTCACAGTAAAGCTGCCGTGCTGGGGTT
F-OlKcreDEL-overlap TTGAGGAGGACTTGTACCACGATCTATGCAGGTTTC
R-OlKcreDEL-overlap GAAACCTGCATAGATCGTGGTACAAGTCCTCCTCAA
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3Bi233CforSacII GCGATCTCCCCGCGGTGGAGGACCCTACGCCGGACCA
3B33CforSacII GCGATCTCCCCGCGGTGGAGGACCTTACGAGGGACCG
3BCrevBam HI GCGATGCGCGGATCCTTACTCGTGGTGTGGTTCGGGGTC
01K/3CF0R AATGGATCCAGTGGTGCCCCACCGACCGACTTG
01K/3CREV GACAAGCTTTTACTCGTGGTGTGGTTCGGGGTC
poly(C)-down-For CCCTAGCAAGTTTTACCGTCGTTCCCGACG
IRES/REV TGAGATCTGTTGTTTAAAAGAAAGGTGCCG
S-frag-FOR CCCTGCAGGAAAGGGGGCATTAGGGTCTC
S-frag-REV CCTCTAGACTAGCTGAAAGGCGGGCGCCG
A10/R92S/FOR CTCATGGTGCTTCACAGCGGGAACTGCGTGAGA
A10/R92S/REV TCTCACGCAGTTCCCGCTGTGAAGCACCATGAG
A10/R95S/FOR GTGCTTCACCGTGGGAACTCCGTGAGAGACATCACG
A10/R95S/REV CGTGATGTCTCTCACGGAGTTCCCACGGTGAAGCAC
A10/R97S/FOR CGTGGGAACTGCGTGAGCGACATCACGAAACAC
A10/R97S/REV GTGTTTCGTGATGTCGCTCACGCAGTTCCCACG
T7-cre31-FOR AATTCTAATACGACTCACTATAGGGACTTGTACAAACAC
GATCTAAACAGGTCCCCG
T7-cre31-REV CTAGCGGGGACCTGTTTAGATCGTGTTTGTACAAGTCCCT
ATAGTGAGTCGTATTAG
T7-cre37-FOR AATTCTAATACGACTCACTATAGGGAGGACTTGTACAAA
CACGATCTAAACAGGTTTTCCCCG
T7-cre37-REV CTAGCGGGGAAAACCTGTTTAGATCGTGTTTGTACAAGT
CCTCCCTATAGTGAGTCGTATTAG
OlKBclI TGCCAAACATTGTGATCATGATCCGTGAG
OlKBlpI TTGCAACCGACCGCTGAGCCAATTTGC
CREts303-FOR CTAAACAGGTTTCCCTAACTGACCCGCTAG
CREts303-REV GCTAGCGGGTCAGTTAGGGAAACCTGTTTA
pT7S3-Ribo-FOR TGGACTAGTTAATACGACTCACTATAGGGCCTTTCAACT
GATGAGGCCGAAAGGCCGAAAACCCCGTATCCGGGGTTC
TTGAAAGGGGGCATTAG
pT7S3-Ribo-REV GCGGCTAGCTGAAAGGCGGGCGCCGGGTG
01K/R92S/F0R GTGCTCCACAGCGGGAACCGT
01K/R92S/REV ACACGGTTCCCGCTGTGGAGC
01K/R95S/F0R CTCCACCGTGGGAACAGCGTGAGGGACATC
OIK R95S/REV GATGTCCCTCACGCTGTTCCCACGGTGGAG
01K/R97S/F0R CTCCACCGTGGGAACCGTGTGAGCGACATCA
OIK /R97S/REV TGATGTCGCTCACACGGTTCCCACGGTGGAG
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